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ABSTRACT

MOTOR PROTEIN REGULATION IN MAMMALIAN MITOSIS
MAY 2018
BARBARA JENKINS MANN, B.S. ROGER WILLIAMS UNIVERSITY
PhD., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Patricia Wadsworth
Developing and maintaining a multicellular organism relies on the fundamental
biological process of cell division, which ensures that genetic material is equally
segregated between daughter cells. During mitosis, cells completely rearrange their
cytoskeleton into a bipolar spindle through the concerted efforts of microtubules, motor
proteins, and microtubule-associated proteins, which cells must regulate spatially and
temporally to prevent errors such as chromosomal missegregation: a major cause of
cancer. Although the mitotic spindle is a validated target for chemotherapy drug
resistance and redundant pathways have highlighted the need for new targets. It is
therefore important to understand how proteins that help build and/or maintain the
spindle are regulated. Consequently, this dissertation focuses on the regulation of two
separate but somewhat redundant mitotic kinesin motor proteins, Eg5 and Kif15, in vitro
and in vivo.
In general, proteins are regulated several ways, including protein-protein
interactions and post-translational modifications. My data show that the C-terminal 37
amino acids of the microtubule-associated protein, TPX2, which were known to regulate
Eg5 localization, are also responsible for Kif15 localization. TPX2 inhibits Eg5 walking
on single microtubules by acting as both a brake and a roadblock but only inhibits Kif15
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as a brake. In vivo, dynamic microtubules are also involved in Kif15 behavior. These
results highlight the differences in the mechanisms that govern the regulation of these
motors. To further demonstrate this, I found that Eg5 activity is also regulated motor
domain phosphorylation by Src kinase. Eg5 phosphomimic mutations produce monopolar
spindles due to reduced Eg5 activity while non-phosphorylatable mutants result in
disorganized spindles. Together, these data suggest that phosphorylation of Eg5 must be
temporally regulated. Finally, using CRISPR/Cas9, I endogenously tagged Eg5 and
TPX2 with EGFP in HeLa cells and quantified protein distribution. My results differed
from reports using non-endogenous tags and reveal that Eg5 and TPX2 have distinct
spindle localization throughout mitosis with TPX2 absent in areas where Eg5 activity is
required. Additionally, I correlated fluorescence to protein concentration both locally and
globally in mammalian cells, which is the first step in developing models to understand
this complex biological process.
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CHAPTER 1

FUNCTION AND REGULATION OF KINESIN-5

1.1 Introduction

The main structural elements of the mitotic spindle are microtubules, hollow polar
filaments built from dimers of α/β tubulin. Spindle formation and function requires
numerous motor and non-motor microtubule-associated proteins (MAPs) that regulate the
nucleation, dynamics, and crosslinking of microtubules. In nearly every organism that has
been studied, a member of the Kinesin-5 family of motor proteins localizes to the spindle
(Fig. 1.1 A, B) and is required for spindle assembly (Blangy et al., 1995; Enos and
Morris, 1990; Ferenz et al., 2010; Goshima and Vale, 2003; Hagan and Yanagida, 1990;
Hoyt et al., 1992). Kinesin-5s function as bipolar homotetramers (Acar et al., 2013;
Gordon and Roof, 1999; Hildebrandt et al., 2006; Kashina et al., 1997; Sharp et al.,
1999a), and this structural organization allows the motor to crosslink and slide
antiparallel microtubules. Inhibition of kinesin-5 activity by genetic or chemical
perturbations results in monopolar spindles that fail to establish bipolarity, demonstrating
the critical role that this protein plays in cell division (Kapoor et al., 2000; Mayer et al.,
1999).
In many cell types, Kinesin-5 also contributes to spindle elongation in anaphase.
Anaphase is typically divided into two temporally overlapping sub-phases, anaphase A
and B (Fig. 1.1 E). In anaphase A, the distance between the kinetochores and the spindle
pole decreases as kinetochore fiber microtubules shorten by microtubule disassembly at
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kinetochores and/or spindle poles (McIntosh et al., 2012; Roostalu et al., 2010). During
anaphase B the distance between the two spindle poles increases as the spindle elongates
(Roostalu et al., 2010; Scholey et al., 2016). In many cells, spindle elongation occurs
when antiparallel microtubules slide relative to each other driven by kinesin-5. In some
cases, this sliding is accompanied by microtubule polymerization. In other cells, kinesin5 motors oppose outward pulling forces, acting as frictional brakes (Hu et al., 2011;
McIntosh et al., 2012; Scholey et al., 2016) (see section 1.4.4). Thus, despite variation
among different cells, kinesin-5 force production plays a key role.
Although Kinesin-5 has been studied for decades, new features of motor behavior
and regulation continue to be discovered. These studies provide insight into how the
motor is spatially and temporally regulated during mitosis, and how various properties of
the motor contribute to mitosis in diverse cells.

1.2 Kinesin-5 motile behavior

1.2.1 Kinesin-5 Motility
Kinesins with the motor domain located at the N-terminus of the protein, like
Kinesin-5, were originally shown to move toward microtubule plus-ends (Miki et al.,
2005; Sawin et al., 1992). Consistent with this, purified vertebrate Kinesin-5s walk
processively toward the plus-ends of microtubules with relatively short run lengths (~8
steps) (Fig. 1.1 C) (Kapitein et al., 2005; Valentine et al., 2006; Valentine and Gilbert,
2007). Additionally, because they are bipolar homotetramers, Kinesin-5s use both their
motor domains and non-motor tail domains to crosslink and simultaneous walk on two
microtubules, showing a preference for microtubules in the antiparallel configuration
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(Kapitein et al., 2008; Kapitein et al., 2005; van den Wildenberg et al., 2008; Weinger et
al., 2011) resulting in microtubules sliding. The ability to move microtubules relative to
each other is thought to be the key feature of kinesin-5 motors that enables bipolar
spindle formation and elongation. This feature also distinguishes kinesin-5 from other
kinesins, which typically transport vesicular cargos along the microtubule lattice. For
kinesin-5, the microtubule is both the cargo and track.
Despite the evidence that kinesin-5 is a plus-end directed motor, several groups
recently made the surprising discovery that kinesin-5s from budding and fission yeast
(Cin8, Kip1, Cut7) can move toward microtubule plus or minus ends using the same
motility mechanism; differences in motor concentration or ionic strength dictate their
directionality on microtubules (Britto et al., 2016; Edamatsu, 2014; Fallesen et al., 2017;
Fridman et al., 2013; Gerson-Gurwitz et al., 2011; Roostalu et al., 2011; Shapira and
Gheber, 2016; Shapira et al., 2017). For example, in vitro assays show that when
individual Cin8, Kip1, and/or Cut7 motors are observed either walking on or gliding
individual microtubules in vitro, they move in a fast (up to 360 nm/s), processive, minusend directed manner (Britto et al., 2016; Edamatsu, 2014; Fridman et al., 2013; GersonGurwitz et al., 2011; Roostalu et al., 2011; Thiede et al., 2012). As the concentration of
motors is increased, motor direction changes to the more canonical plus-end directed
(Figure 1.2 B). This result suggests that kinesin-5s work in mechanically coupled teams
(Fallesen et al., 2017; Roostalu et al., 2011; Shimamoto et al., 2015), although the
mechanism by which this behavior is controlled is not yet established.
In addition to motor number, ionic strength also affects directionality of Cin8,
Kip1 and Cut7. Minus end directed motility is observed under relatively high, close to
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physiological, ionic conditions (~200-300mM NaCl) (Thiede et al., 2012). As ionic
strength is lowered, plus-end directed motility is observed. Further, when engaged by
two antiparallel microtubules, motors switch direction and become less processive but the
net overall movement is plus-end directed, regardless of ionic strength. These data show
that when kinesin-5 is engaged between two antiparallel microtubules plus-end directed
motility is triggered (Thiede et al., 2012).
The Saccharomyces cerevisiae kinesin-5, Cin8, is unique because it has an extra
loop (Loop 8, 99 amino acids long) that is lacking in other kinesin-5 motors. When Loop
8 is deleted, Cin8 becomes unidirectional towards the minus end and can no longer
switch direction as ionic strength is lowered (Gerson-Gurwitz et al., 2011). Expression of
this mutant construct in yeast reduces both motility toward the spindle midzone, where
microtubule plus-ends are located and spindle elongation suggesting a role for directional
switching in anaphase (Gerson-Gurwitz et al., 2011). Further, this loop facilitates unique
binding of the motor to microtubules, which promotes clustering (Bell et al., 2017).
Sequence comparisons of kinesin-5 proteins from diverse organisms have identified
several domains unique to the yeast bi-directional kinesin-5 motors (Singh et al., 2018).
Future studies will likely reveal how these domains contribute to motor bi-directionality
and function in vivo and in vitro (Singh et al., 2018).

1.2.2 Tip-Tracking
The association of molecules with the plus-ends of microtubules is called tip
tracking; some proteins track microtubule tips autonomously while others bind to other
tip tracking proteins (e.g. EB family members) for tracking activity (Akhmanova and
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Steinmetz, 2008; Akhmanova and Steinmetz, 2010). Kinesins from several different
families can tip track including members of the kinesin-13, -8 and -14 families
(Akhmanova and Steinmetz, 2008; Honnappa et al., 2009). In vitro vertebrate kinesin-5s
are observed to move toward the plus-ends where they can remain attached (Fig. 1.1 C),
although these microtubules are non dynamic and are not thought to have the same
structural features as dynamic MTs (Balchand et al., 2015; Kapitein et al., 2005). The
Saccharomyces cerevisiae kinesin-5, Kip1, is one of the only kinesin-5 proteins that has
been shown to autonomously tip track (Fridman et al., 2013). Kip1 localizes to the
midzone in anaphase where it remains associated with the plus-ends of depolymerizing
microtubules eventually translocating to the spindle poles.
Kinesin-5 tip tracking has also been demonstrated using a dimeric Eg5-Kinesin-1
chimera composed of the kinesin-5 motor fused to the Kinesin-1 tail (Chen and Hancock,
2015). In in vitro assays, this chimeric motor protein was shown to both prevent
microtubule catastrophes and track growing ends. This result is in contrast to prior work
showing that in cells the yeast kinesin-5, Cin8, promotes catastrophes at plus-ends
(Gardner et al., 2008). Thus, kinesin-5 may act at microtubule plus-ends, but additional
work is needed to define this activity.

1.3 Kinesin-5 Phosphoregulation

Like many mitotic proteins, kinesin-5 localization and activation are controlled by
cell cycle regulated phosphorylation. Although kinesin-5 phospho-regulation is common
across organisms, the kinases and phosphatases, the phosphorylation sites, timing and
consequences of phosphorylation vary (Table 1.1).
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1.3.1. Tail Domain Phosphorylation
As mentioned, kinesin-5s are important for establishing spindle bipolarity and
therefore must localize to the spindle microtubules and spindle poles early in mitosis.
Kinesin-5s are generally not found on interphase microtubules (Blangy et al., 1995;
Sawin and Mitchison, 1995) except in certain specialized cell types such as neurons
where they contribute to microtubule organization (Falnikar et al., 2011; Kahn et al.,
2015; Myers and Baas, 2007). Kinesin-5 also localizes to interphase microtubules in
plants, but the function is unknown (Bannigan et al., 2007).
In dividing cells, kinesin-5s bind to mitotic microtubules for spindle formation
and this is regulated by phosphorylation within the tail domain. A conserved region
within the C-terminal tail, known as the ‘BimC box’, originally identified kinesin-5
family members (Ferenz et al., 2010). This BimC box contains a consensus Cdk1
phosphorylation site (Blangy et al., 1995) (Table 1.1). In H. sapiens, X. laevis and D.
melanogaster, phosphorylation of kinesin-5s tail domain by Cdk1 is required to localize
the motors to centrosomes and spindle microtubules early in mitosis (Blangy et al., 1997;
Blangy et al., 1995; Cahu et al., 2008; Goshima and Vale, 2005; Heck et al., 1993; Sawin
and Mitchison, 1995; Sharp et al., 1999a). Not only does Cdk1 phosphorylation regulate
microtubule interaction of kinesin-5s, but also facilitates interactions with other proteins.
For example, when Cdk1 phosphorylates HsEg5 early in mitosis it localizes to
centrosomes where it co-localizes and associates with the dynactin subunit p150 (Blangy
et al., 1997; Blangy et al., 1995). In C. elegans, Aurora B (AIR-2) kinase, not Cdk1, is
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responsible for phosphorylating the BMK-1 tail resulting in its localization to both the
mitotic and meiotic spindle microtubules (Bishop et al., 2005).
Interestingly, in fission yeast, the kinesin-5 Cut7 also contains the Cdk1
consensus site (T1011), however it is not required for spindle localization suggesting
divergent regulation (Drummond and Hagan, 1998). Neither of the budding yeast
kinesin-5s (Kip1, Cin8) contain the conserved Cdk1 site (Chee and Haase, 2010) that is
required for localization in other organisms; however, mass spectrometry analysis of in
vivo phosphorylation by Cdk1 identified alternate sites within the tail domain of Kip1 and
Cin8 (Table 1.1) (Chee and Haase, 2010). These sites do not affect protein localization;
however, phosphorylation is essential for protein function as corresponding nonphosphorylatable alanine mutations result in defects in spindle pole body (SPB)
separation (Chee and Haase, 2010).
The tail domain of HsEg5 is also phosphorylated by Nek6/Nek7 (Table 1.1) and
this is necessary for HsEg5 motor function and to establish spindle bipolarity (Bertran et
al., 2011; Rapley et al., 2008). Plk1 phosphorylates Nek9, which then activates
Nek6/Nek7, ultimately resulting in phosphorylation of kinesin-5 at S1033 specifically at
centrosomes (Bertran et al., 2011; Fry et al., 2017). Unlike the Cdk1 site, Nek6/Nek7
phosphorylation does not affect the ability of HsEg5 to bind microtubules, but regulates
spindle pole localization where phosphorylation is needed for motor activity specifically
to separate centrosomes (Rapley et al., 2008). The proposed model is that in prophase,
Cdk1 phosphorylation first localizes HsEg5 to the centrosome microtubules where it
accumulates. Then, Nek6/Nek7 can then phosphorylate the motor initiating centrosome
separation and ultimately spindle bipolarity (Bertran et al., 2011; Fry et al., 2017). Not
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only does Nek6/Nek7 phosphorylation regulate HsEg5 activity at poles but was also
recently found to facilitate interaction with the microtubule associated protein, TPX2,
(Eibes et al., 2017). Although TPX2 is predominantly nuclear in prophase, a centrosomal
pool is required for Eg5 localization and centrosome separation.

1.3.2. Motor Domain Phosphorylation
Once motors have been localized to the mitotic spindle, their activity must be
regulated and several studies have shown that phosphorylation of the motor head, near
the ATP binding pocket contributes to this regulation.
Motor domain phosphorylation was first demonstrated in D. melanogaster
kinesin-5, KLP61F, in which three tyrosine residues within the motor head are
phosphorylated by Wee1 (dWee1) Kinase (Table 1.1) (Garcia et al., 2009).
Phosphorylation at these sites is required for motor function and normal spindle
morphology. Embryos expressing a homozygous loss of function allele (klp61f3) have
spindle defects including monopolar spindles that could only be rescued by expressing
wild-type KLP61F (KLP61FWT), not a non-phosphorylatable (KLP61F3YF) mutant. These
embryos also showed dominant effects including extra microtubule organizing centers
(MTOCs) and abnormal microtubules.
One of the three tyrosine residues phosphorylated in D. melanogaster, Y207, is
conserved in mammalian cells (Y211) where it is also essential for normal spindle
formation (Bickel et al., 2017) (Chapter IV). However, in vitro kinase reactions show that
Src, not Wee1, is the kinase responsible for this phosphorylation (Table 1.1) (Bickel et
al., 2017) (Chapter IV). Although phosphorylation of these sites does not affect the
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motors ability to bind to microtubules, motor activity is altered. When phosphorylation is
mimicked at Y211 (Y211E), ATP hydrolysis and motor driven microtubule gliding both
significantly decrease. In cells, the same mutation results in monopolar spindles. Taken
together, this suggests phosphorylation renders the motor less active and thus unable to
produce sufficient outward force necessary for bipolarity. Conversely, a nonphosphorylatable mutation (Y211F) increases the prevalence of disorganized spindles
similar to those seen when Src specific inhibitors are used (Bickel et al., 2017) (Chapter
IV). These results suggest that motor activity is regulated by temporally specific
phosphorylation and dephosphorylation at this site.
In yeast, a different set of sites in the motor domain regulates activity and spindle
localization. Cdk1 phosphorylates Cin8 and Kip1 at several sites within the motor head
(Table 1.1) (Avunie-Masala et al., 2011; Chee and Haase, 2010; Gerson-Gurwitz et al.,
2011; Goldstein et al., 2017). One of these sites is a conserved consensus site between
Cin8 and Kip1 (S455 and S388 respectively) and is essential for proper spindle pole body
separation and cell proliferation. In Cin8, phosphorylation of S455 in combination with
two other sites in the motor head specific to Loop 8, regulate localization to the spindle
midzone in anaphase (Avunie-Masala et al., 2011). Non-phosphorylatable mutants fail to
localize to the midzone due to a weakened intereraction of Cin8 with the microtubule
resulting in faster minus-end directed motion (Gerson-Gurwitz et al., 2011).
Differential timing of Cdk1 phosphorylation at 3 different sites within the motor
head (Table 1.1) also regulates Cin8 localization to the anaphase spindle (Goldstein et
al., 2017). In early anaphase, phosphorylation of S277 causes Cin8 to detach from the
spindle pole bodies (SPBs) and move to the midzone. As anaphase progresses, S493 also
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becomes phosphorylated and further moves Cin8 from the SPBs to the midzone where it
helps regulate the rate of spindle elongation. Finally, as the cell enters late anaphase,
T285 phosphorylation occurs detaching Cin8 from the spindle because all 3 sites are
phosphorylated. This detachment was also observed in vitro, where a phosphomimic (3D)
mutant motor increased minus end directed motility, increased velocity and had a weaker
interaction with the microtubule (Shapira and Gheber, 2016). This is the only evidence of
phosphorylation regulating localization of a Kinesin-5 late in mitosis but further
investigations are needed in other systems to see if there is conservation.

1.3.3. Stalk Domain Phosphorylation
Aurora Kinase has been shown to phosphorylate Xenopus laevis Eg5 (XlEg5) in
the Stalk region (Giet et al., 1999) at S543 (Cahu et al., 2008). Though it was initially
suggested that this phosphorylation was essential, when the site was mutated to a nonphosphorylatable alanine, spindles were normal suggesting the opposite (Cahu et al.,
2008). There is a (putative) Aurora kinase consensus site in HsEg5 (S511) but no studies
have been done to investigate a potential role in mammalian mitosis.

1.3.4. Kinesin-5 De-Phosphorylation
Although phosphorylation sites and the kinases involved have been well studied
in kinesin-5s, less is known about the corresponding phosphatases. Two recent studies
looked at the phosphatase responsible for removing the phosphate at the HsEg5 Cdk1 tail
domain consensus site (T926) (He et al., 2016; Liu et al., 2017). The first identified was
PTEN phosphatase which interacts with HsEg5 in mitosis and regulates its
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dephosphorylation at T926 (He et al., 2016). Alternately, PP2A is also implicated in
removing the phosphate from T926, which then removes HsEg5 from the spindle later in
mitosis (Liu et al., 2017). In either case, cells fail to progress through mitosis when a
phosphomimic is expressed or when either phosphatase is depleted. Investigators have
just started looking into phosphatases and their role in kinesin-5 regulation.

1.3.5. Other Post-Translational Modifications
While the role of phosphorylation in localization and activity of kinesin-5 has
been well studied, other post-translational modifications are beginning to be explored. Of
note, a recent study found an acetylation site in the motor domain of Eg5 (L146) (Muretta
et al., 2018). This site forms a salt bridge with D91 which when disrupted using an
acetylation mimic (L146Q) results in coupling of the neck-linker with the catalytic
domain and causes Eg5 to act as a brake. Instead of the short run lengths seen under low
load (Valentine et al., 2006), the motor becomes dissociation resistant with an increase in
stalling. In vivo, this modification results in slower spindle pole separation due to this
braking ability. Further investigations might establish other post-translational
modifications that also result in changes to the motor behavior.

1.4 Physiological Roles

1.4.1. Bipolar Spindle Formation
As noted in section 1.1, perhaps the most conserved role of kinesin-5 family
members is to establish spindle bipolarity in early mitosis (Fig. 1.1 D). Although some
organisms do not require kinesin-5s for building a bipolar spindle (i.e. C. elegans,
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Dictyostelium), mitotic spindles fail to form when kinesin-5 is mutated or inhibited across
most organisms that have been studied (Bishop et al., 2005; Kapoor et al., 2000; Mayer et
al., 1999; Sawin and Mitchison, 1995; Tikhonenko et al., 2008). Accumulating evidence
suggests that regulation of kinesin-5 localization and activity as described above, is
responsible for this key function.
For example, although the discovery of minus end directed motility in yeast
kinesin-5 was surprising at first, several studies suggest that this behavior contributes to
spindle formation. Motor accumulation at spindle poles may increase the probability that
antiparallel microtubules from the opposite pole are captured, initiating sliding and
generation of the outward forces required for bipolarity (Saunders et al., 1997). Motor
clustering, like that seen by Cin8 (Bell et al., 2017), at minus ends could also contribute
to plus-end directed motility, allowing Cin8 to redistribute along the microtubules,
further indicating that motor directionality and reversal is important for establishing
bipolarity (Blackwell et al., 2017; Shapira et al., 2017).
Bi-directional motility has only been described for yeast kinesin-5 motors, but
kinesin-5 is enriched at spindle poles in other cells (Cheerambathur et al., 2008; Gable et
al., 2012; Sawin et al., 1992; Sawin and Mitchison, 1995; Uteng et al., 2008) (Chapter
V). Previous work showed that both X. laevis and Human Eg5 are transported toward
spindle poles (microtubule minus-ends) in a dynein/dynactin dependent manner (Gable et
al., 2012; Uteng et al., 2008), although the mechanism is not fully understood. In
mammalian cells, the microtubule associated protein, TPX2, regulates HsEg5 motor
stepping and localization to the spindle, and potentially couples Eg5 to dynein/dynactin
for minus end directed transport (Balchand et al., 2015; Eckerdt et al., 2008; Gable et al.,

12

2012; Ma et al., 2011) (Chapter II). A link between Eg5 and dynein/dynactin was
previously shown (Blangy et al., 1997) and an interaction between Dynein and TPX2 as
was previously suggested (Gable et al., 2012; Wittmann et al., 1998) but more work is
needed to establish a relationship and/or mechanism between these oppositely directed
motors. Recently, it was shown that TPX2 plays a role in localizing HsEg5 to
centrosomes in prophase (Eibes et al., 2017) via an importin-independent cytoplasmic
pool of TPX2 that localizes HsEg5 in a Nek6/Nek7 dependent manner (Table 1.1). Thus
in mammalian cells both transport and interactions with specific binding partners
contribute to kinesin-5 enrichment toward microtubule minus ends. Despite differences
in the mechanism of localization, we speculate that poleward accumulation in prophase
may serve to initiate microtubule sliding when antiparallel microtubules are encountered
(Fig. 1.1 D, D’), as in yeast spindles (Blackwell et al., 2017; Shapira et al., 2017).
A recent computation model has achieved bipolar spindle formation from an
initially monopolar configuration, using parameters from fission yeast (Blackwell et al.,
2017). In the model, bidirectional behavior of kinesin-5 motors was required for bipolar
spindle formation. Removing minus end motion entirely or including it for only single
heads bound to a microtubule prevented bipolar spindle formation (Blackwell et al.,
2017). These results support the idea that motor bidirectionality plays an essential
physiological role in spindle formation in this organism and potentially highlights the
need for a mechanism for pole localization/minus-end directed movement during bipolar
establishment in diverse cells (Fig. 2 A, B).
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1.4.2. Maintenance of Spindle Bipolarity
Although much of the work on kinesin-5 has focused on its essential role in
spindle formation, kinesin-5 is also needed to maintain spindle bipolarity in some
organisms (Hoyt, 1994; Kapoor et al., 2000; Saunders and Hoyt, 1992; Sharp et al.,
2000b; Sharp et al., 1999b). In vertebrate cells, spindles remain bipolar following
treatment with Eg5 inhibitors (Cameron et al., 2006; Ferenz et al., 2009b; Kapoor et al.,
2000) due to the action of kinesin-12 (Sturgill et al., 2016; Sturgill and Ohi, 2013;
Tanenbaum et al., 2009; Vanneste et al., 2009). In cells depleted of kinesin-12, a short
spindle phenotype is observed, demonstrating that the motor also contributes to outward
force production. Additionally, overexpression of kinesin-12 (Kif15) can drive spindle
formation in the absence of kinesin-5, although an alternate pathway for spindle
formation is used (Sturgill et al., 2016; Sturgill and Ohi, 2013). Interestingly, both
kinesin-12 and kinesin-5 are regulated by TPX2 suggesting redundancy in motor
regulation (Balchand et al., 2015; Drechsler et al., 2014; Ma et al., 2011; Mann et al.,
2017; Vanneste et al., 2009) (Chapters II &III). Kinesin-12 has been reported to exist as a
tetramer, although a dimeric form may also be functional (Drechsler and McAinsh, 2016;
Drechsler et al., 2014; Mann et al., 2017; Sturgill et al., 2014) (Chapter III). However,
kinesin-12 tetramers crosslink only parallel microtubules, aligning them into bundles
(Drechsler and McAinsh, 2016). Consistent with a conserved role for kinesin-12 in
establishment and maintenance of spindle bipolarity, kinesin-12 contributes to meiotic
spindle formation in C. elegans by sorting microtubules into an acentrosomal spindle
(Wolff et al., 2016).
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1.4.3. Kinesin-5s on Parallel Microtubules
As noted in section 1.2.1, although kinesin-5s act on antiparallel microtubules,
they can also crosslink parallel microtubules (Kapitein et al., 2005; Shimamoto et al.,
2015). Recent in vitro experiments showed that Eg5 can crosslink parallel microtubules
and generate braking forces that scale with motor number and microtubule overlap length
(Shimamoto et al., 2015). This idea of crosslinking parallel microtubules was also
suggested to be important for ensuring proper chromosome segregation in budding yeast.
Cin8 and Kip1 localize to kinetochore microtubules (kMTs) where they cluster the
kinetochores (Tytell and Sorger, 2006). Cin8 specifically crosslinks these parallel
microtubules creating bundles that help establish and maintain normal metaphase
spindles. Though kinesin-5 is enriched at the spindle poles in metaphase, where parallel
microtubules are located, (Mastronarde et al., 1993; Sharp et al., 1999a) evidence for a
specific role on these microtubules is lacking.

1.4.4. Kinesin-5s in Anaphase
Kinesin-5 motors also contribute to spindle elongation in anaphase in a cell type
specific manner. Anaphase cells are characterized by an array of overlapping antiparallel
microtubules in the interpolar region between the separating chromosomes (Ding et al.,
1993; Mastronarde et al., 1993; McIntosh and Landis, 1971; Winey et al., 1995) which is
established by antiparallel crosslinking microtubule associated proteins (i.e. Ase1/PRC1)
(Scholey et al., 2016). These antiparallel microtubules serve as a scaffold on which
kinesin-5s can act (Fig. 1.1 E).
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In some cells, kinesin-5 motors generate the force for spindle elongation. For
example, in budding yeast, Cin8 and Kip1 drive antiparallel microtubule sliding and the
contribution of each to anaphase is distinct. Kip1 plays a greater role in later anaphase
events than Cin8 ultimately allowing the spindle to increase up to 5 times its initial length
(Straight et al., 1998). Similarly, in D. melanogaster, KLP61F is required to generate the
sliding forces for anaphase B and spindle pole separation (Brust-Mascher et al., 2009;
Scholey et al., 2016).
In other cells, kinesin-5 activity is dispensable for anaphase B and in some cases
contributes antagonistic braking forces. In C. elegans, cells lacking the kinesin-5
homolog, BMK1, show faster elongation than wild type cells (Saunders et al., 2007). This
is also observed in pig epithelial cells, where acute treatment with kinesin-5 inhibitors at
anaphase onset results in faster spindle elongation (Collins et al., 2014). Finally, in
Dictyostelium discoideum, deletion of the kinesin-5 homolog, Kif13, causes premature
spindle pole separation and more extensive elongation (Tikhonenko et al., 2008). Thus
kinesin-5 in these systems is thought to act as a frictional brake, limiting the rate and
extent of spindle elongation (Shimamoto et al., 2015).
In some spindles, forces external to the midzone generate pulling forces to
elongate the spindle; in these cases, braking forces may be required to limit the extent of
elongation (Saunders et al., 2007; Tikhonenko et al., 2008). This is also the case in yeast,
where the Chromosome Passenger Complex (CPC) causes Kip1 and Cin8 to switch from
sliding to braking forces on the spindle countering pulling forces from astral microtubules
(Rozelle et al., 2011). Conversely, astral microtubules are not present or play only a
minor role in elongation and in these cells, active pushing forces from the midzone may
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be critical to achieve chromosome segregation (Brust-Mascher et al., 2009; Scholey et al.,
2016).
Thus, the contribution of kinesin-5 to spindle elongation varies with cell type.
There are several established roles for kinesin-5s in anaphase; however, in almost all cells
that have been examined, redundant mechanisms contribute to spindle elongation. This
redundancy is most evident in anaphase B where different motors, different mechanisms
and different regulation by maps have been described (reviewed (Scholey et al., 2016)).

1.5 Future Directions

Prior work has shown that outward forces generated by kinesin-5 are opposed by
inward forces generated by minus end directed motors (Saunders et al., 1997; She and
Yang, 2017). Disrupting the balance of forces by eliminating the activity of Eg5 leads to
dynein dependent spindle collapse (Ferenz et al., 2009b; Tanenbaum et al., 2008; van
Heesbeen et al., 2014). Interestingly, when both inward and outward motor dependent
forces are eliminated, bipolar spindles form (Mitchison et al., 2005; Sharp et al., 1999b).
Recent work demonstrated that in fission yeast this required the microtubule crosslinker
Ase1 (PRC1) suggesting that forces from crosslinked and growing microtubules are
sufficient for bipolar spindle formation in the absence of motors (Rincon et al., 2017).
However, precisely how the balance of inward and outward forces is achieved is not clear
in any system. Recent work, which directly measured force production by multiple
kinesin-5s, showed that both sliding and braking forces scale with motor number and
overlap length (Fallesen et al., 2017; Shimamoto et al., 2015). Further investigations are
required to understand how these parameters are regulated in vivo.
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Table 1.1 Phosphorylation of Kinesin-5
Region

Tail

Motor

Stalk

Organism

Kinesin-5

Kinase

Site(s)

Function

Reference(s)

Homo sapiens

Kif11/HsEg5

Cdk1

T926

Localization to Spindle
MTs

(Blangy et al.,
1997; Blangy et al.,
1995)

Homo sapiens

Kif11/HsEg5

Nek6/Nek7

S1033

Interaction with TPX2,
Localization to
Centrosomes & Motor
Activity

(Bertran et al.,
2011; Eibes et al.,
2017; Rapley et al.,
2008)

Xenopus laevis

XlEg5

Cdk1

T937

Localization to Spindle
MTs

(Cahu et al., 2008;
Sawin and
Mitchison, 1995)

Drosophila
melanogaster

KLP61F

Cdk1

T933

Localization to Spindle
MTs

(Goshima and
Vale, 2005; Heck et
al., 1993; Sharp et
al., 1999a)

Caenorhabditis
elegans

BMK-1

Aurora B

T921,
T922 &
T928

Localization to Spindle
MTs

(Bishop et al.,
2005)

Saccharomyces
cerevisiae

Cin8

Cdk1

S972

SPB separation defects

(Chee and Haase,
2010)

Saccharomyces
cerevisiae

Kip1

Cdk1

S1037 &
T1040

SPB separation defects

(Chee and Haase,
2010)

Phosphorylation results in
loss of MT gliding, reduced
ATPase activity,
monopolar spindles; No
phosphorylation results in
disorganized spindles

(Bickel et al., 2017)

Homo sapiens

Kif11/HsEg5

Src

Y125,
Y211,
Y231

Drosophila
melanogaster

KLP61F

dWee1

Y23,
Y152,
Y207

Monopolar Spindles

(Garcia et al.,
2009)

Saccharomyces
cerevisiae

Cin8

Cdk1

S277,
T285,
S493

Re-Localization from SPBs
to Midzone of Anaphase
Spindle followed by
detachment

(Goldstein et al.,
2017)

Saccharomyces
cerevisiae

Cin8

Cdk1

S239,
S247

Located in Loop 8,
Localization in anaphase,
pole-directed movements

(Avunie-Masala et
al., 2011; GersonGurwitz et al.,
2011)

Saccharomyces
cerevisiae

Cin8

Cdk1

S455

SPB separation defects,
failure to divide, cell death

(Avunie-Masala et
al., 2011; Chee and
Haase, 2010)

Saccharomyces
cerevisiae

Kip1

Cdk1

S388

SPB separation defects,
failure to divide, cell death

(Chee and Haase,
2010)

Xenopus laevis

XlEg5

Aurora A

S543

Direct interaction but
spindles appear normal
when not phosphorylated

(Cahu et al., 2008;
Giet et al., 1999)
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Figure 1.1 Kinesin-5 Localization and where it is acting. (A) Max projected images of
LLC-Pk1 cells immunostained for Eg5 (green) and MTs (red) through the stages of
mitosis. (B) Max projected images of live, HeLa cells stably expressing endogenously
tagged Eg5-EGFP (green) and labeled MTs (SiR Tubulin; magenta). (C) TIRF images of
Eg5-EGFP accumulating at microtubule plus ends. (D) Schematic of centrosome
separation in prophase. (D’) Zoom of Eg5 accumulation at spindle poles during prophase;
transported by Dynein/dynactin to microtubule minus ends at the pole. (E) Schematic of
anaphase. Scale bars in A and B = 10 μm. Scale bar in C = 1 μm.
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Figure 1.2 Kinesin-5 Motility and Engagement. Mammalian (A) and yeast spindle (B)
diagrams. Boxes highlight areas where Kinesin-5 motors are engaged and/or moving
within each respective spindle.
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CHAPTER 2

TPX2 INHIBITS EG5 BY INTERACTIONS WITH BOTH MOTOR AND
MICROTUBULE

This chapter is adapted from Balchand et al. 2015 and was completed with the guidance
of Patricia Wadsworth in collaboration with Sai K. Balchand, Janel Titus and Jennifer L.
Ross. JT cloned the TPX2 constructs expressed in Sf9 cells. Microtubule gliding,
microtubule-microtubule sliding assays, pelleting assays, and Mean Squared
Displacement (MSD) experiments were performed by SKB. Single-molecule TIRF
experiments and data analysis were performed in collaboration with SKB and JLR.

2.1 Introduction

Accurate chromosome segregation during cell division requires the assembly and
function of the mitotic spindle. The spindle is composed of a bipolar array of dynamic
microtubules that are required for chromosome alignment and segregation. Mitotic motor
proteins play important roles in regulating microtubule organization and dynamics and in
generating the forces required for spindle formation and chromosome motion. Despite the
characterization of many mitotic motor proteins, how their activity is regulated both
spatially and temporally in the spindle remains incompletely understood (Walczak and
Heald, 2008).
TPX2 is a conserved mitotic microtubule-associated protein (MAP) that was
originally identified as a protein required for the dynein-dependent targeting of the
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Xenopus kinesin Xklp2 to mitotic spindle poles (Wittmann et al., 1998). In mammalian
cells, TPX2 localizes to the nucleus in interphase and to the spindle in mitosis with an
enrichment near spindle poles (Garrett et al., 2002; Gruss et al., 2002). Depletion of
TPX2 using siRNA results in short bipolar or multipolar spindles that fail to progress
through mitosis (Garrett et al., 2002; Gruss et al., 2002). The N-terminus of TPX2 binds
and activates the mitotic kinase Aurora A, and is required to localize the kinase to spindle
microtubules (Bayliss et al., 2003; Eyers and Maller, 2004; Kufer et al., 2002). During
spindle formation, TPX2 is required for microtubule formation near kinetochores, an
activity that requires GTP bound Ran, which relieves the inhibitory action of importin
on TPX2 (Tulu et al., 2006). In addition, it has been demonstrated that the Cterminus of TPX2 binds to the bipolar kinesin Eg5 and targets the motor to spindle
microtubules (Eckerdt et al., 2008; Ma et al., 2010). Expression of TPX2 lacking the Cterminal 35 amino acids, which contribute to Eg5 binding, results in defective spindles
with greatly reduced Eg5 on spindle microtubules, unfocussed spindle poles and bent and
buckled microtubules (Ma et al., 2011).
Because Eg5 plays a critical and conserved function in establishing spindle
bipolarity, it is important to understand how this motor is regulated in the spindle.
Previous in vitro experiments have shown that purified TPX2 reduces the velocity of
Eg5-dependent microtubule gliding and microtubule-microtubule dependent sliding (Ma
et al., 2011). Eg5 accumulation on microtubules is enhanced in the presence of full
length TPX2, but less in the presence of TPX2 lacking the Eg5 binding domain (Ma et
al., 2011). These results directly demonstrate that TPX2 inhibits the ability of Eg5 to
translocate microtubules, but the mechanism of inhibition is not established. Here we use
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in vitro assays and single molecule TIRF microscopy to characterize the interaction of
TPX2 with microtubules and to examine the behavior of Eg5 in the presence of TPX2.
Our results demonstrate that TPX2 blocks Eg5 motility by both a direct interaction with
Eg5 and by binding to microtubules and acting as a roadblock. Using microtubule
gliding assays, we further show that dimeric, but not monomeric, Eg5 is differentially
inhibited by full-length and truncated TPX2. Our experiments provide new insight into
the microtubule-associated protein TPX2 and its regulation of the mitotic kinesin Eg5.

2.2 Results

2.2.1 TPX2 binding to microtubules
To examine the regulation of mammalian Eg5 by TPX2, we expressed and
purified full-length TPX2 and a truncated version lacking the C-terminal 35 amino acids
(referred to as TPX2-710) that mediate the interaction with Eg5 (Eckerdt et al., 2008; Ma
et al., 2011) (Fig. 2.1A). To characterize the microtubule binding of these proteins, we
performed microtubule co-sedimentation experiments. Both full-length TPX2 and TPX2710 co-sedimented with microtubules with apparent dissociation constants of 125 and
240 nM, respectively (Fig. 2.1B,C). Both full length and truncated TPX2 could be
released from the microtubule lattice by adding KCl to the buffer, with negligible binding
at 250 mM KCl. This demonstrates that, like other microtubule-associated proteins,
TPX2 makes ionic interactions with the microtubule lattice (Fig. 2.2A).
Microtubule-associated proteins are thought to make electrostatic interactions
specifically with the negatively-charged C-terminal E-hooks of tubulin, named for the
abundance of glutamic acid residues (Paschal et al., 1989). To determine whether the E-
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hooks are either a requirement for or facilitate TPX2 binding to microtubules,
polymerized microtubules were digested with the enzyme Subtilisin A to cleave off the
E-hooks and binding of TPX2 and TPX2-710 to control and digested microtubules was
measured. The results show that binding of full length or truncated TPX2 to
microtubules was not different for untreated, compared to Subtilisin digested,
microtubules (Fig. 2.2B).
To examine the interaction of individual molecules of TPX2 with the microtubule
we performed single molecule TIRF microscopy of Halo-tagged TPX2 full length and
TPX2-710. Individual molecules were stationary on the microtubule lattice and, at the
concentration examined, no enrichment at either end of the microtubule was observed.
The average dwell time of full length TPX2-Halo, measured from image sequences
acquired at 2 s intervals for 15 min, was 60.1 sec (Fig. 2.2C). The average dwell time of
Halo tagged TPX2-710 was 46.6 sec and was not statistically different from the Halo
tagged full length TPX2.
Together these results demonstrate that TPX2 binds to the microtubule lattice
with high affinity, and that the C-terminal 35 amino acids do not contribute significantly
to this interaction. Additionally, TPX2 does not require the tubulin E-hook for
microtubule binding, suggesting that other tubulin residues are responsible for the
interaction.
2.2.2 Functional Eg5 from mammalian cell extracts
We prepared cytoplasmic extracts (Cai et al., 2009) from a mammalian cell line
stably expressing full length, localization and affinity purification (LAP)-tagged Eg5
(hereafter Eg5-EGFP) expressed from a bacterial artificial chromosome under control of
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the native promoter (Cheeseman and Desai, 2005; Gable et al., 2012) (see Methods). The
concentration of Eg5-EGFP in the cell extracts was determined using Western blotting;
values of 20-60 nM were obtained depending on the extract (Fig. 2.3A). The
concentration of TPX2 in these cytoplasmic extracts was less than ~1 nM, consistent with
the localization of TPX2 to the nucleus during interphase (data not shown).
To analyze Eg5-EGFP motors in cell extracts, the extract was diluted into motility
buffer (Methods) to achieve a final motor concentration of ~ 1 nM. Diluted extract was
added to flow chambers containing rhodamine-labeled, taxol-stabilized microtubules
immobilized to the surface using anti-tubulin antibodies (Methods). Using TIRF
microscopy, bright puncta were observed to bind to the microtubules in the absence of
ATP. Upon addition of ATP, robust motility of nearly all puncta was observed (Fig.
2.3B). We observed an accumulation of motors at one end of most microtubules in the
field of view (Fig. 2.3B) indicating that motors remain associated with the microtubule
plus-end after motion. This is consistent with the previously observed tethering of
microtubules near the microtubule end in sliding assays using Xenopus Eg5 (see below)
(Kapitein et al., 2005). At higher motor concentration, microtubules were uniformly
coated with fluorescence, and individual puncta could not be resolved. The average
velocity of individual puncta was 14.7 ± 0.9 nm/s, (SEM, N = 205) similar to the velocity
of purified Xenopus and Drosophila Eg5 motors (Kapitein et al., 2008; Kwok et al., 2006;
van den Wildenberg et al., 2008) (Fig. 2.3D). The average association time of Eg5 with
the microtubules was not determined because motors rarely dissociated over the course of
a 10 min movie and longer movies resulted in photobleaching of individual puncta.
Finally, motor behavior was not altered following storage in liquid nitrogen for several

33

weeks, so a single extract could be used for multiple experiments, making this a robust
and versatile method for studying motor behavior (see Discussion).
To determine the directionality of motor motion, Kinesin-1-EGFP, a plus-end
directed motor, was added to the chamber and the direction of motion observed. Next,
the chamber was washed with 5 chamber volumes of ATP containing motility buffer, to
remove the Kinesin-1-EGFP, and Eg5-EGFP was added to the same chamber and motor
behavior was followed in the same field of view. In all cases, both Kinesin-1-EGFP and
Eg5-EGFP moved to the same end of the microtubule (Fig. 2.3C) demonstrating that the
motile puncta in the mammalian extract walk to the microtubule plus-end.
Next, we wished to determine if the Eg5-EGFP motors in the extract were present
as tetramers. Because the cells expressing Eg5-EGFP also express endogenous Eg5, the
motile motors could be composed of between 1 and 4 EGFP molecules. In this cell line,
the Eg5-EGFP is not resistant to the siRNA designed to deplete endogenous Eg5 (Gable
et al., 2012). Therefore, to estimate the number of labeled Eg5 motors in the motile
puncta, we depleted endogenous Eg5 from parental cells co-transfected with siRNA
resistant Eg5-mEmerald, and prepared cell extracts. The average fluorescence intensity
of Eg5-mEmerald puncta was measured and compared with the fluorescence intensity of
bacterially expressed Kinesin-1-EGFP dimers imaged under identical conditions (Fig.
2.3E). On average, the Eg5-mEmerald puncta were twice as bright as the Kinesin-1EGFP dimers indicating that Eg5 was predominately tetrameric. The increase in quantum
fluorescence yield of mEmerald alone is not sufficient to explain the nearly two-fold
increase in fluorescence intensity (Day and Davidson, 2009). Additionally, the siRNA
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may not deplete 100% of the endogenous Eg5, which could form tetramers with the Eg5mEmerald, resulting in decreased fluorescence of some puncta.
To determine if the Eg5-EGFP molecules function as tetramers, we examined the
ability of Eg5-EGFP from extracts to crosslink two microtubules. To do this we added
Eg5-EGFP to immobilized microtubules in a flow chamber and then added additional
microtubules. The added microtubules bound to the immobilized microtubules and were
translocated upon addition of ATP demonstrating that Eg5-EGFP was capable of
crosslinking and sliding microtubules (Fig. 2.3F). In addition, the moving microtubule
remained associated with the tip of the track microtubule, consistent with previous
observations (Kapitein et al., 2005). Together, these experiments demonstrate that Eg5EGFP from extracts is tetrameric (Fig. 2.3 E,F).
Next, we performed size exclusion chromatography on the extracts from LLCPk1 cells. Owing to the low abundance of Eg5-EGFP in our extracts, we used cells
overexpressing Eg5-mEmerald to aid in the detection. The western blots of the fractions
obtained show that Eg5-mEmerald elutes around the same fractions as the Eg5-EGFP
molecules, which are purified from SF9 insect cells, suggesting that the Eg5 molecules
obtained from cell extracts are tetramers (Fig. 2.3G)
To demonstrate that the bright motile puncta derived from the cell extract are Eg5
molecules, we added S-trityl-L-cysteine (STLC) or 2-[1-(4-fluorophenyl)cyclopropyl]-4(pyridin-4-yl)thiazole (FCPT) which specifically inhibit Eg5 (Groen et al., 2008;
Skoufias et al., 2006b). Each inhibitor completely stopped the motion of motile puncta
(Fig. 2.3H); in the presence of FCPT, motors remained bound to the microtubule lattice,
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whereas in the presence of STLC, motors stopped walking and in many cases were
released from the microtubule (Kwok et al., 2006) (Fig. 2.3H).
Eg5 has been shown to exhibit diffusive behavior on microtubules at
physiological salt concentration (Kwok et al., 2006; Weinger et al., 2011). To determine
if mammalian Eg5 present in diluted cell extracts showed similar diffusive behavior, we
added increasing concentrations of KCl to the motility buffer, and examined motor
behavior. At 20 mM KCl, the velocity of Eg5 was 12.1 nm/s, similar to that observed in
0 mM KCl, and the diffusion coefficient, D, obtained from plots of MSD over time, was
1588 nm2/s. At 50 mM KCl, motor velocity dropped to 3 nm/s and the value of D was
4556 nm2/s (Fig. 2.3I). These results demonstrate that motor processivity is dependent on
the ionic conditions, consistent with previous results using Xenopus Eg5 (Kapitein et al.,
2008; Weinger et al., 2011).
Together, our results show that Eg5-EGFP motors in mammalian cell extracts
behave in a manner similar to purified Xenopus and Drosophila Eg5 tetramers.
Specifically, the velocity, directionality, sensitivity to STLC and FCPT and diffusive
behavior in higher ionic strength buffer are all consistent with previously reported
properties of purified Xenopus and Drosophila Kinesin-5 motors. Somewhat surprisingly,
the behavior of mammalian Eg5 motors has not been previously examined. Our data
show that these motors are similar to insect and other vertebrate Eg5 motors and distinct
from kinesin-5 motors from yeast that show directional switching (Gerson-Gurwitz et al.,
2011; Roostalu et al., 2011). Importantly, the similar properties of the mammalian
motors strongly suggests that components that are present in the cell extract do not have a
major effect on motor behavior.
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2.2.3 Interactions of TPX2 with the microtubule and with Eg5 both contribute to
inhibition of motility
Previous work demonstrated that the gliding of microtubules by surface attached
Eg5 dimers is inhibited by TPX2 full length and to a lesser extent by TPX2-710 (Ma et
al., 2011). Full length TPX2 also inhibits Eg5 mediated microtubule-microtubule sliding
(Ma et al., 2011). In both of these assays, however, the behavior of populations of
motors is examined, so how individual Eg5 molecules are regulated by TPX2 was not
revealed. To gain a better understanding of the mechanism of inhibition of Eg5 by
TPX2, we performed single molecule experiments.
To determine the effect of TPX2 on Eg5 behavior, the cytoplasmic extract
containing Eg5-EGFP was diluted in motility buffer, added to chambers of immobilized
microtubules, and motors were imaged. Next, TPX2 was added to the chamber during
image acquisition (Fig. 2.4A). For these experiments, the velocity of motors following
addition of TPX2 is expressed as a percentage of the velocity prior to addition of TPX2.
The data show that full-length TPX2 is a potent inhibitor of the velocity of individual
Eg5 motors: at 250 nM, TPX2 reduced Eg5 velocity by 83% and at 50 nM Eg5 velocity
was reduced by 32% (Fig. 2.4B). To understand how the interaction of TPX2 with Eg5
contributes to motor inhibition, we repeated the experiment using TPX2-710. Addition
of TPX2-710 also substantially reduced the velocity of Eg5-EGFP indicating that
microtubule binding by TPX2 contributes to the reduction in motor velocity. At low
concentrations (50 nM) both TPX2 and TPX2-710 showed similar inhibition of Eg5
(32% and 24% respectively. However, at higher concentrations (250 nM) TPX2-710 was
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a less effective inhibitor of Eg5-EGFP than TPX2 full length (inhibition of 53% and
83%, respectively) (Fig. 2.4B).
The results further show that TPX2 reduces the velocity of Eg5-EGFP motors
without inducing dissociation of most motors from the microtubule (Fig. 2.4A) consistent
with the established role of TPX2 in targeting Eg5 to spindle microtubules (Ma et al.,
2011). In the presence of TPX2-710, more motors appeared to dissociate from the
microtubule, although photobleaching precluded accurate quantification. In some cases,
we saw that following addition of TPX2 to the motility chamber, motors from solution
associated with the microtubule, and these motors also moved with reduced velocity (Fig.
2.4A).
To confirm the specificity of the Eg5-TPX2 interaction, we added full length
TPX2-Halo covalently tagged with an Alexa 660 ligand to Kinesin-1-EGFP dimers in a
single molecule assay (Fig. 2.4C). Consistent with prior results from microtubule gliding
assays, TPX2 addition did not alter the motility of Kinesin-1-EGFP (11).
To visualize the interaction between Eg5 and TPX2 in the single molecule
experiments, we used TPX2-Halo covalently tagged with an Alexa 660 ligand (Fig.
2.4D). In this experiment, addition of TPX2-Halo (at 20 nM) reduced the velocity of
Eg5-EGFP. Analysis of kymographs showed that individual motors that encountered
TPX2-Halo walked at reduced velocity. In some cases a motor that has reduced velocity
can resume motion when it encounters an area of the microtubule that is relatively free of
TPX2 (Fig. 2.4D, right panels). Note that in this experiment, a lower concentration of
TPX2 was used because at higher concentration, fluorescent TPX2 coated the entire
microtubule surface.
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We also performed experiments in which 50 nM TPX2 or TPX2-710 was premixed with the motor in motility buffer before addition to the chamber. This method
allows Eg5 and TPX2 to potentially interact, and both molecules are introduced to the
chamber simultaneously (Fig. 2.4E,F). This experiment also showed greater inhibition of
Eg5-EGFP by the full-length compared to the truncated TPX2 (Fig. 2.4E,F).
Interestingly, pre-mixing full-length TPX2 with Eg5-EGFP resulted in greater inhibition
than when the same concentration of TPX2 was added to motors pre-bound to
microtubules (60% vs. 32% inhibition, Fig. 2.4B, F). This result indicates that when the
motor and TPX2 bind to the microtubule at the same time, stronger inhibition results. In
contrast, when TPX2 is added to motors already bound to microtubules, TPX2 can bind
to the microtubule at sites distant from the motors, and thus not immediately impact
motor velocity. Interestingly, in the case of TPX2-710, inhibition of Eg5-EGFP was
similar regardless of whether the motors were premixed or added sequentially (Fig. 2.4B,
F).
Finally, to exclude the possibility that adding a Halo tag to TPX2 affected the
TPX2-Eg5 interaction, we compared inhibition of Eg5 by untagged and Halo tagged
TPX2. As seen in Fig. 2.4F, inhibition of Eg5-EGFP by TPX2 was not changed by the
presence of the Halo tag demonstrating that the Halo tag was not detectably affecting
TPX2-Eg5 interaction (Fig. 2.4F).
Together, the results of these experiments demonstrate that Eg5 in cytoplasmic
extracts is inhibited by TPX2. Full length TPX2, which can interact with Eg5 and with
the microtubule, is a more potent inhibitor than TPX2-710, which lacks the Eg5
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interaction domain. However, by binding to the microtubule lattice, TPX2-710 also
substantially reduces the velocity of individual Eg5 puncta.

2.2.4 TPX2 differentially inhibits Microtubule gliding by Eg5 dimers, but not
monomers
To determine how Eg5-EGFP motors are inhibited by TPX2, we performed
microtubule gliding assays using Eg5 dimers and Eg5 monomers (Methods). Dimers
supported microtubule gliding at an average rate of ~20 nm/s. The velocity of gliding
was reduced to ~6 nm/s by 250 nM full length TPX2; addition of the same concentration
of TPX2-710 reduced the velocity of gliding to ~15 nm/s, demonstrating that TPX2-710
was a less effective inhibitor than the full length protein (Fig. 2.5A). This result
demonstrates that dimeric Eg5 retains the ability to interact with TPX2, consistent with
previous in vitro binding assays (Ma et al., 2011). In contrast, the velocity of
microtubule gliding driven by monomeric Eg5 was inhibited to a similar extent by either
full length or truncated TPX2 (Fig. 2.5B). It should be noted that the velocity of
microtubule gliding driven by monomeric Eg5 is approximately half the rate of the
dimeric construct, presumably due to the uncoordinated action of monomers. Further,
our results also show that monomer-driven microtubule gliding is inhibited at lower
concentrations of TPX2 or TPX2-710 (Fig. 2.5B). For example, addition of 25 nM TPX2
or TPX2-710 nearly completely halted microtubule gliding by monomeric Eg5 whereas a
20-fold greater concentration of TPX2 is required to result in a similar reduction in the
velocity of microtubule gliding by Eg5 dimers. The reason for this increased sensitivity
is not known, but may relate to the presence of a single motor head. These results
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suggest that the stalk region in the dimeric construct, or the dimer conformation, is
required for differential inhibition by TPX2 and TPX2-710.

2.3 Discussion

2.3.1 TPX2 binding to microtubules
The results of our experiments provide insight into the interaction of TPX2 with
the microtubule lattice. Our data show that TPX2 and TPX2-710 bind with relatively
high apparent affinity to microtubules; these results are similar to the previously reported
KD of 0.5

M for full length Xenopus TPX2 (Wittmann et al., 2000). The similar binding

of TPX2 and TPX2-710 suggests that the C-terminal region is not a major contributor to
microtubule binding, and instead interacts with the motor. The apparent affinity of TPX2
for microtubules is similar to other MAPs, including the dynein regulator, She1, MAP2
and Cep170 (Illenberger et al., 1996; Markus et al., 2012; Welburn and Cheeseman,
2012). The relatively strong interaction of TPX2 with the microtubule lattice is also
reflected in the long dwell time measured for individual TPX2 puncta using microscopy
(~60 s). Our experiments did not reveal a diffusive component to TPX2 behavior under
the conditions used. Under physiological ionic conditions, however, we expect that
TPX2 would bind less strongly to the microtubule lattice and could exhibit 1-D diffusive
behavior that is characteristic of many MAPs.
Somewhat surprisingly, our results show that the C-terminal tails of tubulin, the
E-hooks, do not contribute to TPX2 interaction with the microtubule. Other MAPs,
including Tau, She1, and XMAP215 require the tubulin E-hooks for microtubule binding
(Brouhard et al., 2008; Hinrichs et al., 2012; Markus et al., 2012). Additionally, the
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processivity of Kinesin-1 and dynein motors, and the diffusive end targeting of MCAK,
are enhanced by the E-hooks (Helenius et al., 2006; Thorn et al., 2000; Wang and Sheetz,
2000). The observation that the interaction of TPX2 with microtubules does not require
the E-hooks indicates that TPX2 binds to tubulin residues that are located between
protofilaments, as opposed to along the ridge where the E-hooks are located. This is
consistent with the observation that TPX2 does not inhibit single molecule motion of
Kinesin-1-EGFP dimers on microtubules (Fig. 2.4C) and previous work demonstrating
that TPX2 does not inhibit Kinesin-1 in a gliding assay (Ma et al., 2011). In contrast,
Tau, which binds along the outer ridge and requires the E-hook for lattice diffusion
(Hinrichs et al., 2012), induces the release of kinesin motors, including both Kinesin-1
and Eg5, from the microtubule. This suggests that the location of MAP binding to the
microtubule lattice results in differential effects on motor behavior (e.g. inhibition of
motility vs. release) (Ma et al., 2011).
The high affinity interaction of TPX2 with microtubules is consistent with its
established role in promoting microtubule assembly near kinetochores (Tulu et al., 2006)
and branched microtubules in the spindle (Petry et al., 2013). However, the interaction of
TPX2 with microtubules in cells is dynamic, as evidenced by its poleward motion in the
spindle (Ma et al., 2010). One possibility that can account for these differences is that
modifications, such as phosphorylation, or interactions with other binding partners, such
as dynein, regulate TPX2 dynamic behavior in cells.
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2.3.2 Functional Eg5 from mammalian cell extracts
Previous work showed that the behavior of motors present in extracts of cultured
mammalian or budding yeast cells is comparable to the behavior of the purified motor
(Cai et al., 2007; Gerson-Gurwitz et al., 2011). We found that the rate of Eg5-EGFP
stepping along the microtubule was ~14 nm/s in the plus-end direction, which is similar
to the values obtained for purified Xenopus or Drosophila Eg5. To our knowledge, our
results are the first report of single molecule data on the behavior of Eg5-EGFP tetramers
from a mammalian source, although the behavior of human Eg5 dimers has been
previously measured (Valentine et al., 2006). Mammalian Eg5-EGFP showed exclusively
plus-end directed motion at low salt and diffusive behavior at higher salt concentrations.
At the highest salt concentration that we examined, no processive minus-end directed
motion was detected, indicating that mammalian Eg5 does not show directional switching
like the yeast homolog, Cin8 (Gerson-Gurwitz et al., 2011; Roostalu et al., 2011).
There are several potential advantages to using motors present in mammalian
extracts for biophysical experiments. For example, the contribution of specific domains
or potential phosphorylation sites can be determined using extracts prepared from cells
transfected with fluorescent constructs encoding mutant versions of the protein of
interest. Similarly, to eliminate binding partners, or accessory subunits implicated in
motor regulation or function, cells can be treated with siRNA prior to preparation of the
extract. In addition, cells can be arrested at particular stages of the cell cycle prior to
preparation of the extract to determine how cell cycle-dependent modifications may
impact motor function. Finally, the ease of preparation and robust motile behavior
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demonstrate that biophysical measurements of motors from cell extracts is a powerful
tool for future experiments.

2.3.3 TPX2 inhibits Eg5 by interactions with both the motor and microtubule
The single molecule data presented here demonstrate that TPX2 has two modes of
inhibition for Eg5. Truncated TPX2 that cannot interact directly with Eg5, still bound to
the microtubule lattice and substantially reduced the velocity of Eg5. Full-length TPX2,
which binds to both the microtubule and the motor, was an even more potent inhibitor of
Eg5. These results show that both binding to the microtubule and to Eg5 contribute to
inhibition of the motor.
Our work is consistent with previous work demonstrating that MAPs can regulate
motor behavior. For example, Tau results in differential regulation of Kinesin-1 and
dynein; upon encountering a Tau patch, Kinesin-1 motors frequently detach from the
microtubule, whereas dynein motors are likely to reverse direction or pause (Dixit et al.,
2008). However, a direct interaction of either Kinesin-1 or dynein with Tau has not been
reported. Other MAPs function to target motors to microtubules. For example, Cep170,
is important for targeting the kinesin-13, Kif2b, to the spindle (Welburn and Cheeseman,
2012) and the yeast microtubule associated protein She-1 prolongs the attachment of
dynein to the microtubule in a stalled state in addition to inhibiting dynein motility
(Markus et al., 2012). In contrast, the MAP ensconsin recruits and activates Kinesin-1
(Sung et al., 2008) independent of microtubule binding by ensconsin (Barlan et al., 2013).
Recent in vitro experiments show that TPX2 inhibits the stepping behavior of the
kinesin-12, Kif15, the human homolog of Xklp2 (Drechsler et al., 2014). TPX2 enhances
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the binding of Kif15 to microtubules in pelleting assays and increases motor binding to
the microtubule under load in optical trapping experiments (Drechsler et al., 2014).
Purified Eg5 has been shown to detach from the microtubule before stalling (Korneev et
al., 2007), suggesting that TPX2 may function to increase Eg5 binding to the microtubule
under load, as is the case for Kif15. In mitotic cells, Eg5 and Kif15 act redundantly to
establish and maintain spindle bipolarity. Furthermore, minus-end directed forces
generated by cytoplasmic dynein antagonize force generated by these plus-end directed
motors. Though TPX2 slows Eg5 and Kif15 motion on microtubules, by increasing the
force generating capacity of these motors, it may play a key role in regulating forces
needed for spindle bipolarity.

2.3.4 Model for Regulation of Eg5 by TPX2
The data presented here are consistent with the following model for the regulation
of Eg5 by TPX2 (Fig. 2.5C): Eg5 motors step along the microtubule protofilament and
encounter TPX2, resulting in reduced velocity without inducing motor detachment from
the microtubule. Our data showing that TPX2 does not require the E-hooks for
microtubule binding suggest that TPX2 and Eg5 do not compete with each other for
microtubule binding. The differential slowing of the motor by full length and truncated
TPX2 demonstrates that binding of TPX2-710 to the microtubule is sufficient to reduce
motor velocity but that the C-terminus of TPX2, which interacts with Eg5, results in
stronger inhibition (Fig. 2.5C). This suggests that TPX2-710 acts as a slowing agent,
reducing velocity when encountered by Eg5 motors. Additionally, our data suggest that
the C-terminal domain may contribute to the retention of the motor on the microtubule
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(Ma et al., 2011). Although our experiments, and those of others (Drechsler et al., 2014),
clearly demonstrate that TPX2 greatly reduces motor stepping on the microtubule, the
TPX2-motor interaction must be regulated in live cells so that the motor can generate
sliding forces to establish and maintain spindle bipolarity. Discovering precisely how
this MAP-motor interaction is regulated spatially and temporally will provide important
insight into spindle function in vivo.

2.4 Materials and Methods

2.4.1 Materials
All chemicals, unless otherwise specified, were purchased from Sigma-Aldrich.

2.4.2 Cell culture
LLC-Pk1 cells were cultured in a 1:1 mixture of F10 Hams and Opti-MEM (Life
Technologies, Grand Island, N.Y.) containing 7.5% fetal bovine serum and antibiotics at
1X and 5% CO2. Cell extracts were made from LLC-Pk1 cells stably expressing LAPtagged Eg5 from a bacterial artificial chromosome (Gable et al., 2012). To prepare the
extract, a confluent 100 mm diameter cell culture dish was washed twice with 5 ml of
room temperature PBS. Then, 300 μl of extraction buffer containing 40 mM
HEPES/KOH pH 7.6, 100 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 μg/ml Leupeptin, 1
mg/ml pepstatin, 0.5% Triton X 100 and 1 mM ATP (Cai et al., 2007) was added
dropwise to the dish and incubated for approximately 2 min, without disrupting the
monolayer. The cell extract was transferred to a microcentrifuge tube and centrifuged at
14,500 RPM at 4°C for 10 min in a tabletop centrifuge. The supernatant was recovered

46

and aliquoted into small tubes, flash frozen and stored in liquid nitrogen. Protein
concentration was determined using the method of Lowry (Lowry et al., 1951). For
fluorescent intensity measurement experiments with Eg5-mEmerald, an siRNA resistant
Eg5-mEmerald construct was transiently co-transfected into LLC-Pk1 cells with siRNA
directed against endogenous Eg5 (target sequence CUGAAGACCUGAAGACAAU).
The extract was made 48 hours post transfection as described. For the extracts used in
size exclusion chromatography, siRNA treatment against endogenous Eg5 was omitted.

2.4.3 Construction of plasmids
For bacterial expression, desired nucleotide sequences of human TPX2 constructs
(full length or truncated at amino acid 710) were cloned into a pGEX vector following an
N-terminal GST tag and a ULP1 protease cleavage site (Markus et al., 2012). At the Cterminus of TPX2, the stop codon was removed and the Halo tag sequence was
introduced. Constructs were verified by sequencing. For expression in SF9 insect cells,
nucleotides coding for full length or the first 710 amino acids of human TPX2 were
cloned into the pFast Bac A vector after an N terminal 6X His tag and the constructs were
verified by sequencing. The virus for infecting the cells was obtained following the Bacto-Bac protocol (Invitrogen, Grand Island, NY). The plasmid for monomeric Eg5-367
containing the first 367 amino acids of human Eg5 was a kind gift from the laboratory of
Dr. Sarah Rice. The plasmid for the expression of dimeric Eg5-513 containing the first
513 amino acids of Eg5 was the kind gift from the laboratory of Dr. Susan Gilbert.
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2.4.4 Protein purification
Full length TPX2 and TPX2-710 were expressed and purified from Sf9 cells using
the Bac-to-Bac expression system (Invitrogen, Grand Island, NY). Infected cells were
harvested, washed with ice-cold water and resuspended in lysis buffer (50 mM potassium
phosphate pH 8, 250 mM KCl, 40 mM imidazole, 1% NP-40, 10 mM beta
mercaptoethanol, and a protease inhibitor tablet (Roche, Indianapolis, IN) on ice. The
lysate was spun at 125,000 x g for 45 min at 4°C. The supernatant was loaded onto preequilibrated Ni NTA agarose beads (Qiagen, Valencia, CA) and incubated for 90 min at
4°C with end-over-end shaking. The flow through was removed and beads were washed
with wash buffer (same as lysis buffer with 10% glycerol and 0.01% NP-40). The protein
was eluted with elution buffer (50 mM potassium phosphate pH 7, 150 mM KCl, 250
mM imidazole, 10% Glycerol, 10 mM beta mercaptoethanol, and 0.01% NP-40) and
dialyzed in a buffer containing 25 mM HEPES, pH 7.6, 10 mM KCl, 2 mM MgCl2, 10%
Glycerol, 0.01% NP-40 and 1 mM DTT for 4 hours at 4°C. Aliquots were flash frozen in
liquid nitrogen and stored at -80°C.
Full length TPX2-Halo and TPX2-710-Halo were expressed and purified from
E.coli Rosetta DE3 pLysS cells. In short, 500 ml of culture was grown to an optical
density of 0.5-0.8, induced with 0.1 mM IPTG at 18°C for 16 hours. The bacteria were
harvested and washed with ice-cold distilled water. The cell pellet was resuspended in 2X
lysis buffer (60 mM HEPES pH 7.4, 0.4 mM EGTA, 2 mM DTT, 1.4 μg/ml pepstatin, 1.0
mM Pefabloc, 4 μg/ml leupeptin, and 2 μg/ml Aprotinin), diluted to 1X with cold dH2O,
sonicated on ice (3X 30 s at maximum setting), and clarified at 15,000 x g for 20 min at
4°C. The supernatant was incubated for 1 hour at 4°C with Glutathione sepharose beads
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that were pre-equilibrated in lysis buffer. The beads were then washed 3X in wash buffer
(10% glycerol, 300 mM KCl, 0.1% Triton X-100, 1 mM DTT, 0.7 μg/ml pepstatin and
0.5 mM Pefabloc) and twice in TEV buffer (5 mM Tris pH 8.0, 150 mM KCl, 10%
glycerol, 0.1% Triton X-100, 1 mM DTT and 0.5 mM Pefabloc). The beads were
resuspended in TEV buffer and incubated with 23 μM Halo tag Alexa fluor 660
(Promega, Madison, WI) for 15-20 min at room temperature and then washed to remove
unbound ligand. The beads were then resuspended in TEV buffer containing Ulp1
protease and incubated at 16°C for 1 hr to cleave protein off the beads. The supernatant
containing the protein was collected by centrifugation and aliquots were flash frozen and
stored in liquid nitrogen.
Monomeric Eg5-367 was purified from E.coli as described in (Larson et al.,
2010). Briefly, 500 ml of bacteria was grown and induced at an OD of 0.5-0.8 with 0.1
mM IPTG and incubated at 16°C for 16 hours. The bacteria were pelleted and washed
with ice-cold water. The pellet was resuspended in lysis buffer (10 mM sodium
phosphate buffer pH 7.2, 20 mM NaCl, 2 mM MgCl2, 1 mM EGTA, 1 mM DTT, and 0.1
mM ATP with protease inhibitor tablet) and lysed by sonication. The lysate was clarified
by centrifuging at 15,000 x g for 30 min at 4°C. The supernatant was incubated with preequilibrated Ni NTA agarose beads for 90 min at 4°C. The beads were then washed in
wash buffer (same as lysis buffer containing 20 mM imidazole) and eluted in elution
buffer (same as lysis buffer with 300 mM imidazole). The eluate was then dialyzed
against buffer containing 20 mM HEPES pH 7.2, 5 mM magnesium acetate, 0.1 mM
EDTA, 0.1mM EGTA, 50 mM potassium acetate, 1 mM DTT, and 5% sucrose for 4
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hours at 4°C. Aliquots were flash frozen in liquid nitrogen and stored at -80°C. Dimeric
Eg5-513 was expressed and purified from E.coli exactly as described (Ma et al., 2011).

2.4.5 TPX2 co-sedimentation with microtubules
Unlabeled tubulin prepared from porcine brains (Hyman et al., 1991b) was
polymerized and resuspended in PEM 100 buffer containing 50 μM Taxol. 500 nM full
length TPX2 or TPX2-710 was incubated with indicated concentration of unlabeled
polymerized microtubules at room temperature for 10 min. The mixture was centrifuged
for 10 min at room temperature in a tabletop centrifuge at maximum speed. The
supernatant and pellet fractions were carefully separated. Samples for SDS
electrophoresis were prepared by boiling the samples with SDS protein sample buffer and
run on an 8% polyacrylamide gel. The proteins were then transferred to a PVDF
membrane and probed using antibodies against TPX2 (Novus Biologicals, Littleton, CO)
and tubulin (DM1A, Sigma-Aldrich). The blots were developed by chemiluminescence
and captured on a Biorad (Hercules, CA) imaging station. Analysis of band intensities
were performed using ImageJ. Data were plotted using KaleidaGraph and fit with a
quadratic equation (Markus et al., 2012). Subtilisin A treated microtubules were prepared
as described (Markus et al., 2012).

2.4.6 TPX2-Halo Microtubule Binding Assays
For TPX2-Halo binding experiments, first 10 μL of 10% Rat YL ½ (0.1 mg/ml)
anti-tubulin antibody (Accurate Chemical, Westbury, N.Y.) was added to the flow
chamber and incubated for 2 min. Second, 0.1 mg/ml Rhodamine-microtubules

50

(untreated or treated with Subtilisin A) were flowed in and incubated for 2 min. Third,
the surface was blocked by adding 5 % Pluronic F-127 and incubated for 2 min. For
assays done in epifluorescence, the chamber was incubated with the indicated
concentration of TPX2-Halo for 2 min in PEM 100, [100 mM K-Pipes, pH 6.8, 2 mM
MgSO4, and 2 mM EGTA] plus 0.5% Pluronic F-127, 50 μM taxol, 5 mM DTT, 15
mg/ml glucose, 1.23 mg/ml glucose oxidase and 0.375 mg/ml catalase). Salt (KCl) from
a 10 X stock of the working concentration was added directly to the buffer. Wide field
images were acquired with a constant exposure time. To measure dwell times of TPX2Halo and TPX2-710-Halo, experiments were performed using TIRF microscopy.

2.4.7 Eg5 single molecule experiments
The concentrations of Eg5 in the extracts were measured by quantitative Western
blots. For the single molecule experiments, the perfusion chambers were made from glass
slides, silanized coverslips and double stick tape. 10 μL of 10% Rat YL ½ anti-tubulin
antibody (Accurate Chemical, Westbury, N.Y.) was flowed into the chamber and
incubated for 3 min. Then, the chamber was blocked by flowing in 5% Pluronic F127 for
3 min. Diluted Cy5 labeled microtubules (composed of a mixture of Cy5 tubulin
(Cytoskeleton, Inc, Denver, CO) and unlabeled brain tubulin) were flowed into the
chamber and incubated for 3 min followed by a second block of 5% pluronic F127. Eg5
was diluted to 1 or 1.5 nM in motility buffer containing PEM 50 (50 mM Pipes pH 6.9, 2
mM EGTA, 2 mM MgSO4), 0.5% F127, 5 mM ATP, 1 mM DTT, 25 μM Taxol
supplemented with oxygen scavenging system (15 mg/ml glucose, 1.23 mg/ml glucose
oxidase and 0.375 mg/ml catalase) and flowed into the chamber and imaged. For pre-
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incubation experiments with TPX2, the indicated concentrations of TPX2 were added to
the motility buffer along with Eg5 in extract and incubated on ice for 2 min before
flowing into the chamber.

2.4.8 Kinesin-1 single molecule experiments
Perfusion chambers were made as described above. 10 μL of 10% Rat YL ½ antitubulin antibody, 5% pluronic F127, and diluted Cy5 labeled microtubules were added
sequentially and incubated for 5 min each. The chamber was washed with PEM 100 plus
Taxol. Kinesin-1 was diluted in PEM 100 with 10 mM DTT. This was then added to the
motility buffer (PEM100, 25 μM Taxol, 0.5% F127, 0.5 mg/mL BSA, oxygen scavenging
system, and 0.5 mM ATP) and flowed into the chamber and imaged. For experiments
with TPX2 addition, TPX2-Halo was diluted into the motility buffer (without Kinesin-1)
and flowed into the chamber during image acquisition.

2.4.9 Microtubule-microtubule gliding assays
Biotinylated, Cy5 labelled microtubules were immobilized on silanized coverslips
using anti-Biotin antibody (Sigma-Aldrich). The chamber was blocked using 5% F127.
Eg5-EGFP from extracts was preincubated with rhodamine labelled microtubules for 3
min and the mixture was flowed into the chamber. Finally, motility buffer was added
followed by acquisition on a TIRF microscope.
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2.4.10 Size Exclusion Chromatography
Eg5-EGFP was purified from SF9 insect cells as per manufacturer’s instructions
(Bac to Bac, Invitrogen, Grand Island, NY). The extract from LLC-Pk1 cells was
prepared as mentioned before. The Superose 6 10/300 GL column (GE Healthcare,
Pittsburgh, PA) was pre equilibrated with 10mM HEPES, pH7.6, 0.05% triton X100,
100mM NaCl, 1mM ATP before use. 100μL of the purified protein was loaded onto the
column and run at a constant flow rate of 0.2ml/min. The Elution profile of Eg5-EGFP
was directly followed by measuring absorbance at 488nm. For the size exclusion of LLCPk1 cell extracts, 175μL of cell extract was loaded on the column and run under identical
conditions. The collected fractions were separated by SDS PAGE, transferred to a PVDF
membrane and were probed for the presence of Eg5 using western blot.

2.4.11 Microtubule surface gliding assays
Perfusion chambers of approximately 10 μL volume were made using glass slides
and coverslips with a double stick tape spacer. For gliding assays with the Eg5-367
monomer, the chamber was incubated with anti-His antibody and 2 mg/ml BSA for 3 min
followed by two washes with motility buffer (80 mM PIPES pH 6.8, 2 mM MgCl2, 1
mM EGTA, 0.2 mg/ml BSA, and 150 mM sucrose). Then, the chamber was incubated
with Eg5-367 for 3 min and washed again with motility buffer. Finally, the activation
mix, consisting of motility buffer containing oxygen scavenging system, ATP, Taxol and
diluted Cy5 labeled microtubules was added and imaged on a Nikon TiE microscope
using epifluorescence. Surface gliding experiments with the dimeric Eg5-513 were
performed exactly as described in Ma et al (2011). For TPX2 addition experiments, the
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TPX2 constructs were added to the activation mix, incubated for 2 min on ice and the
flowed into the chamber.

2.4.12 Microscope Imaging and Analysis
TIRF microscopy was performed using a microscope (Ti-E; Nikon Instruments,
Melville, N.Y.) equipped with a 60X 1.4 NA objective lens. The system was run by
Elements software (Nikon Instruments, Melville, N.Y.). Images were acquired using a
512 x 512–pixel camera (Cascade II; Photometrics, Tuscon, AZ). A 4X image expansion
telescope in front of the camera was used. The micron-to-pixel ratio was 68.5 nm/px. A
blue diode laser (488 nm, 50 mW) was used. Images were acquired every 2 or 3 seconds
for 10 min. For two color TIRF, a 488 nm argon laser and a 647 nm diode laser were
used on a custom built TIRF system on a Nikon TiE stand, run by Elements software. A
60X objective lens was used; exposure times for both red and green illumination were 50100 ms. Wide field Imaging for Eg5-513 gliding assays, and for binding of TPX2-Halo to
microtubules, was performed using epifluorescence illumination.

2.4.13 Quantification of gliding velocity, single molecule velocity and MSD
The velocity of Eg5-513- and Eg5-367-dependent microtubule gliding movement
was calculated using the MTrackJ plugin in ImageJ. To calculate the velocity of Eg5EGFP single molecules from TIRF images, ImageJ was used to generate a kymograph of
moving molecules. Velocities were calculated by manually tracking individual puncta.
The data were ported to excel and a polynomial 2 trendline was added to the MSD vs
time plot to determine D.
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Figure 2.1 Binding of TPX2 and TPX2-710 to microtubules. (A) Schematic diagram
of the TPX2 constructs (left) and Commassie Brilliant Blue stained gel of the purified
proteins (right). (B) Co-sedimentation of TPX2 with microtubules; S-supernatant; Ppellet. Concentration of microtubules in each pair of lanes is noted above. Western blots
stained for TPX2 or tubulin. (C) Quantification of apparent affinity was performed using
a quadratic fit. Experiment was performed twice and the values averaged; Error Bars =
standard deviation.
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Figure 2.2 Binding Dynamics of TPX2 and TPX2-710. (A) Box plot showing release
of TPX2 and TPX2-710 from microtubules in the presence of the indicated concentration
of KCl added to the buffer. TPX2 fluorescence reported as AU = arbitrary units.
Whiskers define the range, boxes encompass 25th to 75th quartiles, lines depict the
medians. (B) TPX2 and TPX2-710 binding to untreated and Subtilisin A digested
microtubules; (upper panels) fluorescence images of TPX2-Halo or TPX2-710-Halo
bound to untreated and Subtilisin A digested microtubules; (middle) quantification of
TPX2 fluorescence; (lower) polyacrylamide gel showing digested and control
microtubules. TPX2 fluorescence measured for at least 60 microtubules for each of two
independent experiments; error bars = SD. (C) Kymograph of TPX2-Halo and TPX2710-Halo on microtubules. Vertical scale (time) is 60 s; horizontal scale bar is 2 μm.
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Figure 2.3 Characterization of Eg5 in mammalian cell extracts. (A) Western blot of
cell extract and purified Eg5. (B) Schematic diagram of the single molecule TIRF
experiments (left) and TIRF images of Eg5-EGFP accumulating at the microtubule plusend (right). (C) Kymographs of Kinesin-1 EGFP dimers and Eg5-EGFP from extracts on
the same microtubule. Note the different time scale. Plus and minus ends of the
microtubules are indicated. (D) Histogram of Eg5-EGFP motor velocity. (E) Histogram
of the fluorescence of Kinesin-1 dimers (light gray) and Eg5 molecules (dark gray) in the
extract. (F) Schematic diagram (left) and fluorescence images (right) showing
microtubule-microtubule sliding by Eg5. Arrowhead marks the end of the sliding
microtubule. (G) Coomassie Brilliant Blue stained gel of Eg5-EGFP purified from insect
cells and the trace of absorbance at 488nm on the size exclusion column for the purified
protein. The western blot shown is for the fractions obtained from size exclusion
chromatography of Eg5-mEmerald from LLC-Pk1 extract probed for Eg5. (H)
Quantification of the velocity of Eg5-EGFP after addition of DMSO, STLC or FCPT
(right). Error bars = SEM. (I) Directional and diffusive motility of Eg5-EGFP in the
presence of 0, 20 or 50 mM KCl added to the motility buffer. Kymographs (upper) and
mean squared displacement (lower). Horizontal scale bar in B, C, F, I is 1 μm; vertical
scale bar in I is 60 s. Vertical scale in C is provided on the image.
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Figure 2.4 Inhibition of Eg5 by TPX2 requires both binding to the microtubule and
an interaction between TPX2 and Eg5. (A) Kymographs of Eg5-EGFP before and
following addition of TPX2 or TPX2-710; arrowhead marks time of TPX2 addition. (B)
Quantification of Eg5-EGFP velocity; error bars = SD. (C) Kymograph of Kinesin-1
EGFP dimers walking on microtubules before and after addition of TPX2 (arrowhead). 1
nM Kinesin-1 EGFP (green) and 500 nM TPX2-Halo (red) were used. (D) Kymographs
of Eg5-EGFP (green) before and following addition of 20 nM TPX2-Halo (red). Right
panels show enlarged view. (E) Kymographs of Eg5-EGFP that was pre-mixed with
TPX2-Halo or TPX2-710-Halo. (F) Quantification of Eg5-EGFP velocity in the presence
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of 50 nM TPX2 that was Halo tagged (left) or untagged (right). Error bars = SEM.
Horizontal scale bars in A, C, E are 1 μm; horizontal scale bar in D is 2 μm; vertical scale
bar in A,D,E is 60 s and is 5 s in C.
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Figure 2.5 Differential regulation of Eg5 dimers, but not monomers, by full length
and truncated TPX2. Velocity of microtubule gliding driven by (A) Eg5 dimers or (B)
Eg5 monomers. Error bars show SEM. (C). Model for inhibition of Eg5 by TPX2. Top
shows inhibition of motor stepping by full length (left, stop symbol) and truncated TPX2
(right, slow symbol) in single molecule assays. Lower panels show inhibition of
microtubule gliding by Eg5 dimers (top) and Eg5 monomers (bottom). Eg5 - green;
TPX2 - orange.
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CHAPTER 3

REGULATION OF KIF15 LOCALIZATION AND MOTILITY BY THE CTERMINUS OF TPX2 AND MICROTUBULE DYNAMICS

This chapter is adapted from Mann et al. 2017 and was completed with the
guidance of Patricia Wadsworth and in collaboration with Sai K. Balchand. PW
generated the GFP-Kif15 LLC-Pk1 cell line used for live cell experiments and extracts
for single-molecule TIRF microscopy. Live cell imaging and analysis were performed in
collaboration with SKB and PW.

3.1 Introduction

During mitosis, microtubules are nucleated and organized into a dynamic
structure called the mitotic spindle, which mediates chromosome segregation into two
daughter cells. In mammalian cells, microtubule nucleation at centrosomes, near
chromatin and from pre-existing microtubules all contribute to spindle formation
(Meunier and Vernos, 2016). Microtubule formation near chromatin and at kinetochores
is regulated by nuclear localization sequence containing spindle assembly factors that are
inactive when bound to importins α/β (Gruss and Vernos, 2004). The small GTPase
Ran, which is locally activated near chromatin (Kalab et al., 2006), binds to importin β
and relieves this inhibitory effect, thus promoting microtubule formation. A well-studied
Ran-regulated spindle assembly factor is TPX2, which stimulates microtubule formation
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at kinetochores and in the chromatin region and is required for spindle assembly and
completion of mitosis (O'Connell et al., 2009; Tulu et al., 2006).
During spindle formation the duplicated centrosomes separate to establish spindle
bipolarity. Centrosome separation is driven by the Kinesin-5, Eg5, a bipolar, tetrameric
motor which crosslinks and slides antiparallel microtubules (Ferenz et al., 2010; Kapitein
et al., 2005). More recently it has been shown that following bipolar spindle formation
the action of Eg5 is dispensable and spindle bipolarity is maintained by a Kinesin-12,
Kif15 (Tanenbaum et al., 2009; Vanneste et al., 2009). Spindles in cells depleted of
Kif15 are shorter than spindles in control cells, consistent with a model in which Kif15,
like Eg5, generates outward force in the spindle (Sturgill and Ohi, 2013). However, in
contrast to Eg5, Kif15 preferentially associates with kinetochore fiber microtubules.
Cells overexpressing Kif15 can form a bipolar spindle in the absence of Eg5 activity
(Raaijmakers et al., 2012; Sturgill and Ohi, 2013; Tanenbaum et al., 2009). The existence
of two mitotic motors that can each power bipolar spindle formation may contribute to
the lack of efficacy of Eg5 inhibitors in clinical trials and understanding how these
motors are regulated may therefore be of clinical significance (Waitzman and Rice,
2014).
Localization of Kinesin-12 and Kinesin-5 motors to spindle microtubules requires
TPX2 (Ma et al., 2011; Tanenbaum et al., 2009; Vanneste et al., 2009). In fact, TPX2
was initially discovered as a factor required for the dynein-dependent targeting of the
Xenopus Kinesin-12, Xklp2 to spindle poles (Wittmann et al., 1998). The C-terminal 37
amino acids of TPX2 are required to target Eg5 to the spindle; targeting of Kif15 requires
the C-terminal leucine zipper of the motor (Wittmann et al., 1998). The C-terminal half
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of TPX2 is required to localize Kif15 to the spindle (Brunet et al., 2004) but if a specific
domain of the protein is necessary is not yet known.
These initial studies on TPX2 and Kif15 were consistent with the idea that dimers
of Kif15 walked along one microtubule while tethered to a second microtubule via TPX2,
thus generating force for spindle formation (Vanneste et al., 2009). Subsequently,
Sturgill et al. provided biochemical data showing that the motor was an autoinhibited
dimer and identified a second, non-motor microtubule binding site in the coil 1 region of
Kif15 (Sturgill et al., 2014). These data led to a model in which autoinhibited Kif15
dimers were first unmasked and then bound to microtubule bundles via motor and nonmotor binding sites (Sturgill et al., 2014). More recent work, however, has shown that
Kif15 exists as a tetramer which displays processive motility along individual
microtubules in vitro (Drechsler et al., 2014; Dreschler and McAinsh, 2016). Thus, the
oligomeric state of Kif15, and how it contributes to mitotic spindle formation remain
unresolved. Finally, experiments using dynamic microtubules in vitro show that Kif15
accumulates at microtubule plus-ends and suppresses catastrophe events, can crosslink
microtubules and move them relative to one another, promoting the formation of parallel
microtubule arrays (Dreschler and McAinsh, 2016). Thus, both Eg5 and Kif15 contribute
to spindle bipolarity and are regulated by TPX2, but their mechanism of action is distinct.
To gain insight into the cellular function and regulation of the Kinesin-12, Kif15,
we investigated the behavior of the motor and its regulation by TPX2 in vitro and in vivo.
Our data show that Kif15 motors, present in diluted mammalian cell extracts, are
processive, track-switching tetramers and that the C-terminal region of TPX2 is required
to inhibit Kif15 motor stepping. Using a knockdown rescue approach in mammalian
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cells, we further demonstrate that the C-terminal region of TPX2 contributes to targeting
the motor to the mitotic spindle and that Eg5-independent bipolar spindle formation by
overexpressed Kif15 requires the TPX2 C-terminal region. In live cells, GFP-Kif15
displays robust, plus-end directed motility at a rate similar to that of microtubule growth,
and this behavior is suppressed by Paclitaxel. Together these results document the
behavior of Kif15 in cells and demonstrate the importance of TPX2 and its C-terminal
region for motor localization and activity.

3.2 Results

3.2.1 TPX2 C-terminus is required for Kif15 targeting to spindle microtubules
The C-terminal 37 amino acids of TPX2 contribute to the targeting of the
Kinesin-5, Eg5, to spindle microtubules (Ma et al., 2011), but if this domain contributes
to the targeting of the Kinesin-12, Kif15, to the spindle is not known (Brunet et al., 2004;
Tanenbaum et al., 2009; Vanneste et al., 2009; Wittmann et al., 1998). To address this,
we first examined the distribution of endogenous Kif15 in LLC-Pk1 cells expressing fulllength TPX2 or TPX2-710, which lacks the C-terminal 37 amino acids, from bacterial
artificial chromosomes (BAC), and depleted of the endogenous protein using siRNA (Ma
et al., 2011). Cells were fixed and stained for microtubules and Kif15 at 40 hours
following nucleofection with TPX2 siRNA, a time when the majority of TPX2 is
depleted (Fig. 3.5A) (Ma et al., 2011). Kif15 was present along spindle microtubules in
parental LLC-Pk1 cells, but not in parental cells depleted of TPX2 (Fig. 3.1A). In LLCPk1 cells expressing full-length TPX2 or TPX2-710 from a BAC, and depleted of
endogenous TPX2, Kif15 was detected on spindle microtubules when full-length TPX2
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was present and was reduced when TPX2-710 was expressed (Fig. 3.1A). Quantification
of the ratio of Kif15 to microtubules at the spindle pole and in the spindle, midway
between the chromosomes and pole, shows a statistically significant reduction at both
locations in cells expressing TPX2-710, as compared with cells expressing full-length
TPX2 (Fig. 3.1C). As previously reported (Ma et al., 2011), expression of TPX2-710 in
cells depleted of TPX2 resulted in aberrant spindle morphology (Fig. 3.1B). These results
demonstrate that for both Eg5 and Kif15, the C-terminal domain of TPX2 contributes to
spindle targeting.

3.2.2 Full-length TPX2 inhibits Kif15 motor velocity
Next, we wished to determine if the C-terminal domain of TPX2 was required to
regulate Kif15 motor stepping in vitro. To do this, we transfected LLC-Pk1 cells with
full-length Kif15 tagged with EGFP (hereafter GFP-Kif15) (Vanneste et al., 2009) and
used these cells to prepare cytoplasmic extracts for use in single molecule total internal
reflection fluorescence (TIRF) microscopy experiments (Fig. 3.2A) (Balchand et al.,
2015; Cai et al., 2007). Rhodamine-labeled, Paclitaxel stabilized microtubules were
attached to the surface of a microscope flow chamber and cell extract, diluted in motility
buffer, was added (Methods). Fluorescent puncta were observed to bind to microtubules
and processively move upon addition of ATP (Fig. 3.2B, C, G). Notably, nearly every
GFP-Kif15 puncta that bound a microtubule was motile, demonstrating that Kif15 from
mammalian cells is not autoinhibited (Sturgill et al., 2014), but displays robust motility.
TPX2 is undetectable in these cytoplasmic extracts because they are prepared from
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asynchronous cells, >95% of which are in interphase, a time when TPX2 is located in the
nucleus (Balchand et al., 2015).
GFP-Kif15 was observed to move predominantly in a plus-end directed manner
(86% of events) with a smaller percentage of events toward the minus-end (see Methods)
(14% of events) (Drechsler et al., 2014) (Fig. 3.2B). The average velocity of plus-end
directed motion was 128.7 nm/sec while the velocity of minus-end directed motion was
slower, 86.6 nm/sec. Motility was processive with average run lengths of 1.9 and 0.9
microns in the plus- and minus-end directions, respectively (Fig. 3.2B). In addition to
directional reversals, Kif15 motors moving on one microtubule could switch to a
neighboring microtubule and continue processive motility (Fig. 3.2C). In extracts
prepared from LLC-Pk1 cells arrested in mitosis with a low concentration of nocodazole
(Methods), motor velocity (151 nm/sec, n = 54, 53 plus- and 1 minus-end directed) was
not different from that measured in interphase, with the caveat that TPX2 is present in
these extracts. Interestingly, minus-end directed motility was reduced in the mitotic
compared with interphase extract. This data suggests that in in vitro assays motor
microtubule affinity is sufficiently strong to overcome any potential mitotic regulation
(vanHeesbeen et al., 2016). This possibility is consistent with the observation that Eg5
prepared from interphase extracts, and thus lacking the mitosis specific phosphorylation
that is required for spindle microtubule binding (Blangy et al., 1995) shows robust
motility in vitro (Balchand et al., 2015).
Kif15 has been previously reported to exist as a tetramer or dimer using purified
motors (Drechsler et al., 2014; Sturgill et al., 2014), or motors in mammalian cell extracts
(Dreschler and McAinsh, 2016; Sturgill et al., 2016). Understanding the quaternary
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structure of the molecule is significant because tetramers can potentially interact with
more than one microtubule simultaneously, and because formation of tetramers could
potentially alter the availability of a second microtubule binding site in the motor tail
(Sturgill et al., 2014). To determine the oligomeric state of GFP-Kif15 in our
experiments, we acquired images of purified Kinesin-1-GFP, which is known to be a
dimer, and GFP-Kif15 using identical imaging conditions and using only motors that
bound to microtubules. For this experiment, endogenous Kif15 was depleted from the
cells prior to preparation of the extract, so that the motors would be composed
predominantly of the expressed GFP-tagged protein (Fig. 3.5B). As shown in the
histogram in Fig. 3.2D, bottom), Kif15 puncta showed a range of fluorescence intensities
with an average intensity that was 1.6X the average fluorescence intensity of Kinesin-1GFP (Fig. 3.2D, top) (average fluorescence of 220.5 and 141.0 A.U.). The reason that the
average value was not twice the intensity of Kinesin-1-GFP may result from incomplete
depletion of endogenous Kif15 by siRNA (Fig. 3.5B), resulting in a mixture of motors
containing two, three or four GFP-tagged motors. Additionally, some motors may
dissociate into dimers during preparation (Drechsler et al., 2014; Sturgill et al., 2014;
Sturgill et al., 2016). We also imaged GFP-Kif15 in the absence of ATP and counted
bleach steps. We observed at least three discreet bleach events for approximately half of
the particles (Fig. 3.2E) consistent with at least some of the GFP-Kif15 existing as a
tetramer under these conditions. To determine if Kif15 exists as a tetramer in mitosis,
mitotic extract was added to microtubules in chambers without ATP and the number of
bleach steps counted. In this experiment, we observed particles with greater than three
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bleach steps for more than half of the particles (Fig. 3.2E) demonstrating that in both
interphase and mitotic extracts some of the Kif15 motors exist as tetramers.
In summary, these data show that GFP-Kif15, prepared from mammalian cells,
moves rapidly and processively toward microtubule plus-ends and can both switch
microtubule tracks and reverse direction. The motile parameters of Kif15 prepared from
mammalian cells are strikingly similar to motors prepared from Sf9 cells and indicate that
the native state of Kif15 in interphase and mitotic mammalian cells is likely a tetramer
(Drechsler et al., 2014) that can dissociate into dimers depending on the experimental
conditions (Drechsler et al., 2014; Dreschler and McAinsh, 2016; Sturgill et al., 2014;
Sturgill et al., 2016).
To identify the region, or regions, of TPX2 that regulate Kif15 motility in vitro,
TPX2 was incubated with diluted extract containing GFP-Kif15, and then introduced into
the motility chamber. When full-length TPX2 was present in the reaction, motor velocity
was reduced to ~65% of controls (Fig. 3.2F and G). Next, we added TPX2-710 which
binds microtubules (Balchand et al., 2015) and contributes to motor targeting (Figure 1)
to determine if it also regulates motility in vitro. Incubation of TPX2-710 with GFPKif15 prior to addition to the motility chamber did not result in a statistically significant
reduction in motor velocity (Fig. 3.2F and G) demonstrating that full-length TPX2 is
required for motor inhibition. Two additional constructs, one lacking a larger C-terminal
region (TPX2-657) and one containing a deletion of a conserved PFAM domain near the
C-terminus (TPX2 ΔPFAM) (Fig. 3.5C) also failed to inhibit Kif15 (Fig. 3.2F and G).
The lack of inhibition with the ΔPFAM construct, which is missing only part of the
region deleted in TPX2-710, indicates that these nine amino acids may play a role in
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motor inhibition. Both TPX2-657 and TPX2 ΔPFAM bound microtubules following
expression in mammalian cells that were depleted of endogenous TPX2 (Fig. 3.5D)
demonstrating that failure to inhibit Kif15 did not result from failure of these proteins to
bind microtubules. In summary, these experiments show that full-length TPX2 is required
to inhibit Kif15 motor stepping in vitro.

3.2.3 TPX2 is required for bipolar spindle formation in cells overexpressing Kif15
Previous work has shown that bipolar spindle formation can proceed in cells
lacking Eg5 activity and overexpressing Kif15, demonstrating that Kif15 can generate
force for spindle formation in vivo (Sturgill and Ohi, 2013; Tanenbaum et al., 2009). To
understand how TPX2 contributes to Kif15-dependent spindle formation in vivo, we
examined spindle formation in LLC-Pk1 cells overexpressing GFP-Kif15. In these cells,
the distribution of GFP-Kif15 on spindle microtubules was similar to the distribution of
Kif15 in the parental cells, showing a punctate staining pattern with enrichment along
kinetochore fiber microtubules and near spindle poles (Fig. 3.3A). This distribution is
equivalent to that observed in Xenopus cultured cell spindles (Wittmann et al., 2000) and
similar to the distribution in other cultured mammalian cells (Sturgill and Ohi, 2013;
Tanenbaum et al., 2009; Vanneste et al., 2009). Western blots of an extract of GFP-Kif15
cells show that GFP-Kif15 is present at approximately 10X the level of endogenous
Kif15 in the parental cells (Methods) (Fig. 3.3B).
First, we asked if TPX2 is required for Kif15 localization in the overexpressing
cells. Treatment with siRNA targeting TPX2 resulted in a dramatic reduction in GFPKif15 on spindle microtubules and an ensuing increase in the level of cytoplasmic
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fluorescence (Fig. 3.3C). In some cells, residual GFP-Kif15 was detected near spindle
poles (Fig. 3.3C). These results demonstrate that TPX2 contributes to the localization of
GFP-Kif15 to spindle microtubules, even when high levels of the motor are present.
In control cells, Kif15 is enriched on kinetochore fiber microtubules (Sturgill and Ohi,
2013) and when overexpressed Kif15 binds and stabilizes non-kinetochore microtubules
as well, where it is thought to play a key role in Eg5-independent spindle formation
(Sturgill and Ohi, 2013). We asked if kinetochore fiber microtubules are needed for
Kif15 localization in LLC-Pk1 GFP-Kif15 cells. In cells depleted of Nuf2, a treatment
that prevents kinetochore fiber formation (Fig. 3.6), GFP-Kif15 remained associated with
the spindle (Fig. 3.3C, left) despite the loss of kinetochore fibers and concomitant failure
of chromosome congression (Fig. 3.3C, right). We also tested the requirement for
kinetochore fibers for Kif15 localization in parental cells by depleting Nuf2 and staining
for Kif15; in these cells the spindle localization of Kif15 is reduced, but not completely
abolished, consistent with previous observations (Vanneste et al., 2009). Together these
results show that overexpressed GFP-Kif15 is distributed in a manner similar to that of
the endogenous protein and that TPX2, but not kinetochore fibers, is required for spindle
localization.
To examine Kif15-dependent spindle formation in LLC-Pk1 GFP-Kif15 cells we
first treated parental and GFP-Kif15 cells with 1

M STLC (DeBonis et al., 2004) for 18

hours and quantified spindle morphology (Fig. 3.3D). In parental cells treated with
STLC, 96% of spindles were monopolar. In STLC treated GFP-Kif15 cells, the majority
of spindles were bipolar (87%), demonstrating that GFP-Kif15 can support bipolar
spindle formation in these cells, consistent with results in other mammalian cells either
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overexpressing Kif15 or treated to develop resistance to STLC (Raaijmakers et al., 2012;
Sturgill et al., 2016; Sturgill and Ohi, 2013; Vanneste et al., 2009). Next, we assessed the
ability of STLC treated GFP-Kif15 expressing cells to form bipolar spindles following
siRNA mediated depletion of TPX2. As shown in Figure 3D, 97% of spindles were
monopolar, indicating that TPX2 is required for Kif15 dependent bipolar spindle
formation (Tanenbaum et al., 2009). It should be noted, however, that depletion of TPX2
in control cells also leads to defects in spindle formation, resulting in short bipolar
spindles, multipolar spindles and monopolar spindles (Gruss and Vernos, 2004)
Because our data showed that the C-terminal 37 amino acids of TPX2 are important for
spindle localization of Kif15 and inhibition of Kif15 motility in vitro, we next used cell
lines expressing full-length or truncated TPX2 from a BAC to determine if the C-terminal
region is important for force generation by Kif15 in vivo. Cells were co-nucleofected
with siRNA to deplete endogenous TPX2 and with a plasmid encoding mCherry-Kif15.
40 hours post nucleofection cells were treated with STLC and spindle morphology
scored. As shown in Figure 3D, bipolar spindles were present in the majority of cells
expressing full-length TPX2, but not in cells expressing TPX2-710. This result
demonstrates that the C-terminal region of TPX2 is necessary for Eg5-independent
bipolar spindle formation in cells overexpressing Kif15.
The mechanism by which Kif15 promotes spindle bipolarity in the absence of Eg5
activity is not known, but has been proposed to result from Kif15 action on parallel,
bundled microtubules (Sturgill and Ohi, 2013). Consistent with this, recent work shows
that some Kinesin-5 inhibitor-resistant cell lines express low levels of a rigor mutant of
Eg5 that promotes microtubule bundle formation (Sturgill et al., 2016). To determine if
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microtubule bundles are sufficient for Kif15 localization in the absence of TPX2, we
depleted cells of TPX2 and added FCPT, which induces microtubule bundle formation by
promoting rigor binding of Eg5 to microtubules (Groen et al., 2008). Treatment of
parental cells with FCPT alone promoted microtubule bundle formation as expected;
however, very few bundles were observed in the absence of TPX2 (Fig. 3.3E).
Immunostaining showed that Eg5 bound to microtubule bundles in FCPT treated cells,
was reduced in siTPX2 treated cells, and bound to residual bundles in cells treated with
both FCPT and siRNA to TPX2 (Fig. 3.3E). Although Kif15 was detected on bundles in
FCPT treated cells, it was not detected in cells treated with siRNA targeting TPX2, even
when FCPT was added to promote bundle formation (Fig. 3.3E). These results show that
Eg5 can bind to spindle microtubules in the absence of TPX2 when rigor binding of Eg5
to microtubules is promoted by FCPT treatment. However, in cells lacking TPX2, the
formation of microtubule bundles using FCPT treatment alone may not be sufficient to
localize Kif15 properly to the spindle.

3.2.4 Dynamic microtubules contribute to Kif15 behavior in vivo
Although Kif15 motility in vitro has been characterized (Drechsler et al., 2014;
Sturgill et al., 2014), the motile behavior of Kif15 in vivo has not been reported. To
investigate this, we performed time-lapse confocal microscopy of GFP-Kif15 expressing
LLC-Pk1 cells, which facilitate imaging due to their flat morphology throughout mitosis
remain relatively flattened during mitosis, facilitating imaging. We observed rapid
motion of fluorescent particles of GFP-Kif15 toward the spindle equator, where
microtubule plus-ends are located (Fig. 3.4A). Close inspection of the confocal image
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sequences revealed some variation in the fluorescence intensity and morphology of the
motile particles (Fig. 3.4A,D). The larger or brighter particles may represent clusters of
Kif15 tetramers, a possibility that is consistent with recent in vitro experiments that show
accumulation of Kif15 at intersections of dynamic microtubules and at microtubule plusends (Dreschler and McAinsh, 2016). However, the fluorescent puncta move rapidly,
and photobleach quickly, so variation in morphology of individual puncta could not be
quantified. When cells progressed into anaphase, GFP-Kif15 was enriched along
kinetochore fibers and in some cases showed an accumulation near kinetochore fiber
plus-ends (Fig. 3.4B, Fig. 3.7B).
We also performed TIRF microscopy of live cells to visualize motors on
microtubules that extended to the peripheral regions of the cell (Gable et al., 2012). In
accord with results from confocal microscopy, GFP-Kif15 motors appeared to move in a
directed manner, away from the centrosome, consistent with predominantly plus-end
directed motion (Fig. 3.7A).
To determine if the fluorescent particles of GFP-Kif15 are walking along the
lattice of spindle microtubules or moving with the tips of growing microtubules, we
measured the velocity of GFP-Kif15 in vivo, from kymographs (Fig. 3.4C) of fluorescent
particles in the image sequences taken of metaphase and anaphase cells (Methods). We
also imaged LLC-Pk1 cells expressing GFP-EB1, using identical imaging parameters, to
determine the rate of microtubule growth (Piehl et al., 2004). This analysis showed that
particles of GFP-Kif15 moved in a processive manner at a velocity of 133  43 nm/sec
This value was not different from the rate of microtubule growth determined from the
GFP-EB1 movies, 119  26 nm/sec (P = 0.09) suggesting that Kif15 motility results from
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association with growing microtubule ends. We also imaged both GFP-Kif15 and GFPEB1 at room temperature, which reduced photobleaching, and again found that the
velocities were not different (data not shown). The relatively wide distribution in the
velocities of GFP-Kif15 puncta could reflect different rates for single or multiple motors,
for motors walking on one microtubule with a second microtubule as cargo, or because
some motors are moving on microtubule growing ends and others are walking along the
microtubule lattice (Dreschler and McAinsh, 2016). To determine if this motile behavior
is unique to GFP-Kif15, we overexpressed Eg5-Emerald from a plasmid, and imaged the
cells. In this case, plus-end directed motile behavior was not observed (data not shown),
consistent with previous work demonstrating that Eg5, expressed from a BAC, bound and
unbound rapidly from mitotic microtubules and showed dynein-dependent minus-end
motion (Gable et al., 2012; Uteng et al., 2008).
To determine if GFP-Kif15 motility results from motors associating with dynamic
microtubule plus-ends (Dreschler and McAinsh, 2016), we treated GFP-Kif15 cells with
nanomolar concentrations of Paclitaxel, to suppress microtubule dynamics (Yvon et al.,
1999). Under these conditions (Methods), the velocity and number of growing
microtubule plus-ends, measured in GFP-EB1 expressing LLC-Pk1 cells was reduced,
confirming a suppression of microtubule dynamics (Fig. 3.7C,D). Time-lapse movies of
Paclitaxel treated GFP-Kif15 cells showed a dramatic reduction of Kif15 motility on the
spindle, which precluded tracking. This result shows that microtubule dynamics
contribute to GFP-Kif15 behavior in vivo (Fig. 3.4D). Because of the high density of
microtubules in the spindle, and the fact that the Kif15 antibody is only compatible with
methanol fixed cells, we were not able to document co-localization of Kif15 and GFP-
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EB1 in fixed cells, and in live cells expression of both GFP-Kif15 and mCherry-EB1
resulted in aberrant spindle morphology.
To determine if the distribution of Kif15 and TPX2 was altered in Paclitaxel
treated cells, as might be expected if the motors preferentially associate with dynamic
microtubules, parental cells were fixed and stained for microtubules and TPX2 or Kif15.
The results show that suppression of dynamics with Paclitaxel resulted in an increase in
TPX2 and Kif15 near the spindle poles and a reduction along spindle microtubules (Fig.
3.4E). To quantify this, TPX2 and Kif15 levels were normalized to tubulin, and the ratio
of each protein in the half-spindle and at the pole was determined; the results show that
Paclitaxel treatment reduced this ratio for both Kif15 and TPX2 (Fig. 3.4E’). This result
shows that the distribution of TPX2 and Kif15 is impacted by microtubule dynamics,
consistent with the enrichment of TPX2 and Kif15 at plus-ends of dynamic microtubules
in vitro (Dreschler and McAinsh, 2016; Reid et al., 2016; Roostalu et al., 2015). Kif15
and TPX2 lack a short amino acid motif, composed of Serine, any amino acid, Isoleucine
and Proline and abbreviated SxIP, that is commonly found in proteins that localize to
microtubule plus-ends in a EB-1–dependent manner (Honnappa et al., 2009). This
suggests that the association of TPX2 and Kif15 with microtubules is direct rather than
mediated by EB1. TPX2 has been reported to associate with dynamic microtubule ends in
vitro at low concentrations (Reid et al., 2016; Roostalu et al., 2015) but has not been
reported to tip track in vivo, where it is present at higher concentrations (~20 nM in a
mitotic cell extract). One possibility is that TPX2 is required to load Kif15 onto
microtubules but not required for it to remain at the growing plus-end (Fig. 3.4Fa);
alternatively TPX2 may remain at the plus-end with Kif15 (Fig. 3.4Fb), but may not be
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detectable in vivo (Dreschler and McAinsh, 2016; Reid et al., 2016; Roostalu et al.,
2015).

3.3 Discussion

The results of these experiments demonstrate that the C-terminal region of TPX2,
which was shown previously to contribute to the regulation of the Kinesin-5, Eg5, also
contributes to the regulation of the Kinesin-12, Kif15. Specifically, the C-terminal 37
amino acids of TPX2 contribute to the spindle localization of each motor and inhibition
of motor walking in vitro. In the case of Eg5, both TPX2-710 and full length TPX2 had
an inhibitory effect on motor stepping in vitro, although full-length TPX2 was a more
effective inhibitor (Balchand et al., 2015). This is in contrast to Kif15, which was only
inhibited when the full-length protein was added. The reason for these differences is not
clear; one possibility is that Eg5 is more susceptible to inhibition because of differences
in the neck linker and stalk which are unique to Eg5 (Waitzman and Rice, 2014).
Our results showing that the C-terminal region of TPX2 contributes to the spindle
localization of both Eg5 and Kif15, two kinesins that contribute to spindle bipolarity,
raises the question of how bipolarity is achieved in cells expressing truncated TPX2.
First, for both motors, spindle localization is reduced but not eliminated when TPX2-710
is expressed, which is consistent with the observation that the Eg5-TPX2 interaction is
not completely abolished when the C-terminal region is removed from the protein
(Eckerdt et al., 2008; Ma et al., 2011); the residual binding may be sufficient to generate
bipolar spindles. In addition, incomplete knockdown of TPX2 may contribute to motor
binding to spindle microtubules. Second, in LLC-Pk1 cells centrosome separation
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typically occurs during prophase when most of TPX2 is in the nucleus and thus before
complete inhibition of Eg5 by TPX2 can occur (Raaijmakers et al., 2012). Finally, it is
possible that TPX2 also impacts minus-end directed motility (Wittmann et al., 1998), and
that the reduction of both inward and outward force generators enables spindle
bipolarization via microtubule pushing forces (Ferenz et al., 2009b; Toso et al., 2009;
Wittmann et al., 1998).
In Kif15 overexpressing cells treated with STLC, spindle formation is thought to
occur when a monopolar spindle breaks symmetry, driven by Kif15 acting on parallel,
bundled microtubules (Sturgill et al., 2014; Sturgill and Ohi, 2013). When TPX2 is
depleted from these cells, bipolar spindles are not observed (this report and (Tanenbaum
et al., 2009)). One possibility is that TPX2 is needed to generate microtubule bundles to
which Kif15 binds (Sturgill et al., 2014); alternatively, TPX2 may play a more direct role
in promoting force generation by Kif15 (Drechsler et al., 2014). It should be noted that
depletion of TPX2 results in a dramatic alteration of spindle morphology resulting in
short spindles with extensive astral arrays and few or no spindle microtubules (Gruss et
al., 2002), and these changes impact spindle formation. However, in Kif15
overexpressing cells expressing TPX2-710, microtubule formation in the chromosome
pathway can proceed (Ma et al., 2011), and these cells also fail to generate bipolar
spindles. This suggests that TPX2 is needed not only to promote microtubule formation
but to also regulate motor activity, which is consistent with in vitro experiments showing
that the C-terminus of TPX2 is required for motor regulation on individual, unbundled,
microtubules (this report) and experiments showing that Kif15 can generate greater force
in the presence of TPX2 (Drechsler et al., 2014).
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Our analysis is the first report of the motile behavior of GFP-Kif15 on spindle
microtubules in vivo. We observed plus-end directed motion of Kif15 puncta in
prometaphase, metaphase and anaphase cells. In live cells, Kif15 puncta moved at a rate
(133 nm/sec) that was indistinguishable from microtubule plus-end growth in these cells
(119 nm/sec) and was suppressed in cells treated with Paclitaxel to reduce microtubule
dynamics. These observations support the idea that motion of Kif15 is due, at least in
part, to tracking with microtubule plus-ends. This possibility is also consistent with in
vitro experiments showing that Kif15 tracks, and accumulates at the plus-ends of
dynamic microtubules, in the absence of other microtubule-associated proteins (Dreschler
and McAinsh, 2016). The velocity of GFP-Kif15 puncta in live cells overlaps with the
velocity of GFP-Kif15 measured in vitro on stable microtubules (~130 nm/sec) but is
slower than the velocity on dynamic microtubules (~500 nm/sec) (Dreschler and
McAinsh, 2016). Because microtubules in vivo are highly dynamic, the velocity of Kif15
in vivo would be predicted to be ~500 nm/sec (Verhey et al., 2011). The similarity of the
velocities of microtubule growth and Kif15 puncta motility is thus consistent with motors
tracking plus-ends, but we cannot eliminate the possibility that Kif15 walking on spindle
microtubules in vivo also contributes to the observed motility. Because puncta composed
of multiple tetramers of GFP-Kif15 are easier to detect in live cells, our imaging
experiments may preferentially capture the brighter puncta at microtubule ends and
individual motors on the microtubule lattice may be insufficiently bright to track. It
should be noted that measuring the rate that a mitotic motor walks in vivo is challenging.
In the case of Eg5, prior work showed that motors bound and unbound rapidly to spindle
microtubules (Gable et al., 2012). In the interzonal region, short excursions were
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measured with a rate of ~6.5 nm/sec, similar to the rate that Eg5 walks in vitro (Balchand
et al., 2015; Weinger et al., 2011). In contrast, in the half-spindle, Eg5 moved toward the
spindle poles in a dynein dependent manner (Gable et al., 2012; Uteng et al., 2008). To
our knowledge, the in vivo motile behavior of individual molecules of other mammalian
mitotic motors has not been reported. Therefore, additional experiments will be required
to establish if Kif15 walks on the microtubule lattice, tracks the microtubule plus-end, or
both, in vivo (Dreschler and McAinsh, 2016).
We observed Kif15 puncta on kinetochore fibers, in fixed and live cells,
consistent with the fact that Kif15 can crosslink parallel microtubules in vitro (Drechsler
et al., 2014; Sturgill et al., 2014). One appealing possibility is that Kif15 can aid in the
formation of parallel microtubule bundles in the spindle by walking along a kinetochore
microtubule while associated with a dynamic growing microtubule. In late anaphase and
telophase cells, Kif15 was not detected on interzonal microtubules, consistent with
preferential binding to parallel microtubules.
Mitotic motors, including Eg5 and Kif15, and TPX2 are all subject to mitotic
regulation (Blangy et al., 1997; Fu et al., 2015a; Nousiainen et al., 2006; vanHeesbeen et
al., 2016), but how these modifications impact motor behavior in vitro and in vivo
remains incompletely understood. For example, modifications of mitotic motors regulate
their binding to spindle microtubules as cells enter mitosis, but if these modifications also
impact their interaction with TPX2 is not known. Additionally, if there is competition
between these motors for interaction with TPX2 has not been determined. Enrichment of
GFP-Kif15 on kinetochore fibers was observed as cells progressed into anaphase
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suggesting that Kif15 distribution and function may change not only as cells enter
mitosis, but also as cells progress into anaphase.
In conclusion, the results of these in vitro experiments show that Kif15 is a
processive, track-switching motor and that a fraction of the motors exist as tetramers in
both interphase and mitotic extracts, supporting the view that Kif15, like Eg5, functions
as a tetramer. The results presented here demonstrate that the C-terminal 37 amino acids
of TPX2 regulates in vitro motility of Kif15, contributes to the spindle localization of
Kif15 and to Eg5-independent force generation in vivo. Our live cell imaging shows that
Kif15 moves in a manner consistent with tracking microtubule plus-ends in vivo, a
property that likely aids the motor aligning microtubules into kinetochore fibers and
generating force for bipolarization. Together with other recent work, our results highlight
the essential role of microtubule-associated proteins in regulating of the cellular activity
of kinesin motors (Barlan et al., 2013; Dixit et al., 2008; Li et al., 2016; Wignall and
Villeneuve, 2009).

3.4 Materials and Methods

3.4.1 Materials
All chemicals, unless otherwise specified, were purchased from Sigma-Aldrich.

3.4.2 Cell Culture, nucleofection and inhibitor treatments
LLC-Pk1 cells were cultured in a 1:1 mixture of F10 Hams and Opti-MEM
containing 7.5% fetal bovine serum and antibiotics and maintained at 37 C and 5% CO2.
LLC-Pk1 cells were nucleofected using an Amaxa nucleofector (Lonza) using program
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X-001 and Mirus nucleofection reagent (Mirus Bio LLC, Madison, WI) according to the
manufacturers recommendations. The following siRNAs were used: TPX2,
GGACAAAACUCCUCUGAGA; Nuf2, AAGCAUGCCGUGAAACGUAUA; Kif15,
UGACAUCACUUGCAAAUAC. siRNAs were purchased from Dharmacon (GE
Healthcare Life Sciences, Pittsburgh, PA).
LLC-Pk1 cells expressing full-length TPX2 or TPX2-710 from a bacterial
artificial chromosome (BAC) were grown as previously described (Ma et al., 2011). To
generate cells expressing GFP-Kif15, parental cells were nucleofected with GFP-Kif15
and selected using the appropriate antibiotic; cells were subcloned to enrich for GFPKif15 expressing cells. For some experiments, GFP-Kif15 cells that had been further
selected for fluorescence using cell sorting were used. mCherry-Kif15 was prepared by
subcloning of GFP-Kif15 into the appropriate vector.
Paclitaxol, FCPT and STLC were prepared as stock solutions in DMSO, stored at
-20 °C and diluted with culture medium prior to use. FCPT was used at 200
Paclitaxol at 330 nM and STLC at 1

M,

M.

3.4.3 Preparation of cell extracts
Cell extracts for TIRF experiments were prepared from LLC-Pk1 cells expressing
GFP-Kif15. A confluent 100 mm diameter cell culture dish was washed twice with
calcium and magnesium free PBS and then 300

l extraction buffer (40 mM

HEPES/KOH pH 7.6, 100 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 μg/ml Leupeptin, 1
mg/ml pepstatin, 0.5% Triton X 100 and 1 mM ATP) was added drop wise to the dish
and incubated with gentle rotation for approximately 2 min (Balchand et al., 2015; Cai et
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al., 2007). The extract was transferred to a microcentrifuge tube on ice and centrifuged at
15,000 RPM at 4 C for 10 min in a tabletop centrifuge. The supernatant was recovered
and used immediately or stored in aliquots in liquid nitrogen; protein concentration was
determined using the method of Lowry (Lowry et al., 1951). For quantification of the
fluorescence intensity of individual puncta using TIRF microscopy, the cells were treated
with siRNA targeting endogenous Kif15 72 hours prior to preparation of the extract.
To prepare mitotic extracts, GFP-Kif15 cells were treated with siRNA targeting
endogenous Kif15, and were synchronized using 330nM Nocodazole for the final 18
hours of the 72 hr siRNA treatment. Extracts were prepared as described above with the
addition of Simple Stop 1 Phosphatase Inhibitor Cocktail (1X)(Gold Biotechnology Inc.,
St. Louis, MO) to the extract buffer.

3.4.4 Protein purification
Full-length and truncated TPX2 were expressed and purified from bacteria as
previously described (Balchand et al., 2015). Kinesin-1-GFP was prepared using the
dimeric construct as previously described (Balchand et al., 2015). To generate TPX2-657,
a stop codon was introduced at amino acid 657 in the bacterially expressed Full-length
TPX2 construct. To generate TPX2 Δ PFAM, PCR was used to remove amino acids 662
to 719 from full-length TPX2. Proteins were run on 8% polyacrylamide gels using
appropriate MW standards, and stained with Commassie brilliant blue.
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3.4.5 Single molecule experiments
For the single molecule experiments, perfusion chambers (~10

l volume) were

made from glass slides, silanized coverslips and double stick tape (Balchand et al., 2015).
First, 10

l of 10% Rat YL ½ anti-tubulin antibody (Accurate Chemical and Scientific,

Corp) was flowed into the chamber and incubated for 3 min. Next, the chamber was
blocked by flowing in 5% pluronic F127 for 3 min. Diluted rhodamine labeled
microtubules, composed of 10% rhodamine tubulin (Cytoskeleton, Inc.) and unlabeled
porcine brain tubulin, were flowed into the chamber and incubated for 3 min followed by
a second block of 5% pluronic F127. Cell extract containing GFP-Kif15 was diluted in
PEM 20 motility buffer (20 mM Pipes pH 6.9, 2 mM EGTA, 2 mM MgSO4), containing
0.25% F127, 100 μM ATP, 1 mM DTT, 25 μM Paclitaxel and supplemented with oxygen
scavenging system (15 mg/ml glucose, 1.23 mg/ml glucose oxidase and 0.375 mg/ml
catalase), flowed into the chamber and imaged. To determine the directionality of Kif15,
polarity marked microtubules were used and confirmed that Kif15 walked toward the
plus-end for the majority of excursions. For pre-incubation experiments with TPX2, the
indicated concentrations of TPX2 were added to the motility buffer containing GFPKif15 and incubated on ice for 2 min before flowing into the chamber. Single molecule
imaging of Kinesin-1-GFP was performed as described previously (Balchand et al.,
2015).

3.4.6 Microscope Imaging and Analysis
TIRF microscopy was performed using a Nikon Ti-E microscope with a 100X
1.49 NA objective lens, and an Andor Zyla sCMOS camera; the system was run by
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Nikon Elements software. TIRF imaging was performed at room temperature; images
were collected at 1 frame per second for a total of 300 seconds. To measure motor
velocity, individual puncta were tracked using the Particle Tracking function of Nikon
Elements software and exported to Excel for analysis. For the experiment with mitotic
extract, a Nikon Ti-E microscope run by Metamorph software and with a Hammamatsu
Flash 4.0 camera was used.
Live and fixed cells were imaged using either spinning disc confocal microscopy
or point scanning confocal microscopy. For spinning disc confocal, two different
systems were used, either a Nikon Ti-E microscope with a CSU-X1 Yokogawa spinning
disc confocal scan head (PerkinElmer, Wellesley, MA), and an Andor iXon+ EMCCD
camera (Andor, Belfast, Northern Ireland), and a 100X 1.4 NA objective lens or a CSU10 Yokogawa spinning disc confocal on a Nikon TE300 as previously described (Tulu et
al., 2003). For live cell imaging, exposures were adjusted without saturating the camera's
pixels; typical exposures were 50 - 800 msec. For point scanning confocal, a Nikon A1R
system with a 60X 1.4 N.A. objective lens was used. Images of live cells were acquired
every 2 sec at room temperature or every 3 sec at ~34

C; images were typically

collected for 2-5 min. For both fixed and live cell imaging, a laser power of 1-2 % was
used. For heating the cells during imaging, a Nicholson Precision Instruments (Bethesda,
MD) Air Stream Stage Incubator was used; temperature was measured using a thermistor
probe taped to the microscope stage outside of the cell chamber. When the thermistor
temperature is 37 C, the temperature inside the chamber is ~34 C.
To quantify the fluorescence intensity of tubulin and Kif15, a 1 X 1 micron box
was placed midway between the spindle pole and the chromosomes, or at the spindle
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pole, and the ratio of Kif15 to tubulin fluorescence was measured, after background
subtraction. Statistical analysis was performed in Excel. Velocity of GFP-EB1 dashes
and Kif15 puncta were tracked in ImageJ using the M Track J plug-in.

3.4.7 Immunofluorescence
LLC-Pk1 cells were plated on #1.5 glass coverslips approximately 48 hours prior
to experiments. For Kif15 staining, cells were rinsed twice with room temperature PBS
lacking calcium and magnesium, and fixed in -20

C methanol for 5-10 minutes, and

rehydrated in PBS containing 0.1 %Tween and 0.02 % sodium azide (PBS-Tw-Az).
Kif15 primary antibodies (Cytoskeleton, Inc.) were used following the manufacturers’
recommendation and subsequently stained with fluorescent secondary anti-rabbit
antibodies (Ma et al., 2011). For TPX2 staining, cells were fixed in 2%
paraformaldehyde, 0.25% glutaraldehype, 0.5% Triton X 100, made fresh daily in PBS
lacking calcium and magnesium. TPX2 antibodies were obtained from Novus
Biologicals; Hec1 antibodies (Abcam) were the kind gift of T. Maresca. Microtubules
were stained with either DM1a mouse anti-tubulin (Sigma Chemical Co.) or YL1/2 rat
anti-tubulin (Accurate Chemical and Scientific Corporation) and appropriate secondary
antibodies as previously described (Ma et al., 2011). Stained cells were mounted on glass
slides using Fluomount G (Southern Biotech) to which DAPI was added to stain DNA.

3.4.8 Western blotting and detection
Whole cell extracts of control or siRNA treated cells were prepared by adding
SDS sample buffer to 35mm dishes of cells, followed by sonication. Extracts were run
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on 8% SDS polyacrylamide gels using the formulation of Laemmli (Laemmli, 1970).
Gels were transferred onto Amersham Hybond-P membrane (GE Healthcare, Waukesha,
WI). Blots were probed with Kif15 or TPX2 antibodies used at 1:1,000 for 1 h at room
temperature in 5% non-fat dry milk dissolved in Tris buffered saline containing 0.02%
Tween-20 (TBS-Tween). The blots were then probed with goat anti-rabbit HRP
conjugated secondary antibody (Jackson Immunoresearch Laboratories, Inc.) (1:5,000)
for 1 hr at room temperature in 5% non-fat dry milk dissolved in TBS-Tween and were
detected using chemiluminescence.
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Figure 3.1 The C-terminal region of TPX2 contributes to spindle localization of
Kif15. (A). Immunofluorescence staining for microtubules (left) and Kif15 (right). Top
row, parental cells; bottom three rows show cells depleted of TPX2 and expressing: no
transgene (parental); transgene encoding full length TPX2 (middle) or TPX2-710
(bottom). (B). Spindle morphology for parental cells and cells expressing full-length or
truncated TPX2; cells on the right were additionally treated with siRNA targeting TPX2.
(C). Quantification of fluorescence ratio of Kif15 to tubulin at pole and in the half
spindle. Error bars are standard deviation. Parental cells depleted of TPX2 were only
measured at spindle pole due to loss of spindle microtubules. Scale bar in (A) is 2 μm.
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Figure 3.2 Inhibition of Kif15 motor stepping requires full-length TPX2. (A)
Schematic diagram of experiment. (B) Histograms of GFP-Kif15 velocity (left) and run
length (right) for plus-end and minus-end directed motion, n = 261 and 43 motors,
respectively. Data from 2 independent experiments. (C) GFP-Kif15 switches microtubule
tracks; arrow marks moving GFP-Kif15 puncta. Time in min:sec. (D) Histogram of
fluorescence intensity of Kinesin-1-GFP (top) and GFP-Kif15 (bottom); fluorescence in
arbritary units (AU). For Kinesin-1-GFP, n = 295 and for GFP-Kif15, n = 652, from 2
independent experiments. (E) Photobleaching of microtubule bound GFP-Kif15 from
interphase and mitotic extracts. Horizontal pink lines show bleach steps. For interphase,
n = 11 particles, 5 >3 steps and 6 <3 steps; data from 2 independent experiments; for
mitotic extracts n = 15 particles, 10 > 3 steps and 5 < 3 steps. (F) Schematic diagram of
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constructs used for inhibition experiments (top) and bar graph (lower) showing ratio of
velocity without and with added proteins; error bars SEM. (G) Kymographs showing
motility of GFP-Kif15; added TPX2 construct indicated at top; vertical axis marker bar =
15 sec; horizontal axis marker bar = 1 μm. Bar in C = 1 μm.
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Figure 3.3 TPX2 is required for bipolar spindle formation in cells overexpressing
Kif15. (A) LLC-Pk1 cells expressing GFP-Kif15 (left) and parental cells fixed and
stained for Kif15 (right). (B) Western blot of extracts from parental and GFP-Kif15
expressing cells; blot stained for Kif15 (top) and tubulin as loading control (bottom). (C)
Images of GFP-Kif15 expressing cells treated with siRNA targeting TPX2 (top) or Nuf2
(bottom); GFP-Kif15 (left) and co-nucleofected mCherry-H2B to label chromosomes
(right). (D) Bar graphs showing percent of bipolar, monopolar and multipolar spindles for
each treatment condition. Error bars show standard deviation. (E) Parental cells treated
with FCPT, with siRNA targeting TPX2, or with both. Cells were stained for
microtubules (lower panels) and either Kif15 or Eg5 (upper panels). Marker bar, A, C, E
= 2 μm.
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Figure 3.4 Dynamics of GFP-Kif15 in vivo. (A) Selected frames from a movie of GFPKif15 expressing cells; red and yellow arrowheads mark fluorescent particles traveling
toward the chromosome region (spindle equator to right; dark ovals are chromosomes).
(B) Live cell expressing GFP-Kif15 progressing from prometaphase (0:00) to metaphase
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(3:30) and anaphase (9:00); arrows show accumulation of fluorescence near the
kinetochores. (C) Kymographs from movie sequences of GFP-Kif15 expressing
metaphase and anaphase cells; distance, horizontal axis; time, vertical axis; dark regions
are chromosomes; spindle midzone to right. (D) Sequential frames (2 sec interval) from
movies of GFP-Kif15 expressing control and Paclitaxel treated cells (inverted contrast);
motion of fluorescent particles toward the kinetochore region (right in all panels) in
control but not Paclitaxel treated cells. Green arrowheads mark moving puncta. (E) LLCPk1 parental cells fixed and stained for microtubules and Kif15 (top) or TPX2 (bottom);
control and Paclitaxel as indicated; merged images to the right. (E’) Bar graph showing
quantification of images in E. (F) Cartoon showing GFP-Kif15 cells in the presence of
STLC; bipolar spindle formation requires TPX2. TPX2 could load Kif15 onto the
microtubule, followed by motor motion to the microtubule + end (a) or TPX2 and Kif15
could both localize to microtubule ends (b). Marker bars in A,B,C,D,E = 2 μm; time
scale in C, 30sec.
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Figure 3.5 TPX2 constructs purified from bacteria and binding to microtubules in
vivo. Western blot showing protein depletion following siRNA treatment. (A) TPX2, (B)
Kif15. Tubulin was used as a loading control (lower). For the blots shown, TPX2 was
depleted 95% and Kif15 75.5%. (C’, C’’) Polyacrylamide gel showing the truncated and
full length TPX2 proteins used in in vitro experiments. (D) Images of truncated TPX2mCherry constructs bound to microtubules in LLC-Pk1 cells depleted of full length TPX2
using siRNA. Molecular weight of markers in kilodaltons. Marker bar = 5 μm.
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Figure 3.6 Depletion of Nuf2 reduces cold-stable kinetochore fibers. LLC-Pk1 cells
were treated with siRNA targeting Nuf2, treated with 5 M MG132 to arrest cells in
metaphase, and then in ice-cold medium for 10 min, fixed and stained for microtubules
and DNA. Bar = 2 μm.
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Figure 3.7 Tracking GFP-Kif15 and EB1 puncta in vivo. (A) TIRF microscopy of
GFP-Kif15 expressing cells; region marked with red box is shown enlarged in lower
panels; red arrowhead shows initial position of puncta (contrast inverted); yellow arrow
marks puncta. Time in seconds. Kymograph of an individual puncta of GFP-Kif15
(upper right); time: vertical axis; distance: horizontal axis. (B) GFP-Kif15 associates
with kinetochore fibers in anaphase. Image of GFP-Kif15 expressing cell fixed and
stained with antibodies to Hec1 to mark kinetochores. GFP-Kif15 (left) associates with
fibers that end at Hec1 positive dots (middle). (C,D) Microtubule dynamics in LLC-Pk1
cells treated with Paclitaxel. (C) Live cells expressing GFP-EB1; control (left) and
Paclitaxel treated (right). (D) Velocity of GFP-EB1 dashes in control and Paclitaxel
treated. Bar = 2 μm; error bars show Std. Dev.
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CHAPTER 4

SRC FAMILY KINASE PHOSPHORYLATION OF THE MOTOR DOMAIN OF
THE HUMAN KINESIN-5, EG5
This chapter is adapted from Bickel et al. 2017 and was completed with the guidance of
Patricia Wadsworth. This project was performed in collaboration with Kathleen G. Bickel
(Northwestern Medical School), Joshua S. Waitzman (Northwestern Medical School) and
Taylor A. Poor (Northwestern Medical School) under the guidance of Dr. Sarah E. Rice
(Northwestern Medical School). KGB performed in vitro phosphorylation assays,
immunoprecipitations, and bacterial protein purifications. JSW performed initial in silico
and in vitro work, ITC experiments and assisted KGB with microtubule gliding assays.
JSW and TAP performed Mass Spectrometry and analysis (data not shown).

4.1 Introduction

Chromosome segregation during mitosis requires the mitotic spindle, a dynamic
structure composed of microtubules (MTs), motor proteins, and non-motor MTassociated proteins. All spindles are bipolar and in most cell types, spindle bipolarity
relies on the activity of kinesin-5 motor proteins (Blangy et al., 1995; Enos and Morris,
1990; Goshima and Vale, 2003; Hagan and Yanagida, 1990; Hoyt et al., 1992; Kapitein
et al., 2005; Scholey et al., 2014). The bipolar arrangement of tetrameric kinesin-5 family
members allows them to crosslink and slide MTs originating from each of the two
centrosomes, thus establishing the bipolar spindle (Kapitein et al., 2005). Inhibition of
the mammalian kinesin-5, Eg5, early in mitosis induces the formation of monopolar
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spindles that are incapable of proper chromosome segregation (Goshima and Vale, 2003;
Maliga et al., 2002).
During spindle formation, outward forces generated by kinesin-5 and other
motors are opposed by motor-dependent inward forces. How these forces are balanced
and regulated remains incompletely understood (Brust-Mascher et al., 2009; Ferenz et al.,
2010; Saunders et al., 1997; Tanenbaum et al., 2008). Past studies have shown that
phosphorylation of the kinesin-5 tail domain and interaction with binding partners such as
TPX2 are important for motor localization to the spindle (Blangy et al., 1997; Blangy et
al., 1995; Ma et al., 2011; Ma et al., 2010). Phosphatase and tensin homolog (PTEN)
activity has also been shown to contribute to Eg5 localization (He et al., 2016). Other
work demonstrated that phosphorylation of the motor domain contributes to kinesin-5
regulation in yeast and Drosophila (Avunie-Masala et al., 2011; Garcia et al., 2009;
Shapira and Gheber, 2016; Shapira et al., 2017); whether similar modifications affect Eg5
is not yet established.
Although Eg5 is mostly degraded as cells exit mitosis (Uzbekov et al., 1999;
Venere et al., 2015), some studies show an interphase function for the motor in neurons,
where it contributes to neuronal migration and growth cone behavior (Falnikar et al.,
2011; Myers and Baas, 2007; Nadar et al., 2008; Venere et al., 2015). Eg5 fails to
undergo cell-cycle regulated degradation in patient-derived glioblastoma cells and
contributes to the invasive behavior of these cells (Venere et al., 2015). These data
suggest that Eg5 function is precisely regulated by a variety of mechanisms, and that
dysregulation of Eg5 function can contribute to human disease.

105

Here we present evidence that Eg5 is phosphorylated at three sites in its motor
domain by Src family kinases (SFKs) in mammalian cells. This phosphorylation
modulates Eg5 activity in vitro and spindle morphology in vivo. Several SFKs,
particularly those that are activated and upregulated in mitosis (c-Src, Fyn, c-Yes, and
Lyn; (Kuga et al., 2007) overlap in substrate and inhibitor specificity (Thomas and
Brugge, 1997). Therefore, in this work we refer to the SFKs as kinases collectively
acting on Eg5, except when discussing experiments that specifically use c-Src. SFKs are
best known for activating cell proliferation, migration, and cytoskeletal reorganization
(Sen and Johnson, 2011). Their dysregulation also contributes to oncogenesis (Kim et al.,
2009) and recent data points to a new role for SFKs in regulating spindle establishment
and orientation (Nakayama et al., 2012). Other recent work suggests that
phosphotyrosine (pTyr) modifications are more prevalent than previously appreciated,
particularly in the kinetochore/spindle region and particularly by SFKs (Caron et al.,
2016). To date, however, few mitotic SFK targets have been identified and none of them
are known to regulate the MT cytoskeleton (Bhatt et al., 2005; Fumagalli et al., 1994;
Wang et al., 2008). SFK phosphorylation of the Eg5 motor domain is potentially a novel
regulatory mode that links SFK activity to the MT cytoskeleton during spindle
establishment and may provide insight into how Eg5 becomes dysregulated in the context
of cancer.
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4.2 Results and Discussion

4.2.1 Endogenous Eg5 is phosphorylated on motor domain tyrosines in mammalian
cells
To test whether Eg5 is phosphorylated on tyrosine residues, we
immunoprecipitated Eg5 from HEK293T cells and used a two-color Western blot to
probe for tyrosine phosphorylation (Fig. 4.1 A; signals from red (Eg5) and green (pTyr)
channels are displayed separately). We observed co-localization of pTyr and Eg5 signals,
suggesting that human Eg5 is phosphorylated on tyrosines. Additionally, we observed
tyrosine phosphorylation of Eg5 immunoprecipitated from pig-derived LLC-Pk1 cells
(Fig. 4.1 A). Treatment of immunoprecipitated Eg5 with lambda phosphatase diminished
pTyr signal (Fig. 4.4 A), confirming that the anti-pTyr antibody binds specifically to
phosphorylated protein. These data and previous work showing that Eg5 is
phosphorylated at multiple tyrosines in the motor domain (Fig. 4.1 B, 4.4 B; (Han et al.,
2010; Hornbeck et al., 2015; Iliuk et al., 2010; Kim et al., 2010; Li et al., 2009; Luo et al.,
2008) establish that mammalian Eg5 is phosphorylated on tyrosines.

4.2.2 Src kinase phosphorylates Eg5 more efficiently than Wee1 in vitro
Previous data reported that the mitotic kinase Wee1 phosphorylates the
Drosophila kinesin-5, KLP61F, at three tyrosines in the motor head, including the
tyrosine homologous to mammalian Y211 (Garcia et al., 2009). However, querying the
complete Eg5 peptide sequence in the Scansite 3 kinase predictor site (Methods;
(Obenauer et al., 2003) suggested SFKs as potential kinases targeting Y211. In addition,
a Src homology domain 3 (SH3) targeting sequence (–PXXP−) is located in the MT
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binding face of several kinesin-5s, including Eg5 (Fig. 4.1 B, inset, Fig. 4.1 C and Fig.
4.4 C-D; (Kim et al., 2010). Furthermore, post-translational modification databases
recorded Y125, Y211, and Y231 as phosphorylation sites in the motor domain (Fig. 4.4
B; (Hornbeck et al., 2015; Li et al., 2009). We performed in vitro kinase assays to test
whether Eg5 motor heads could be phosphorylated on these residues and to compare the
ability of c-Src and Wee1 to phosphorylate Eg5 motor heads in vitro (Fig. 4.2 A, B).
For all in vitro kinase assays we used a previously well-characterized 367-amino
acid monomeric Eg5 motor head construct (Eg5-367; (Cochran and Gilbert, 2005;
Cochran et al., 2004; Maliga et al., 2002) that additionally harbored an E270A mutation
in the active site (termed Eg5-367 E270A; in KLP61F-364, E266A was mutated, Fig. 4.4
E, F). This mutation served to abolish the basal ATPase activity of Eg5 and thus to
prevent motor heads from depleting the kinase’s supply of ATP during the assay
(Methods; (Kull et al., 1996). We incubated either human c-Src or human Wee1 (Fig. 4.2
A, B) with the indicated kinesin-5 substrates and radiolabeled ATP. In addition to Eg5367 E270A and KLP61F E266A, we also tested a non-phosphorylatable Eg5 mutant with
phenylalanines at the three putative sites (Eg5-367-3Y->F E270A), and a -PXXP-null
mutant (Eg5-367-GSTY E270A) as kinase substrates (Methods; Fig. 4.4 E). c-Src
robustly phosphorylated Eg5-367 E270A and KLP61F E266A motor heads under these
conditions (Fig. 4.2 A). c-Src phosphorylated the -PXXP-null construct Eg5-367-GSTY
E270A in vitro, albeit markedly less efficiently than wild-type (Fig. 4.2 A), suggesting a
role for the –PXXP- targeting motif in Eg5 phosphorylation. In contrast to c-Src, Wee1
showed minimal phosphorylation of all motor head constructs, including Drosophila
KLP61F E266A, despite robust autophosphorylation (Fig. 4.2 B).
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To identify the residues phosphorylated by c-Src, we performed an in vitro
phosphorylation assay with purified Eg5 motor heads and c-Src kinase, and performed
liquid chromatography-mass spectrometry (LC-MS) on the trypsinized protein products.
The LC-MS data confirmed that c-Src phosphorylated Y211 and Y231 (data not shown;
provided by KGB). We generated a construct harboring Y211F and Y231F mutations as
well as the E270A mutation and showed that it was still robustly phosphorylated by cSrc. However, an additional Y125F mutation diminished c-Src phosphorylation of Eg5
to near background levels (data not shown). Notably, c-Src showed no phosphorylation
of Eg5-367-3Y->F E270A (Fig. 4.2 A), despite the presence of 7 other tyrosines in the
motor head, confirming c-Src phosphorylates Y125. These data show that c-Src
phosphorylates Eg5 on Y125, Y211, and Y231, and that this effect is aided by the
presence of the SH3-targeting –PXXP- motif in the Eg5 MT binding domain.

4.2.3 SFKs phosphorylate Eg5 in mammalian cells
To examine the ability of c-Src to phosphorylate Eg5 motor heads on Y125,
Y211, and Y231 in the cellular environment, we transfected HEK293T cells with either a
constitutively active human c-Src construct (c-Src-Active, Fig. 4.4 F), a C-terminal myctagged Eg5 motor head construct (Eg5-367myc), or both. We then immunoprecipitated
Eg5-367myc from the cells and analyzed the motor heads for phosphorylation by twocolor Western blot (Fig. 4.2 C, Methods). In cells co-transfected with c-Src-Active and
either Eg5-367myc-WT or Eg5-367myc-GSTY, robust phosphorylation was observed.
However, c-Src-Active did not phosphorylate Eg5-367myc-3Y->F. This result shows
that c-Src is capable of phosphorylating Eg5 motor heads in a cellular environment and
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that it likely phosphorylates Eg5 on the Y125, Y211, and Y231 residues. We did not
detect phosphorylation of transfected Eg5-367myc by endogenous SFKs in cells lacking
a transfected c-Src-Active construct, as we did for endogenous Eg5. This apparent
difference may be because the expressed motor heads lack the tail domain, which is
required for localization of Eg5 to spindles (Blangy et al., 1995; Rapley et al., 2008),
where a subset of SFKs is known to localize during mitosis (David-Pfeuty et al., 1993;
Levi et al., 2010; Ley et al., 1994). Phosphorylation was not observed in cells cotransfected with c-Src-Active and Eg5 motor heads and treated with the SFK-specific
inhibitor, A-419259 (Fig. 4.2C; (Calderwood et al., 2002). This confirms that
phosphorylation of Eg5-WT and Eg5-GSTY motor heads was due to c-Src-Active.
Finally, we used a chemical genetics approach to determine whether SFKs
phosphorylated endogenous Eg5 in cells. We transfected HEK293Ts with either an
empty vector control, cSrc-Active, or a constitutively active point mutant of c-Src that is
resistant to A-419259 (cSrc-IR, Fig. 4.4 F), with or without treatment with A-419259,
and measured endogenous Eg5 phosphorylation (Fig. 4.2 D). Phosphorylation of
endogenous Eg5 was detected even in the absence of transfected c-Src but was
significantly enhanced following transfection of cSrc-Active. In both cases treatment
with A-419259 abrogated Eg5 phosphorylation. In contrast, Eg5 from cells transfected
with the resistant cSrc-IR showed robust phosphorylation regardless of whether they
were treated with A-419259. These results strongly suggest that Eg5 tyrosine
phosphorylation in cells is dependent on SFK activity.
In summary, these data show Eg5 is phosphorylated in an SFK-dependent manner
at the same three residues both in vitro and in cells. Also, since the A-419259 inhibitor
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that blocked Eg5 phosphorylation in cells is relatively specific for SFKs (Calderwood et
al., 2002; Wilson et al., 2002), these results give us confidence that SFKs phosphorylate
Eg5.

4.2.4 Tyrosine phosphomimetic mutants alter Eg5 activity in vitro
Since Eg5 motor domains are phosphorylated in an SFK-dependent manner, we
tested how phosphomimetic mutations at Y125, Y211, and Y231 affect Eg5 motor
activity. For these experiments we generated phosphomimetic (E) and nonphosphorylatable (F) mutants of Eg5-367, as well as the -PXXP-null mutant, Eg5-367GSTY (Fig. 4.4 E). We measured both the MT-stimulated ATPase rate and MT-sliding
motility velocities (Methods) for each mutant and compared these rates to both wild-type
monomeric Eg5 motor heads and an Eg5-367 construct lacking the eight residues
125

YTWEEDPL132 from loop L5 (Eg5-367-DL5, Fig. 4.4 E; (Maliga et al., 2002). L5

includes Y125 and lies near Y211. The Eg5-Y211E phosphomimetic mutant exhibited
the greatest changes in activity, with an ATPase rate and sliding velocity that were twofold and three-fold decreased compared to wild-type, respectively (Table 4.1). In fact,
Eg5-367-Y211E motor properties were quite similar to those of Eg5-367-DL5 (Table
4.1), consistent with the idea that SFK-dependent phosphorylation may regulate Eg5 by
directly altering its motor characteristics, although other mechanisms are possible.
L5 is the binding site for many small molecule inhibitors of Eg5 (Maliga et al.,
2002) some of which are in clinical trials for use as cancer therapy (Sarli and Giannis,
2008). One could speculate based on our results that Eg5 phosphorylation may affect
inhibitor efficacy, and vice-versa (Smith et al., 2015). As a preliminary test of this, we
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conducted isothermal calorimetry (ITC) experiments (methods and data provided by
KGB) to measure the binding affinity of the Eg5-367 phosphomimetic and nonphosphorylatable mutants for the inhibitor s-trityl-L-cysteine (STLC), which binds near
L5 in human Eg5 (Kim et al., 2010; Skoufias et al., 2006a). The ITC data showed that
each of the phosphomimetic mutations significantly diminished STLC binding to Eg-367,
and the largest effect was observed for the Y211 E mutant (Table 4.1). Binding of STLC
to the non-phosphorylatable mutants was similar to wild-type (Table 4.1).
Phosphomimetic mutations give only a first approximation of the effects of a
uniformly phosphorylated protein sample, but the latter is nearly impossible to generate.
Corroborating our results, L5 is a major conformational regulator of the Eg5
mechanochemical cycle, and several mutations and deletions in this region diminish
motor activity (Behnke-Parks et al., 2011; Kaan et al., 2009; Maliga and Mitchison, 2006;
Maliga et al., 2006; Muretta et al., 2013; Waitzman et al., 2011). Furthermore, key
structural transitions during the Eg5 mechanochemical cycle require pi-stacking and
hydrophobic interactions between Y211 and residues in L5, specifically W127; L5
inhibitors bind through similar interactions (Muretta et al., 2015). By introducing a
negatively-charged glutamate residue at position 211 we are most likely abolishing those
interactions. It is worth noting that phosphate groups have double the negative charge and
increased bulk relative to glutamate (Waksman et al., 1992). In summary, the available
structural data suggest that any substantial modification in the L5 region, including
phosphomimetic mutation or phosphorylation, is likely to affect Eg5 motor properties,
and that phosphorylating Y211 would be at least as disruptive to the mechanochemical
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cycle as a glutamate phosphomimetic mutation. Based on these results and our ITC data,
we would expect that phosphorylation would similarly disrupt L5 inhibitor binding.

4.2.5 SFK phosphorylation of Eg5 regulates spindle morphology
Because Eg5 plays a critical role in mitotic spindle assembly and maintenance, we
next assessed the effects of SFK phosphorylation of Eg5 on mitotic spindle morphology.
LLC-Pk1 cells were used for these studies because they remain relatively flat during
mitosis, facilitating imaging. In initial experiments, we transfected cells with plasmids
encoding Emerald-tagged Eg5 with mutations at Y125, Y211, and Y231, to generate
stable cell lines for use in experiments. Despite multiple attempts, we were unable to
achieve this, suggesting that these mutants have deleterious effects on cell division. Next
we adapted and optimized a previously described protein replacement strategy (Gable et
al., 2012; Zaytsev et al., 2014), in which we expressed Emerald-tagged Eg5 wild-type,
phosphomimetic, and non-phosphorylatable mutants, while simultaneously inhibiting
endogenous Eg5 expression using siRNA (Methods). For these experiments, we targeted
Y211, which has been shown to alter mitosis in Drosophila (Garcia et al., 2009) and
resulted in the most pronounced defects in Eg5 motor behavior in vitro (Table 4.1).
Using this protocol, endogenous Eg5 protein levels decreased to approximately 50% of
wild-type (Fig. 4.5) which caused cells to exhibit a large percentage of monopolar
spindles (56% of cells), consistent with previous work (Goshima and Vale, 2003; Ma et
al., 2010; Mayer et al., 1999; Skoufias et al., 2006a). Spindle bipolarity was rescued
(81%) when LLC-Pk1 cells were co-transfected with Eg5 siRNA and an siRNA-resistant
Eg5-WT-Emerald construct (Eg5-WT-Em, Fig. 4.3 A). In contrast, co-transfection of
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cells with siRNA and siRNA-resistant phosphomimetic Eg5-Y211E-Em resulted in a
significant increase in monopolar spindles as compared to the wild-type rescue construct
(p < 0.01), suggesting that modification of this site inhibits Eg5 activity in mitosis (Fig.
4.3 A). When this site was made non-phosphorylatable (Y211F) there was also a
significant increase in spindle defects, specifically disorganized spindles (p<0.01).
Aberrant spindles that could not be designated as monopoles or multipoles and included
spindles with extra foci, fragmented poles, shorter length, and bent morphology were
classified as disorganized (Fig. 4.3 A). In addition to these phosphomimetic and nonphosphorylatable mutants, we also tested the -PXXP-null mutant (GSTY) which alters
the MT binding site. As expected, since the GSTY mutation weakens MT binding by Eg5
(Table 4.1), there was a significant increase in monopolar spindles as compared to the
wild-type rescue construct (p<0.01).
To determine whether the monopolar spindle phenotype resulted from spindle
collapse or from failure of centrosome separation we performed live cell imaging of
mCherry-tubulin-expressing LLC-Pk1 cells. Cells co-transfected with siRNA targeting
Eg5 and rescued with Eg5-WT-Em progressed through mitosis (Fig. 4.3 B). In contrast,
cells rescued with Eg5-Y211E-Em initially formed a bipolar spindle that eventually
collapsed into a monopolar spindle. Residual endogenous Eg5 in the siRNA treated cells,
or the presence of Kif15, which functions redundantly with Eg5, could support the initial
bipolarization in these cells (Tanenbaum et al., 2009; Vanneste et al., 2009). Distinct
from the monopolar spindles observed in cells rescued with Eg5-Y211E-Em, cells
rescued with Eg5-Y211F-Em formed disorganized spindles, consistent with the
disorganized phenotype observed in fixed cells (Fig. 4.3 B).
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While phosphomimetic Eg5 is an imperfect substitution for phosphorylated
protein, generating cells with hyper-phosphorylated Eg5 is not trivial. Mitosis involves a
complicated and inter-connected network of kinase signaling that is highly regulated
(Caron et al., 2016). Simply over-expressing c-Src kinase would not guarantee that Eg5
is hyper-phosphorylated at Y211 and the interpretation of spindle phenotypes would be
complicated by the effect of c-Src overactivation on other mitotic targets, potentially
including other mitotic kinases. Thus, the use of phosphomimetics allows us to examine
the effects in cells of introducing a negative charge at position 211 directly.
In addition to evaluating spindle phenotypes using cells expressing nonphosphorylatable and phosphomimetic mutants of Eg5, we treated non-synchronized
LLC-Pk1 cells with the SFK inhibitor SU6656. Similar to our observations in LLC-Pk1
cells expressing the non-phosphorylatable Eg5-Y211F-Em, we observed that LLC-Pk1
cells treated with SU6656 (Methods) displayed high percentages of disorganized mitotic
spindles (Fig. 4.3 C, D). Consistent with this, Nakayama et al. observed mis-oriented
spindles in HeLa cells treated with the SFK inhibitor PP2 (Nakayama et al., 2012). The
SU6656 inhibitor we used has been reported to have some activity on other kinases that
contribute to spindle formation, for example, Aurora kinases (Bain et al., 2007). To
determine if treatment with SU6656 inhibits Aurora A, we stained LLC-Pk1 cells for
phosphorylated Aurora A after treatment with SU6656 (Fig. 4.3 E). Phosphorylated
Aurora A was detected at spindle poles/centrosomes, similar to controls. Additionally,
cells treated with BI-2536, an inhibitor of the mitotic kinase Plk1, showed a phenotype
distinct from cells treated with SU6656, with pronounced bundling of interzonal
microtubules in anaphase (Fig. 4.3 F; (Brennan et al., 2007). Under these conditions
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(Methods), we did not observe a statistically significant increase in disorganized spindles
as with SU6656 or monopolar spindles as had been previously reported (Lenart et al.,
2007). These results suggest that SFK inhibition alters spindle phenotypes in a manner
distinct from inhibition of other mitotic kinases indicating that the phenotype of cells
treated with SU6656 is not due to off-target effects.
Distinct spindle phenotypes were observed in LLC-Pk1 cells transfected with
either Eg5-Y211E-Em or Eg5-Y211F-Em mutants suggesting that the optimal properties
of Eg5 are tuned by phosphorylation such that abnormal mitotic phenotypes can occur
when Eg5 is either hyperphosphorylated or hypophosphorylated at this site. The simple
model is that Eg5 phosphorylation at Y211 alters spindle phenotypes by inhibiting its
motor activity, because of the inhibitory effects seen in Table 4.1 and the monopolar
phenotype in cells expressing Eg5-Y211-E-Em (Goshima and Vale, 2003; Ma et al.,
2010; Mayer et al., 1999; Skoufias et al., 2006a). Furthermore, the largely monopolar
spindle phenotype of cells expressing the phosphomimetic Y211E mutant is consistent
with the decrease in Eg5 motor activity that is observed when cells are treated with L5
inhibitors, which are thought to act by a similar mechanism (Maliga et al., 2002; Muretta
et al., 2015). Finally, it is worth noting that in many systems, Eg5 plays an important role
in centrosome separation (Tanenbaum et al., 2008; van Ree et al., 2016; Whalley et al.,
2015) and the monopolar phenotype observed in cells expressing Eg5-Y211E-Em could
be due to abnormal Eg5 activity during this earlier phase of mitosis.
It is less simple to speculate about how overactive Eg5 would cause the
multipolar/disorganized spindle phenotype observed in the Eg5-Y211F-Em transfected
LLC-Pk1 cells. One possibility is that excessive force from Eg5 in the spindle midzone
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could lead to disorganized spindles. A second possibility is that phosphorylation of Eg5
Y211 could also modulate Eg5 localization, protein turnover rates, or its ability to bind
MTs, as was observed for the yeast kinesin 5, Cin8p (Shapira and Gheber, 2016).
Regardless of how the multipolar/disorganized spindle phenotype arises, its physiological
relevance is reinforced by its similarity to the spindle phenotype observed in cells in
which SFKs are inhibited, which has both been observed by other groups and is distinct
from the phenotypes observed when other mitotic kinases are inhibited (Bain et al., 2007;
Brennan et al., 2007; Nakayama et al., 2012).
Given that endogenous Eg5 is homotetrameric (Kapitein et al., 2005; Scholey et
al., 2014; van den Wildenberg et al., 2008), it is likely that not all of the Eg5 motor heads
in a homotetramer are phosphorylated. Eg5 motor heads are highly cooperative when
assembled into dimers (Krzysiak and Gilbert, 2006; Krzysiak et al., 2008), with dimers
having distinct kinetic properties from monomers (Cochran et al., 2006; Krzysiak and
Gilbert, 2006). Additionally, recent structural studies of the Eg5 coiled-coil domain
responsible for the assembly of Eg5 into homotetramers suggests that instead of being a
dimer of dimers, each subunit in an Eg5 homotetramer directly contacts every other
subunit in a highly intertwined and unique coiled-coil structure (Scholey et al., 2014).
These data suggest that phosphorylation of even one motor head within the Eg5
homotetramer could alter the function of the molecule. There is also a substantial body of
evidence that mitotic spindle establishment and maintenance involves a balance of forces
(Brust-Mascher et al., 2009; Saunders et al., 1997; Tanenbaum et al., 2008), making it
feasible that even small changes to Eg5 motor activity could disrupt this balance. In
support of this possibility, we observed that endogenous Eg5 was only reduced to 50% of
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wild-type levels in our experiments using LLC-Pk1 cells, so one can imagine that many
Eg5 homotetramers in our experiments had both mutant and wild-type subunits. Despite
this, nearly 90% of cells in those experiments had monopolar spindles (Fig. 4.3 A). The
severity of this defect supports the view that either not all of the motors in a
heterotetrameric motor are simultaneously modified, or that Eg5 undergoes a cycle of
phosphorylation and dephosphorylation in vivo.
In summary, these experiments revealed a significant mitotic phenotype in LLCPk1 cells expressing Eg5 with phosphomimetic and non-phosphorylatable mutations at
Y211, the same site that was shown to impact spindle assembly in Drosophila (Garcia et
al., 2009). Y211 is a particularly interesting site because it is conserved in both insects
and vertebrates, coinciding almost without exception with the presence of a –PXXP−
SH3-targeting domain (Fig. 4.1 B, Fig. 4.4 D). Conversely, neither Y211 nor the -PXXP−
motif is found in worms, which are viable with diminished levels of kinesin-5, suggesting
that this organism has evolved alternative pathways for establishing bipolar spindles
(Bishop et al., 2005).
Motor domain phosphorylation has also been described for the yeast kinesin-5,
Cin8p (Avunie-Masala et al., 2011; Shapira and Gheber, 2016; Shapira et al., 2017).
Only one of these sites, S337 (H. sapiens numbering) is in a region of the motor that is
conserved in Eg5. Phosphorylation of each of these sites has unique effects on motor
behavior including Cin8p microtubule binding, motor directionality, and velocity
(Shapira and Gheber, 2016; Shapira et al., 2017). Although the precise locations of these
modifications are not conserved from yeast to humans, one notable similarity amongst
these modifications is that the changes to Cin8p motor behavior are primarily mediated
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by electrostatic interactions, which we find to be a compelling hypothesis for the effects
of Eg5 Y211 phosphorylation given the available structural data. Future experiments
examining phosphorylation of kinesin-5 motors could illuminate the extent of their
modifications and could reveal a potential mechanism by which kinesin-5s are
differentially regulated to play similar, but non-identical, roles in varying cell types and
species.
Our results support a growing body of data identifying phosphoregulatory
mechanisms governing the activity of several different kinesin motors (for example:
(Chee and Haase, 2010; DeBerg et al., 2013; Garcia et al., 2009). Previously identified
Eg5 phosphoregulatory mechanisms target serine or threonine residues in the motor stalk
and tail, and have been reported to affect Eg5 localization to the spindle or centrosome
during mitosis (Blangy et al., 1995; Rapley et al., 2008). Our results showing
phosphorylation of Eg5 in its motor domain at Y125, Y211, and Y231 suggest that in
addition to altering motor localization, phosphoregulatory mechanisms can tune Eg5
enzymatic activity for optimal spindle morphology (Avunie-Masala et al., 2011; Garcia et
al., 2009). Furthermore, our data suggest this post-translational modification could affect
the efficacy of small molecule inhibitors that bind to L5, although further study is
required to gauge whether this has any practical implications for use of Eg5 inhibitors as
cancer therapy.
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4.3 Materials and Methods

4.3.1 In silico prediction of phosphorylated residues in Eg5 and targeting kinases
There are several databases summarizing the results of large-scale proteomics
experiments that provide evidence for the post-translational modification of specific
residues in thousands of proteins. We searched PhosphositePlus (Hornbeck et al., 2015)
and SysPTM (Li et al., 2009) for modifications entered for human Eg5 and narrowed the
list of modifications down to tyrosine phosphorylations. We also did a manual search of
PubMed articles for entries presenting phosphoproteomics experiments that included
human Eg5 in their results. These searches generated a list of putative tyrosine
phosphorylation sites in Eg5 (summarized in Fig. 4.4 B).
To generate hypotheses regarding possible kinases targeting human Eg5, we
entered its full sequence as found in the UniProt database (accession number P52732,
(UniProt, 2015) into the search engine found in the Scansite3 kinase predictor site
(Obenauer et al., 2003). We used the “medium stringency” setting, which returns kinases
for which the queried protein sequence is in the top percentile of sequences in the
vertebrate subset of SWISS-PROT matching the optimal targeting motif (Obenauer et al.,
2003). This search revealed three SFKs as possible kinases targeting the Y211 location.
It also revealed a –PXXP− SH3 targeting site.

4.3.2 Cloning
Mutagenesis of the Eg5-367 monomer construct has been described previously
(Larson et al., 2010). Briefly, Eg5-367 constructs for bacterial expression include the first
367 amino acids of H. sapiens Eg5 immediately followed by a C-terminal 6X-histidine
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tag in a pRSET plasmid. KLP61F-364 constructs include the first 364 amino acids of the
Drosophila kinesin-5, KLP61F, similarly followed by a 6X-histidine tag.
Phosphomimetic (Y->E) and non-phosphorylatable (Y->F) point mutations were made
using Quikchange site-directed mutagenesis (Agilent Technologies, Santa Clara, CA), as
were enzymatically inactive mutations (E270A in Eg5-367 and E266A in KLP61F). To
generate an Eg5-367 mutant lacking the -PXXP- SH3-targeting motif in its MT-binding
domain, site-directed mutagenesis was used to replace residues 305RTPH308 with the
homologous residues in H. sapiens kinesin-1 heavy chain (GSTY). This removes the
initial proline from the SH3 targeting motif. The resulting motor can still hydrolyze ATP
and bind MTs, albeit at reduced affinity (Table 4.1).
For expression in mammalian cells, we replaced the C-terminal 6X-histidine tag
of Eg5-367 constructs with a 10-residue Myc tag (EQKLISEEDL). Myc-tagged Eg5-367
constructs were then cloned into the pcDNA3 vector (gift of Dr. Cara Gottardi,
Northwestern University) between the Xho1 and HindIII restriction sites using Phusion
polymerase (New England Biolabs, Ipswich, MA). All constructs were verified by
sequencing. A mammalian c-Src construct in the pCMV-SPORT6 mammalian
expression plasmid was a kind gift from Dr. Thomas Smithgall, University of Pittsburgh.
This construct was mutated using Quikchange site-directed mutagenesis to generate a
constitutively active c-Src construct (Y527F). This constitutively active construct was
then further mutated to render it resistant to treatment with A-419259 (T338M, (Meyn
and Smithgall, 2009). All c-Src construct numbering refers to the structure of human cSrc (PDB: 1FMK).
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The Eg5-Emerald wild-type (Eg5-WT-Em) construct consisted of full-length
human Eg5 fused to pmEmerald with an 18 amino acid linker; expression is under the
control of a pCMV promoter. This construct was used to express fluorescent Eg5 in
LLC-Pk1 cells, was a gift from the late Dr. Michael Davidson Florida State University
and was made siRNA resistant using PCR site-directed mutagenesis (Forward primer:
GTCACAAAAGCAATGTGGAAACCTAACTGAAGATCTCAAGACTATAAAGCAG
ACCC; reverse primer:
CAAAGTTCCTGGGAATGGGTCTGCTTTATAGTCTTGAGATCTTCAGTTAGGTT
TCC) and verified by sequencing. Each mutant was then made in this backbone using
PCR site-directed mutagenesis and verified by sequencing.

4.3.3 Protein Expression and Purification
Expression and purification of Eg5-367 constructs has been described previously
(Larson et al., 2010). Briefly, 6x-His-tagged Eg5-367 and KLP61F-364 constructs were
transformed into E. coli BL21-CodonPlus(DE3)-RP cells for expression. Cells were
grown in TPM media (2% tryptone, 1.5% yeast extract, 137 mM NaCl, 14 mM
Na2HPO4) with in 50 µg/mL carbenicillin and 34 µg/mL chloramphenicol at 37  C while
shaking at 200 rpm until cells reached an OD600 between 0.6 and 1.0. Plasmid expression
was induced through the addition of 0.125 mM IPTG. Cells were allowed to express at
18  C overnight. 2 L cultures were then harvested by centrifugation (6,300 rpm for 10
min at 4  C) and re-suspended in 20 mL Eg5 lysis buffer (10 mM HEPES, 2 mM MgCl2,
1 mM EGTA, 5% sucrose, 0.02% polyoxyethylenesorbitan monolaurate (TWEEN-20),
10 M ATP, leupeptin (1 g/mL), aprotinin (1 g/mL), pepstatin (1 g/mL), and 100
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M PMSF, pH 8). Cells were lysed by sonication and the clarified lysate was batchbound with pre-equlibrated nickel-nitrilotriacetic acid resin (Qiagen, Valencia, CA) for 2
h at 4  C. The resin was washed with nickel wash buffer (10 mM HEPES, 2 mM
MgCl2, 1 mM EGTA, 5% sucrose, 0.02% TWEEN-20, 10 M ATP, 300 mM NaCl, and
20 mM imidazole, pH 6) and bound protein eluted in 5 mLs using nickel elution buffer
(10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 5% sucrose, 0.02% TWEEN-20, 10 M
ATP, 300 mM NaCl, and 400 mM imidazole, pH 6). Peak fractions were collected and
diluted 20-fold in Buffer A (10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 5% sucrose,
0.02% TWEEN-20, 10 M ATP, 1 mM DTT pH 6) to decrease the ionic strength of the
buffer. Diluted fractions were then purified further on a 5 mL HiTrap S-Sepharose cation
exchange column (GE Healthcare, Little Chalfont, UK). Protein was eluted using a linear
0.05-1 M NaCl gradient. Peak fractions were identified by SDS-PAGE and pooled.
After adding an additional 15% sucrose, protein was flash-frozen in liquid nitrogen and
stored at -80  C until use.

4.3.4 In vitro kinase assay
E. coli-purified Eg5-367 E270A and KLP61F-364 E266A proteins were first
dialyzed against Src kinase assay buffer (10 mM HEPES pH 6.8, 2 mM MgCl2, 1 mM
EGTA, 2.0 mM DTT, 10% glycerol, 0.02% TWEEN-20). Each reaction contained 3 μM
Eg5 protein, [32P]-ATP (Perkin-Elmer) to 50 nCi acitivity per reaction, and 200 μM
ATP. Src kinase (Invitrogen, Carlsbad, CA) was diluted to a concentration of 2 M in
assay buffer with 0.2 mg/mL BSA (Sigma-Aldrich, St. Louis, MO), and 2 L of this
solution was added to each 20 L reaction. Reactions were incubated at 30 º C for the
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indicated reaction times, quenched with SDS sample buffer and run on an SDS-PAGE
gels using the formulation of Laemmli (Laemmli, 1970). Gels were dried and exposed to
film for 30 min.
Wee1 kinase assays were performed identically except for the buffer used. A
Wee1 kinase assay buffer based on conditions cited by Garcia et al. (Garcia et al., 2009)
was used instead (50 mM HEPES ph 6.8, 15 mM MgCl2, 1 mM EGTA, 2 mM DTT, 10%
glycerol).

4.3.5 Coupled-enzyme ATPase assay
MTs were purified from porcine brains according to published protocol
(Mitchison and Kirschner, 1984). A subset were labeled with tetramethylrhodamine (as
described in (Hyman et al., 1991a). For use in coupled-enzyme ATPase assays, MTs
were prepared exactly as described in (Woehlke et al., 1997). ATPase assays were
performed as described previously, with 10-60 nM Eg5 protein (Huang and Hackney,
1994; Woehlke et al., 1997). Briefly, reactions were conducted in ATPase assay buffer
(10 mM HEPES, 2 mM MgCl2, 1 mM EGTA, 5% sucrose, 50 mM KCl, 500 nM ATP).
Eg5-367 protein and MTs were incubated with a coupled NADH oxidation system (0.3
M phosphoenolpyruvate, 0.5 M NADH, pyruvate kinase (11 U/mL), and lactate
dehydrogenase (10 U/mL)). We calculated the decrease in absorbance at 340 nm over
time to determine the ATPase rate. ATPase rates were determined at MT concentrations
from 60 nM - 4 μM, and data were fit to a Michaelis-Menten shown below (R2 > 0.8)
with kcat and K0.5, MTs as the only two fit parameters using KaleidaGraph software
(Synergy Software, Reading, PA). Errors shown are errors in fit parameters.
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𝜈=

𝑘𝑐𝑎𝑡 [𝑡𝑢𝑏𝑢𝑙𝑖𝑛]
𝐾0.5𝑀𝑇𝑠 + [𝑡𝑢𝑏𝑢𝑙𝑖𝑛]

4.3.6 Motility assay
For use in motility assays, a mixture of tetramethylrhodamine-labeled tubulin
(Cytoskeleton, Inc., Denver, CO) and unlabeled tubulin was combined 1:1 with a 2X
polymerization mix (80 mM Pipes buffer, 1 mM MgCl2, 1 mM EGTA, 2 mM GTP, 20%
DMSO, pH 6.8) and incubated at 37  C for 45 min. Paclitaxel (50 M) was then added
to stabilize MTs. For motility assays flow chambers were created using glass coverslips,
microscopy slides, and double-sided tape. Anti-His H8 antibody (ab18184, Abcam,
Cambridge, MA) in motility buffer (80 mM PIPES, pH 6.8, 2 mM MgCl2, 1 mM EGTA,
0.2 mg/mL BSA, 150 mM sucrose and 1 mM ATP) was incubated in the flow chamber
for two minutes. The flow chamber was then washed three times with motility buffer.
Next, the flow chamber was incubated with motility buffer containing Eg5-367 proteins
for two minutes, before being washed three times with motility buffer. Finally, motility
buffer containing an oxygen scavenging system (glucose oxidase (0.432 mg/mL),
catalase (0.072 mg/mL), glucose (45 mM), and -mercaptoethanol (61 mM), an ATP
regenerating system (2 mM creatine phosphate and 810 U/mL creatine phosphate), and
tetramethlyrhodamine-labeled polymerized MTs stabilized with GTP (1 mM) and
paclitaxel (100 M) was flowed into the cell, which was then sealed with vacuum grease.
MT sliding was visualized on a Nikon TE-2000 E microscope fitted with a X60 objective
(N. A. 1.4) using epifluorescence. Images were captured using a Photometrics CoolSnap
EZ camera (1392 x 1040 imaging pixels, 6.45 x 6.45 m/pixel) and Metamorph software.
The concentration of MTs and Eg5-367 construct was adjusted to promote sliding
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populations suitable for tracking and quantification. For Eg5-367, Eg5-367 nonphosphorylatable, and Eg5-367 GSTY mutants, movies were 30 minutes long with a 20
second interval between frames. For Eg5-367 DL5 and Eg5-367 phosphomimetic
mutants, movies were one hour long with a 40 second interval between frames to
accommodate slower sliding velocities while minimizing photobleaching of MTs. We
reported the mean non-zero sliding velocity calculated in the following manner. We
tracked the ends of individual fluorescent MTs using the ImageJ plug-in MTrackJ. This
plug-in calculates a step velocity based on the difference in location between consecutive
frames in a movie. For each movie we tracked 3-7 MTs for a total of  190 step velocity
measurements per slide. The non-zero mean velocity and standard deviation of these
measurements for each individual slide were calculated using Microsoft Excel. For each
Eg5-367 we calculated the weighted average and standard deviation for all step velocity
measurements from three different movies to generate the final average velocity and
standard deviation reported in Table 4.1.

4.3.7 Transient Transfection and Nucleofection of Mammalian Cell Lines
HEK293T cells, the kind gift from Dr. Cara Gottardi, Northwestern University,
were cultured in 100 mm dishes containing DMEM medium (Corning Life Sciences,
Tewksbury, MA) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals,
Flowery Branch, GA) and penicillin/streptomycin (200 U/mL, Life Technologies,
Carlsbad, CA) in 5% carbon dioxide (CO2) at 37  C. LLC-Pk1 cells were cultured in 1:1
Ham’s F-10 medium and Opti-MEM (Life Technologies, Carlsbad, CA) supplemented
with 7.5% FBS and 1X antibiotic/antimycotic solution (final concentrations 100 U/mL
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penicillin, 0.1 mg/mL streptomycin, 0.25 g/mL amphotericin B; Sigma-Aldrich, St.
Louis, MO) at 37  C and 5% CO2.
To transfect HEK293T cells, 100 mm plates at 70-80% confluence were
transfected with 2 μg of DNA using the Effectene transfection reagent (Qiagen, Redwood
City, CA), and allowed to express for 24 h.
LLC-Pk1 cells (parental or expressing mCherry- Tubulin) were transfected
using an Amaxa nucleofector (Lonza, Portsmouth, NH) using program X-001 and Mirus
nucleofection reagent (Mirus Bio LLC, Madison, WI) according to the manufacturers
recommendations. siRNA used to target endogenous Eg5
(CUGAAGACCUGAAGACAAU) was obtained from Dharmacon (GE Healthcare Life
Sciences, Pittsburgh, PA). Following nucleofection, cells were plated on #1.5 coverslips
or Mattek glass bottom dishes (Mattek Corporation, Ashland, MA). Cells were used at
72 hours following nucleofection.

4.3.8 Inhibitors
For treatment of cells with the SFK inhibitor A-419259 (Sigma Aldrich, St. Louis,
MO), the protocol developed and verified by the Smithgall lab was followed (Meyn and
Smithgall, 2009). Specifically, A-419259 was dissolved in water (100 M stock
solution), aliquoted, and stored at -20  C. Twenty-four hours prior to harvest, cell
culture media was aspirated from plates and carefully replaced with warmed media
containing A-419259 (1 M final concentration). Cells incubated at 37  C and 5% CO2
until harvest. In cases where cells were both transiently transfected and treated with A419259, the SFK inhibitor was added to cell media during the transfection procedure.
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Stock solutions of SU6656 and BI-2536 were prepared in DMSO, stored at -20°C
and diluted into culture medium before use. SU6656 was used at a final concentration of
500 nM and BI-2536 was used at 2 M. Each was incubated on cells for 15-30 min prior
to fixation.

4.3.9 Immunoprecipitation and 2-color Western Blot
Before harvesting, mammalian cells were first treated with pervanadate to inhibit
phosphatase activity. Briefly, hydrogen peroxide (1.7%) was added to PBS containing 5
mM sodium orthovanadate to convert it to pervanadate, after which exposure to light was
limited. Next, 0.5 mL of this solution was added to warmed DMEM to generate a final
media concentration of 0.25 mM pervanadate. Existing media was then aspirated off
each plate of cells and gently replaced with DMEM containing pervanadate. Cells were
then incubated at 37  C and 5% CO2 for 30 minutes. Next, cells were dislodged from
the plate with a cell scraper and pelleted at 1000 x g for 5 minutes. The media was then
aspirated off and pellets were re-suspended in PBS containing calcium (0.9 mM) and
magnesium (0.49 mM) and washed 3 times. Finally, cells were re-suspended in 1%
Triton lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 1%
Triton X-100, plus COmplete protease and PhosStop phosphatase inhibitor tablets
(Roche, Mannheim, Germany)) and incubated on ice for one hour. Total protein
concentration of lysate samples was determined using a standard Bradford assay. All
samples were normalized to the same protein concentration.
To immunoprecipitate endogenous Eg5, 5 L of the polyclonal rabbit anti-Eg5
antibody NB500-181 (Novus Biologicals, Littleton, CO) was added to 2.0 mg total
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protein lysate in the case of HEK293T lysates or 2.5 mg total protein lysate in the case of
LLC-Pk1 lysates and incubated while rotating for 2 h at 4  C. To create IgG isotype
controls, 1 L of rabbit IgG (EMD Millipore, Billerica, MA) was added to 2.0 mg of total
protein lysate and incubated similarly. Then, 60 L of pre-equilibrated 50% Pierce
Protein A agarose resin slurry (ThermoFisher Scientific, Rockford, IL) was added to each
sample, which were then incubated while rotating for another 2 h at 4  C. To
immunoprecipitate transfected myc-tagged Eg5-367 constructs, 25 μL of pre-equilibrated
goat anti-myc beads, epitope EQKLISEEDL (Bethyl, Montgomery, TX), were tumbled
with 2.0 mg of cell lysate for 3 h at 4  C. After 3 washes with 1% Triton lysis buffer and
one wash with 0.1% Triton lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM
EDTA, 5% glycerol, 0.1% Triton X-100, plus COmplete protease and PhosStop (Roche,
Mannheim, Germany) inhibitor tablets), beads were re-suspended in 30 L of 2X SDSPAGE sample buffer (200 mM Tris-Cl, 0. 130 mM SDS, 33 mM DTT, 3 mM
bromophenol blue, 20% glycerol, pH 6.8), boiled for 20 minutes, and run on a 6% SDSPAGE gel overnight. For loading controls and verification of transfection, prior to
immunoprecipitation we retained 2.5% of each 2.0 mg total protein lysate sample, to
which we added an equal volume of hot 6X SDS-PAGE sample buffer (300 mM Tris-Cl,
0.4 M SDS, 0.1 M DTT, 9 mM bromophenol blue, and 60% glycerol). Each input
sample was then boiled for 20 min and run on a 9% SDS-PAGE gel overnight.
After transfer to nitrocellulose (0.45 m, Thermo Fisher Scientific, Waltham,
MA), and blocking with 5% non-fat dehydrated milk in PBS at room temperature for one
hour and washing three times with TBS containing 0.1% TWEEN-20 (TBS-T), we
probed with primary antibodies in 5% BSA in TBS while rocking at 4  C overnight. For
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detection of endogenous Eg5 we used 1:5000 polyclonal rabbit anti-Eg5 NB500-181
antibody (Novus Biologicals, Littleton, CO). For detection of myc-tagged Eg5 constructs
we used 1:5000 rabbit anti-myc ab9106 antibody (Abcam, Cambridge, MA). To probe
for pTyr we used 1:200 mouse anti-pTyr PY20 antibody (sc-508, Santa Cruz
Biotechnology, Dallas, TX). To detect -catenin and -tubulin as loading controls, we
used 1:250 mouse anti--catenin BD160154 antibody (BD Biosciences, San Jose, CA)
and 1:5000 mouse anti--tubulin AA2 antibody (Sigma-Aldrich, St. Louis, MO),
respectively. To probe for c-Src, we used 1:200 rabbit anti-c-Src SRC2 antibody (sc-18,
Santa Cruz, Dallas, TX). After briefly washing blots three times with TBS containing
0.1% TWEEN-20, we incubated them in secondary antibodies diluted in 5% non-fat
dehydrated milk in TBS at room temperature for one hour while rocking. For detection
of all rabbit antibodies, we used a 1:5000 dilution of the donkey anti-rabbit IRDye
680RD fluorescent antibody (LI-COR, Lincoln, NE). For detection of all mouse
antibodies, except for the anti-pTyr PY20 antibody, we used a 1:5000 dilution of the
donkey anti-mouse IRDye 800CW (LI-COR, Lincoln, NE). The pTyr antibody signal
was below the minimum detection limit of fluorescent secondary antibodies. Instead, we
used a 1:5000 dilution of a goat anti-mouse IgG-HRP conjugate secondary antibody (BioRad, Hercules, CA) for detection by chemiluminescence, which amplifies the signal.
After incubation in secondary antibodies, blots were washed three times with TBS-T.
Blots exposed only to fluorescent secondary antibodies were then dried for 20 min
sandwiched between paper towels in a drawer. Blots exposed to the HRP-conjugate
secondary antibody were instead developed for 20 min using the Pierce ECL2 Western
Blotting substrate (Thermo Fisher Scientific, Rockford, IL) and imaged while wet. All
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blots were imaged on a LI-COR Odyssey Fc imaging system (Lincoln, NE). Fluorescent
antibody exposure times were 2 min; chemiluminescent detection occurred over 10 min.
Entire images were contrast-adjusted using LI-COR Image Studio software without
altering gamma settings before being exported to Adobe Illustrator for preparation for
publication.

4.3.10 Phosphatase Assay
To verify that signal from the anti-pTyr antibody was specific to phosphorylated
protein and not due to non-specific binding, we submitted our immunoprecipitated
endogenous Eg5 to a lambda protein phosphatase assay according to the commercial
protocol that came with the lambda protein phosphatase used (New England Biolabs,
Ipswich, MA). Briefly, we immunoprecipitated Eg5 from 4.0 mg of HEK293T cell
lysate by doubling reagents in the preceding protocol. After incubation with Pierce
Protein A agarose resin (Thermo Fisher Scientific, Rockford, IL), we washed the beads 3
times with 1% Triton lysis buffer lacking protease and phosphatase inhibitor tablets, and
once with 0.1% Triton lysis buffer lacking protease and phosphatase inhibitors. After the
final wash the beads were re-suspended in an equal volume of 0.1% Triton lysis buffer
lacking inhibitors, divided into two separate and equal samples. Both samples were spun
down briefly in a tabletop microcentrifuge and the supernatants removed by aspiration.
The resin in one sample was re-suspended in lambda protein phosphatase assay buffer
(50 mM Hepes, 100 nM NaCl, 2 mM DTT, 0.01% Brij 35, 1 mM MnCl2) containing
lambda protein phosphatase (8000 U/mL). The resin in the other sample was resuspended in lambda protein phosphatase buffer without the enzyme as a negative
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control. Both samples were incubated at 30  C for an hour while agitating. Lambda
protein phosphatase reactions were quenched by the addition of 50 L of 2X SDS-PAGE
sample buffer, boiled for 20 min, and run on an SDS-PAGE gel overnight. They were
blotted for endogenous Eg5 and pTyr as described above.

4.3.11 Mammalian Cell Fixation and Immunofluorescence
LLC-Pk1 cells were rinsed twice with room temperature PBS lacking calcium and
magnesium and were then fixed for 10 minutes in 2% paraformaldehyde, 0.25%
glutaraldehyde, and 0.5% Triton X 100, made fresh daily in PBS lacking calcium and
magnesium. Fixed cells were rinsed in PBS containing 0.02% TWEEN-20 and 0.02%
sodium azide (PBS-Tw-Az), treated with sodium borohydride (10mg/10mL H2O) for 10
minutes and then rehydrated in PBS-Tw-Az. The following antibodies were used:
Phospho Aurora-A/B/C (Cell Signaling Technology, Danvers, MA); tubulin, DM1α
mouse anti-tubulin (Sigma-Aldrich) or YL1/2 rat anti-tubulin (Accurate Chemical and
Scientific Corporation, Westbury, NY) and appropriate secondary antibodies as
previously described (Ma et al., 2011). Primary antibodies were mixed with 2% BSA in
PBS-Tw-Az to block non-specific binding and used at the following final dilutions:
Phosoho Aurora-A/B/C 1:1,000, DM1α and YL1/2 1:100; cells were incubated in
primary antibodies for 1 hour at 37°C. Stained cells were mounted on glass slides using
DAPI Fluomount G (Southern Biotech, Birmingham, AL) to stain DNA.
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4.3.12 Immunofluorescence Microscopy/Imaging
To quantify mitotic phenotypes of fixed cells, a Nikon Eclipse Ti with an X-Cite
series 120Q excitation light source, and a 100 X, 1.3 N.A., objective lens, was used.
Images of fixed cells were acquired using a CSU-10 Yokogawa spinning-disk confocal
scan head on a Nikon TE300 as previously described (Tulu et al., 2003). Transfected
cells (identified by the Eg5-Emerald signal) were classified by spindle morphology based
on microtubule staining as bipole, multipole, monopole, or disorganized. Disorganized
spindles included spindles with extra foci, fragmented poles, short spindles, no pole, and
bent spindles. For live cell imaging, a Nikon Ti-E microscope with a CSU-X1 Yokogawa
spinning-disk confocal scan head (PerkinElmer, Wellesley, MA), an Andor iXon+
electron-multiplying charge-coupled device camera (Andor), and a 100×/1.4 NA
objective lens was used. For live-cell imaging, exposures were adjusted without
saturating the camera’s pixels; typical exposures were 50–800 ms.
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Table 4.1 Effects of phosphomimetic and non-phosphorylatable mutations on Eg5
motor characteristics and STLC binding.
Construct Velocity

kcat (s-1)

K0.5(MT) (μM)

(nm/s)

KD - STLC

N (STLC)

(nm)

WT

11.7 ± 3.4

7.01 ± 0.15

0.073 ± 0.008

86±21

1.07

DL5

4.2 ± 1.3

2.09 ± 0.07

0.181 ± 0.023

--

--

GSTY

12.3 ± 3.2

7.60 ± 0.38

0.261 ± 0.047

--

--

Y125E

4.9 ± 1.2

6.47 ± 0.25

0.128 ± 0.022

540±150

0.95

Y211E

4.4 ± 1.2

2.95 ± 0.15

0.336 ± 0.053

1600±250

0.74

Y231E

11.0 ± 3.0

8.68 ± 0.28

0.231 ± 0.024

304±32

0.89

Y125F

12.5 ± 3.5

5.42 ± 0.11

0.63 ± 0.008

42±18

1.03

Y211F

12.5 ± 3.4

4.94 ± 0.07

0.089 ± 0.009

45±6.0

0.62

Y231F

14.9 ± 3.8

7.33 ± 0.25

0.086 ± 0.017

55±19

1.09

Steady-state ATPase rates and MT sliding velocities of Eg5 phosphomimetic (E) and
non-phosphorylatable (F) mutants were measured and compared to those of Eg5-367-WT
and Eg5-367-DL5 mutants using standard in vitro assays (Methods). Dissociation
constants of the L5 inhibitor STLC to Eg5-367 phosphomimetic and nonphosphorylatable mutants (KD) was calculated from ITC titrations. Errors in KD were
estimated based on the nonlinear least-squares fits to raw ITC data. Stoichiometries (N)
show some variability reflecting protein concentration determination, but are generally
consistent with single-site binding.
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Figure 4.1 Human Eg5 is phosphorylated on tyrosine residues. (A) Two-color
Western blot showing endogenous Eg5 immunoprecipitated from HEK293T or LLC-Pk1
cell lysates, with each channel displayed separately in black and white. A-419259 was
added as indicated; the lower panel shows a β-tubulin loading control (green). (B) The
structure of Eg5 bound to S-trityl-L-cysteine (STLC) is marked with tyrosines Y125,
Y211, and Y231 (orange space fill, PDB: 3KEN). A predicted SH3 binding site in the
MT-binding site of the Eg5 motor domain is shown in the inset. L5 is shown in dark blue;
Loop 12 within the MT binding domain is shown in red. (C) Sequence alignment
comparing the putative phosphorylation sites and the –PXXP− SH3 targeting domain.
Putative phosphorylated tyrosines and the –PXXP− SH3 targeting motifs are shown in
red. The accession numbers for each protein are listed in Fig. 4.4 C.
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Figure 4.2 SFK dependent phosphorylation of Eg5 in vitro and in mammalian cells.
Kinesin-5 constructs (denoted across the top) were incubated with human c-Src (A) or
human Wee1 kinase (B) and radiolabeled ATP for the times indicated. Reactions were
quenched and run on an SDS-PAGE (top) that was then dried and exposed to film
(bottom). Position of c-Src, Eg5, and Wee1 marked on the left side.
(C)
Immunoprecipitation of Eg5 from HEK293T cells co-transfected with myc-tagged Eg5
motor head and c-Src constructs; A-419259 added as indicated. Western blot stained
using anti-myc and anti-pTyr antibodies which here are displayed separately in black and
white. The lower panel shows inputs and β-tubulin level as a loading control. (D)
Endogenous Eg5 was immunoprecipitated from HEK293T cells transfected with the
indicated constructs; A-419259 was added as indicated. pTyr was detected using a twocolor Western blot. Each channel is displayed separately in black and white.
Transfection efficacy was verified by detection of c-Src in the lysates from transfected
cells. -catenin level is shown as a loading control.
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Figure 4.3 Mitotic spindle defects in cells expressing phosphomimetic and nonphosphorylatable mutants of Eg5. (A) Percent of mitotic phenotypes in LLC-Pk1 cells
transfected with siRNA targeting endogenous Eg5 alone or co-transfected with an siRNA
138

resistant Eg5 Emerald construct (WT, Y211E, Y211F, GSTY). Monopole (yellow),
bipole (red), muitipole (blue), disorganized (green). Examples of each phenotype are
shown on right. (B) Time-lapse imaging of LLC-Pk1 cells expressing mCherry-α-tubulin
(right panels) co-transfected with Eg5 siRNA and siRNA resistant Eg5 Emerald
constructs (WT, Y211E, and Y211F left panels). (C) Immunofluorescence staining for
MTs in control (left) and SU6656-treated (right) parental LLC-Pk1 cells. (D)
Quantification of mitotic spindle phenotypes shown in C. (E) Immunofluorescence
staining for MTs (top) and phospho-Aurora (bottom) for control and SU6656 treated
cells. (F) Immunofluorescence staining of -tubulin in anaphase LLC-Pk1 cells: control
(top), BI-2536 (middle), SU6656 (bottom). ** = p ≤ 0.01. Scale bars in A, B, C, E, F = 5
μm. Time in B (min:sec). Error Bars = St Dev.
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Figure 4.4 Eg5 is phosphorylated on a conserved tyrosine in its motor head. (A) A
single immunoprecipitation reaction from HEK293Ts (3.5 mg total lysate) was divided in
two. Half was incubated with λ-phosphatase (right); the other was incubated with
phosphatase buffer alone (left). (B) Table summarizing Eg5 tyrosine phosphorylations as
reported in databases collecting results from phosphoproteomics experiments, including
PhosphositePlus (Hornbeck et al., 2015). (C) Table showing the UniProt Accession
numbers used to generate the alignment of kinesin-5 family members in Figure 4.1 C.
(D) Alignment of kinesins from families 1-7, highlighting the MT binding region. The –
PXXP- SH3 targeting motif, when present, is highlighted in red. Residues that are
identical across the alignment are marked in dark grey, while similar residues are marked
in light grey. While there is extensive conservation of sequence in this region across
kinesin family members, the PXXP motif is only seen in kinesin-5s of higher order
organisms. (E) List of the sequence mutations made in Eg5 constructs and (F) other
constructs for experiments using Eg5 mutants.

Figure 4.5 Eg5-targeting siRNA decreases endogenous Eg5 levels. Western blot
showing the efficiency of Eg5 knockdown using siRNA in LLC-Pk1 cells. Treatment
with siRNA led to an approximately 50% reduction in Eg5 signal as measured by
densitometry.
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CHAPTER 5

PROTEIN TAGGING AT THE ENDOGENOUS LOCUS AS A TOOL FOR
STUDYING MITOTIC PROTEIN DYNAMICS AND LEVELS

5.1 Introduction

Cell division is a carefully controlled, dynamic process, which ensures that
genetic material is equally segregated between daughter cells. Mitosis requires precise
spatial and temporal regulation of proteins to guarantee proper division. Understanding
where and when these proteins localize and their local concentrations would help us gain
insight into this basic, dynamic biological process.
Kinesin-5 is an essential motor protein that has been extensively studied
(reviewed (Ferenz et al., 2010; Singh et al., 2018; Waitzman and Rice, 2014)). The
human kinesin-5, HsEg5, is a homotetrameric, bipolar, protein that crosslinks parallel and
antiparallel microtubules generating force between microtubules (Kapitein et al., 2005;
Shimamoto et al., 2015). When these microtubules are antiparallel, outward forces are
generated that antagonize inward forces caused by the minus-end directed activity of
Dynein (Ferenz et al., 2009a; Mitchison et al., 2005; Sharp et al., 2000a; Tanenbaum et
al., 2008). Cells depleted of Eg5 or treated with Eg5 specific inhibitors fail to establish
bipolar mitotic spindles (Ferenz et al., 2010; Kapoor et al., 2000; Mayer et al., 1999).
Despite decades of study, how Eg5 is regulated to achieve spindle bipolarity remains
incompletely understood.
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TPX2 is a multifunctional, microtubule associated protein first identified for its
role in dynein-dependent targeting of the Xenopus kinesin-12, Xklp2, to spindle poles
(Wittmann et al., 1998). During interphase, TPX2 resides in the nucleus due to
importin-α/β binding to a nuclear localization signal. Following nuclear envelope
breakdown, RanGTP binds importin-α/β releasing active TPX2 (Gruss et al., 2001; Gruss
and Vernos, 2004; Schatz et al., 2003). Reduction in TPX2 by siRNA results in short
bipolar or multipolar spindles that fail to progress through mitosis due to the essential
roles TPX2 plays in spindle formation (Garrett et al., 2002; Gruss et al., 2002). The Nterminus of TPX2 activates and targets the mitotic kinase Aurora A to spindle
microtubules, which then phosphorylates TPX2 contributing to spindle flux (Fu et al.,
2015b; Kufer et al., 2002). TPX2 also nucleates microtubules around chromosomes,
stabilizes microtubules, regulates motor proteins, and is involved in microtubule branch
formation in vitro (Alfaro-Aco et al., 2017; Drechsler et al., 2014; Mann et al., 2017;
Petry et al., 2013; Reid et al., 2016; Tulu et al., 2006; Vanneste et al., 2009).
TPX2 has been reported to show a distribution on the spindle that overlaps with
Eg5 (Ma et al., 2011). The C-terminal 37 amino acids of TPX2 facilitate localization of
both Eg5 in vivo and inhibit motor walking on microtubules in vitro (Balchand et al.,
2015; Eckerdt et al., 2008; Ma et al., 2011; Ma et al., 2010). In cells, active Eg5 is needed
on microtubules to separate centrosomes and form a bipolar spindle (Kashina et al.,
1997). Eg5 also plays a role on interpolar microtubules in anaphase to facilitate spindle
elongation (Scholey et al., 2016), suggesting that TPX2 may not globally inhibit Eg5.
Identifying when and where these proteins localize to specific spindle regions
may provide clues as to where Eg5 is actively sliding microtubules and generating forces
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and where TPX2 regulates its activity in vivo. Knowing the relative levels of these
proteins will also provide insight into how TPX2 is able to perform all of its mitotic
functions. Further, Eg5 has been shown in vitro to produce both pushing and braking
forces that scale with motor number and microtubule length (Shimamoto et al., 2015) but
how this relates in vivo remains unclear. Quantification of protein concentrarion in
mammalian cells may help address these questions.
We therefore wanted a reliable system for protein quantification in vivo. In yeast,
fluorescent protein tagging at endogenous loci has allowed researchers to ask questions
about protein copy numbers and stoichiometry both globally and locally
(Dhatchinamoorthy et al., 2017; Joglekar et al., 2006; Lawrimore et al., 2011; Wu and
Pollard, 2005). Although some labs have attempted to quantify proteins in mammalian
cells, protein overexpression was used (Johnston et al., 2010; Suzuki et al., 2015).
Recent advances in genetic engineering in mammalian cells have made it possible
to tag proteins at the endogenous locus (Dambournet et al., 2014; Mali et al., 2013; Ran
et al., 2013). With these approaches, it has also come to light that our understanding of
dynamic processes may be incomplete or incorrect due to the technical limitations of
previously used methods (Dambournet et al., 2014). For example, when the distribution
of clathrin tagged at the endogenous locus was compared to the same protein expressed
from a plasmid, differences in both the abundance and distribution were observed (Doyon
et al., 2011).
To understand how pervasive this situation might be we tagged TPX2 and Eg5
using CRISPR/Cas9 and examined the distribution along the spindle throughout mitosis.
The results obtained with CRISPR tagging differ from either expression from a BAC
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(Gable et al., 2012) or via antibody staining, suggesting that novel insight can be gained
by tagging proteins at the endogenous locus. Further, through quantitative imaging we
found that TPX2 and Eg5 display distinct patterns of localization throughout mitosis;
TPX2 is absent in areas where Eg5 activity is required. These results not only further
strengthen the evidence that endogenous tagging may provide new understanding of
dynamic processes, such as mitosis, but also be used for protein quantification by
fluorescence in vivo.

5.2 Results

5.2.1 Knock-sideways is functional and rapidly moves motor proteins
Determining when proteins are specifically needed in mitosis requires a method to
control protein localization and function with better temporal control than siRNA. Cells
use compensatory pathways when proteins are depleted by methods such as siRNA; it
can take days to reach desired depletion levels and other pathways can mask the effect of
protein loss (Wordeman et al., 2016). Small molecule inhibitors provide temporal control
that allows for rapid inactivation, however, only a small percentage of proteins have
specific inhibitors. Alternately, researchers can inject single cells with antibodies that
specifically target a protein rendering it inactive, though this also has its disadvantages
(i.e. low number and time consuming). Recently, several novel approaches have been
developed to inactivate proteins with improved temporal resolution. For example,
proteins can be tagged with an Auxin-inducible degron, which induces rapid degradation
by the proteasome following addition of Auxin or, Rapamycin-induced dimerization in
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which fusion proteins with dimerization tags are used (Holland et al., 2012; Robinson et
al., 2010; Wordeman et al., 2016).
We decided to adapt the “knock-sideways” approach for our system. To establish
the functionality of knock-sideways, we chose to re-localize Eg5. There are specific small
molecule inhibitors of Eg5 (STLC/Monastrol), which prevent ATP hydrolysis and
ultimately the ability to bind microtubules (Kapoor et al., 2000; Mayer et al., 1999).
When Eg5 is not bound to microtubules early in mitosis, outward forces cannot be
generated resulting in spindles collapsing into monopoles. Therefore, if we knock Eg5
sideways, then we would expect to see monopolar spindles indicating that we can relocalize proteins to produce physiologically relevant phenotypes.
We therefore generated an LLC-Pk1 cell line expressing an siRNA resistant Eg5FKBP-GFP and mCherry-Tubulin (Fig. 5.1A; Methods). To these cells we conucleofected siRNA, to knock down endogenous Eg5, and the FRB “trap” (LDR-FRBBFP) (Wordeman et al., 2016). Cells containing Eg5-FKBP-GFP, mCherry-Tubulin, and
FRB-BFP were bipolar in the absence of Rapamycin (Fig. 5.1B). Upon addition of
200nM Rapamycin for ~30 min, Eg5-FKBP-GFP re-localized to the membrane and
spindles collapsed into monopoles (Fig. 5.1B) and this was specific to cells expressing
both the trap and Eg5; cells with no FRB-BFP remained bipolar even in the presence of
Rapamycin (Fig. 5.1B).
These results not only highlighted the functionality of Knock-sideways but how
quickly it could produce a phenotype. We therefore wanted to determine how fast relocalization occurs. For this, we used a CRISPR modified cell line where we Cterminally tagged Dynein Heavy Chain (DHC) with FKBP-GFP (Fig. 5.1C; methods).
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We chose Dynein (DHC) because it is expressed and functional in both interphase and
mitosis (reviewed (Roberts et al., 2013)) allowing us to observe its movement in any cell
that was expressing both the FKBP and FRB. We nucleofected the FRB-BFP membrane
targeted trap and added the Rapamycin during time-lapse image acquisition. Within 2-3
minutes, the diffusive GFP observed in the cytoplasm of interphase cells began to relocalize to the membrane (Fig. 5.1D). Taken together, these results indicate that knocksideways has physiological functionality and provides high temporal control. Due to the
success of our knock-sideways initial experiments, we decided to tag other mitotic
proteins at the endogenous locus using CRISPR/Cas9 but unfortunately only yielded
heterozygotes (see section xxx; Discussion) and thus prohibited further knock-sideways
experiments.

5.2.2 Generating CRISPR cells for protein localization
In order to generate mammalian cells expressing proteins that were fluorescently
tagged at the endogenous locus, we added a C-terminal EGFP tag using CRISPR/Cas9 in
HeLa cells (Methods; Fig. 5.2A; Fig. 5.3A). To do this a cassette containing the coding
sequence for EGFP and a selectable marker was inserted downstream of each gene. After
introduction of Cas9 and the repair cassette by nucleofection, only those cells that had
undergone homologous recombination survive in antibiotic containing medium
(Methods). Genotyping of clonal populations revealed that approximately half of all
selected clones (6/10 Eg5 and 2/5 TPX2) were modified; of the clones that were
genotyped (3 and 2 Eg5 and TPX2 respectively), all were heterozygous, with one allele
tagged with the EGFP and the other wild-type (Fig. 5.3A, B). Western Blotting of total
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cell extracts of cell clones, using Eg5 or TPX2 specific antibodies also verified genotypes
(Fig. 5.3C, D). Quantification of Western blots showed that Eg5 clones expressed ~50%
(55 ± 3.7%) EGFP tagged and ~50% (44.9 ± 3.7%) untagged protein. In contrast, TPX2
clones expressed ~20% (20.7 ± 2.4%) tagged vs. ~80% (79.3 ± 2.4%) untagged protein.
Because we used HeLa cells for tagging and these cells are known to have irregular
karyotypes (Landry et al., 2013; Macville et al., 1999) we wanted to ensure that
expression in our TPX2 tagged cells was stable over time. In order to test this, we
passaged the cells for >30 passages and compared the protein expression levels to the
earlier passage number (Fig. 5.3C). No difference in the expression levels was observed
indicating that this clone was stable over the period of our analysis (see Discussion).
Finally, both the TPX2 and Eg5 CRISPR modified cells display mitotic morphology
indistinguishable from the parental HeLa cells (Fig. 5.3E) and progressed through mitosis
without any abnormalities, suggesting that the tag does not interfere with mitosis in these
cells. In summary, this approach is a straightforward method to generate clonal cell
populations with fluorescent tags at the endogenous locus. Because large numbers of
cells are present following selection, testing additional clones is likely to yield
homozygous lines. For the present experiments, having a fluorescent tag at both alleles is
not required, so the heterozygous cells were used for the following experiments.

5.2.3 TPX2 but not Eg5 is enriched relative to microtubules at spindle poles
The CRISPR modified cells were used to quantify protein distribution throughout
mitosis. This is important because knowing the distribution and relative levels of
proteins in the mitotic spindle can provide information about the mechanisms by which
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the proteins might interact and function. In previous work, enrichment of mitotic
proteins, including Eg5 and TPX2, at spindle poles has been reported; however, the
extent of enrichment, and if a given protein is enriched relative to microtubules, which
are also more condensed at spindle poles, has not been established.
To measure protein distribution along the spindle axis, cells were arrested in
metaphase using MG132 and Z-stacks of metaphase cells were acquired using spinning
disc confocal microscopy (Methods). The distribution of Eg5 and TPX2 was measured
using line scans along the pole-to-pole axis and additionally by quantifying fluorescence
in selected regions: near the pole, in front of kinetochores and at the spindle midzone
(Methods; Fig. 5.2). The results show that each protein is enriched at spindle poles
relative to the midzone, consistent with earlier work. TPX2 was nearly 2-fold more
enriched at poles compared to Eg5 (5 ± 1.12X vs. 2.6 ± 0.63X respectively) in cells with
and without microtubule labels (Fig. 5.2D, Fig. 5.6A). When the level of each tagged
protein was compared near the pole and just in front of kinetochores, however, there was
a more similar enrichment for Eg5 and TPX2 (1.27 ± 0.22X vs. 1.48 ± 0.2X respectively)
however they were still significantly different (p=0.01) (Fig. 5.6B). In summary, these
results demonstrate that Eg5 and TPX2 have distinct distributions on the spindle,
suggesting independent mechanisms for localization.
To determine if Eg5 and TPX2 were enriched relative to microtubules, we
additionally imaged microtubules in the CRISPR cells. This was done in two different
ways. First, Eg5-EGFP cells were transfected with mCherry tubulin, selected, and sorted
using flow cytometry. The second way microtubules were labeled was using SiR Tubulin
(Methods) (Hueschen et al., 2017) under conditions that had no detectable effect on
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mitotic spindle morphology. In either case, similar ratios of tubulin at the pole compared
to the midzone (2.3X for both) were obtained, and thus data from both approaches were
averaged. When the enrichment level of each protein was compared to that of tubulin,
the results show that Eg5 is not significantly enriched at spindle poles relative to
microtubules, with a ratio of ~1 (1.2 ± 0.36X). In contrast, TPX2 was ~2 fold (2.2 ±
0.41X) enriched relative to microtubules. When the levels of Eg5 and TPX2 were
compared to the microtubules near the pole and just in front of kinetochores, Eg5 was not
enriched relative to microtubules while TPX2 was still slightly enriched (1.00 ± 0.13X,
Eg5; 1.28 ± 0.16X, TPX2) (Fig. 5.4B).
As a control for our analysis method, cells expressing CRISPR tagged HURP
were used. Unlike Eg5 and TPX2, HURP has been shown to be enriched towards
kinetochores not poles (Koffa et al., 2006; Sillje et al., 2006). HURP indeed shows a
distinct distribution from Eg5 and TPX2, and quantification shows that it is not enriched
at the poles either alone or relative to tubulin (Fig. 5.2 B, C, D).
Because these data suggest that Eg5 and TPX2 are distributed differently along a
metaphase spindle we were curious what their relative protein levels were on the spindle.
On average, there was ~4 fold (3.9X) more TPX2 on a metaphase spindle than Eg5 (Fig.
5.2E), and this relationship was constant throughout all stages of mitosis (Fig. 5.8A).
Additionally, by measuring the total cellular fluorescence and spindle-associated
fluorescence for both Eg5 and TPX2, the fraction of each protein that is spindle
associated can be determined. The data show that on average only a fraction of the total
fluorescence (19.8% Eg5 and 33.9% TPX2) was associated with the spindle, regardless
of mitotic stage (Fig. 5.8B, C).

156

5.2.4 Immunofluorescence quantification of metaphase spindles
Next we wished to compare the distribution of Eg5-EGFP and TPX2-EGFP
obtained using CRISPR tagged cells with the distribution obtained using conventional
immunofluorescence. To do this, parental HeLa cells were arrested at metaphase using
MG132, fixed and stained for microtubules and either TPX2 or Eg5 and Z-stacks of
metaphase cells were acquired using spinning disc confocal microscopy as with the live
cells. Analysis was performed identically to the live cells (Fig. 5.6). In the case of
TPX2, protein distribution on the spindle was similar to that obtained using the CRISPR
EGFP tagged cells, although there is increased spindle-to-spindle variability using
immunofluorescence (Fig. 5.6 A, B, C). In the case of Eg5, however, the results obtained
with immunofluorescence suggest that Eg5 is concentrated relative to microtubules at
spindle poles (1.76 ± 0.55X) which was not observed using CRISPR tagging (Fig. 5.6 C,
D). The results obtained from the fixed and stained cells are more similar to cells
overexpressing Eg5 (Gable et al., 2012). We then wondered if these differences might be
a result of the method used and therefore looked for differences in spindles between the 2
techniques. On average spindles were significantly shorter (9.96 ± 0.87 μm; CRISPR vs.
5.91 ± 0.98 μm; IF) and they were shorter in Z (Fig. 5.4C). These differences might be
attributed to the differences we observe between the two methods.

5.2.5 Redistribution of Eg5 and TPX2 are distinct in anaphase
Next, we quantified the dynamics and distribution of Eg5 and TPX2 as cells
progressed through mitosis using time lapse imaging of cells expressing either Eg5-EGFP
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or TPX2-EGFP. Cells were observed starting at anaphase onset when fluorescence of
both proteins appears to decrease in the spindle midzone (Fig. 5.7). Analysis of the
fluorescence intensity within the spindle midzone as anaphase progresses revealed that
Eg5 redistributes to the midzone before TPX2 (Fig. 5.7 B, D). In fact, TPX2 remains
accumulated at spindle poles throughout anaphase and showed only minimal
redistribution to the midzone compared to Eg5 (Fig. 5.7C). This distinct distribution
further suggested that Eg5 and TPX2 have different regulation and function in anaphase.

5.2.6 Eg5 but not TPX2 is found on overlapping microtubules
Eg5 generates outward force on overlapping antiparallel microtubules (Kapitein et
al., 2005; Shimamoto et al., 2015), and this action is thought to be critical to maintain
spindle length and bipolarity (Ferenz et al., 2009a). In vitro, TPX2 regulates Eg5 activity
by acting as a brake, causing motors to slow on microtubules (Balchand et al., 2015).
Because both proteins localize to spindle microtubules, the data suggest that Eg5’s
activity would be inhibited by TPX2 on spindle microtubules, preventing the generation
of outward forces.
To understand how TPX2 regulates Eg5, the distribution of Eg5 and TPX2 in the
region of the spindle where overlapping microtubules are present was examined
(Mastronarde et al., 1993; McIntosh and Landis, 1971; Polak et al., 2017). To do this we
took advantage of cells with spindles oriented perpendicular (90°) to the coverslip
surface. We acquired Z-stacks of these perpendicular spindles and asked if Eg5 and/or
TPX2 co-localized with microtubules in the mid-region of the spindle (between sets of Kfibers) (Fig. 5.8A). As expected, discrete puncta of microtubules in both metaphase and
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anaphase cells (Fig. 5.8 B, C, Fig. 5.9) were detected in the 1.32 μm region in the spindle
midplane. These microtubule puncta were generally organized in a circle consistent with
the distribution of chromosomes on the periphery of the spindle at metaphase (Magidson
et al., 2011). Z-planes away from the midplane contained microtubule bundles that were
considerably brighter, consistent with kinetochore fibers which contain on average 17
microtubules (Simunic and Tolic, 2016; Tolic, 2017; Wendell et al., 1993).
Imaging of Eg5-EGFP CRISPR modified cells revealed that Eg5-EGFP was also
present in the mid-region of both metaphase and early anaphase spindles (Fig. 5.8 B, C,
Fig. 5.9 A, B) and further that these Eg5 puncta were present in a distribution that
overlapped with the microtubule distribution (Fig. 5.8 B, C, Fig. 5.9 A, B). In the
midplane of TPX2-EGFP CRISPR modified cells, however, fluorescent puncta above
background fluorescence levels were rare for both metaphase and later anaphase cells.
Moreover, TPX2 puncta that could be detected did not match the microtubule distribution
except at the cell periphery (Fig. 5.8 B, C, Fig. 5.9 A, B). These few visible puncta at the
cell periphery are likely part of long microtubules originating from the poles or K-fibers
where TPX2 and Eg5 were both detected (Fig. 5.8 B, C). These results suggest that TPX2
is not significantly localized to regions of microtubule overlap. This result supports the
hypothesis that Eg5 is active on overlapping antiparallel microtubules in the midzone and
is not subject to inhibition by TPX2 in this location.

5.2.7 Absolute Protein Concentrations using Quantitative Fluorescence Microscopy
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One of the advantages of endogenous tagging is that we can address relative
protein accumulation as well as measure protein concentration both locally and globally
in vivo (Wu and Pollard, 2005).
A major function of Eg5 is to drive centrosome separation during prophase;
consistent with this function, Eg5 is detected at the centrosome (Blangy et al., 1995;
Eibes et al., 2017; Gable et al., 2012; Rapley et al., 2008). Z-stacks of prophase Eg5EGFP CRISPR modified cells were collected using spinning disc confocal microscopy
and fluorescence of the whole cell vs. the centrosomes was determined (methods). For
centrosome measurements, we chose an area ~2 μm (2.08 μm) in diameter centered on
each centrosome (Area = 3.4 μm2) with a height between 2-5 μm based on the number of
z-steps needed to encompass all the centrosome fluorescence. This volume was similar in
dimensions to the size of the total functioning centrosome which includes centrioles, and
pericentriolar material (Alieva and Uzbekov, 2016). On average, the fluorescence of the
centrosome, as defined here, is only ~2% (2.25 ± 1.18%) of the total cell fluorescence.
We therefore determined the relative accumulation at the centrosomes and compared it to
the entire cell by calculating their fluorescence per area (μm2) (Fig. 5.5D). On
centrosomes, Eg5 is ~7.5X (7.6 ± 1.94X) concentrated relative to the whole cell (Fig.
5.5D).
We then determined the local concentration of Eg5 at the centrosome. For this, we
used cells with a known number of GFP molecules in a defined structure. We therefore
imaged HeLa cells stably expressing Hec1-EGFP using identical conditions as our
CRISPR modified cells. Knowing that there are 244 Hec1-EGFP molecules per
kinetochore (Suzuki et al., 2015) we were able to measure the average total fluorescence
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for Hec1-EGFP spots and convert fluorescence intensities to number of molecules (Fig.
5.10 A, B). We found that the concentration of Eg5 at a prophase centrosome to be ~4
μM (4.08 ± 1.93 μM) (Fig. 5.10C; methods). This is significantly concentrated compared
to the whole cell Eg5 concentration of ~2 μM (1.97 ± 0.45 μM) (Fig. 5.10C). Similar
calculations can be performed for other sub-regions of the mitotic cell to gain insight into
local concentrations of mitotic proteins.
TPX2 is also detected at prophase centrosomes in animal cells (Eibes et al., 2017;
Ma et al., 2011) and at the nuclear periphery in plant cells. Recent work shows that this
pool of TPX2 contributes to Eg5 localization to prophase centrosomes (Eibes et al.,
2017). However, given the bright nuclear signal of TPX2, which typically overlaps the
centrosome signal, the enrichment of TPX2 at prophase centrosomes was not measured.
Regulation of Eg5 is only one of the many functions of TPX2 in mitosis and
therefore one would expect that it is more abundant than Eg5 but this has never been
quantified. Using our Hec1-EGFP standard, and the volume of an average HeLa cell
(methods) we determined that TPX2 is significantly more concentrated in mitosis
compared to Eg5 (3.14 μM vs. 1.97 μM respectively).
Finally, we asked how much Eg5 and TPX2 were on the spindle itself. We
therefore measured the relative local accumulation of TPX2 and Eg5 on the spindle by
comparing their respective fluorescence intensities (Figure 5.11). On average, there is
~3.5X more TPX2 than Eg5 on the spindle (Figure 5.11A). However, our live cell data
suggest that the localization of these proteins change throughout mitosis. Therefore, we
measured the relative local accumulation of TPX2 and Eg5 throughout mitosis and found
that while Eg5 levels remain relatively constant early in mitosis (Figure 5.11 B,C), TPX2
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is significantly higher early in mitosis compared to later stages (Figure 5.11 B,C) and
remains significantly higher than Eg5 by the spindle poles. Taken together this suggests
that there is spatial regulation of Eg5 by TPX2.

5.3 Discussion

5.3.1 Advantages and Disadvantages of CRISPR Tagging
Our data show that using CRISPR tagging provides insight into protein
distribution in mitosis and that the values obtained differ from prior work using either
BACs or immunofluorescence (Figures 5.2, 5.6) (Gable et al., 2012). These data
highlight the differences in information gathered due to technical limitations. As others
have argued, CRISPR and other endogenous tagging methods prevent overexpression
artifacts (Dambournet et al., 2014; Doyon et al., 2011). More specifically, overexpression
of TPX2 is a marker for many cancers as well as results in abnormal spindle phenotypes
(Gruss et al., 2002; Neumayer et al., 2014). Additionally, because CRISPR modifications
are permanent and specific, the chances of a plasmid integrating into unwanted places in
the genome or being lost as cells divide is reduced.
Despite the value of using endogenous tagging, it may not be feasible to use this
approach in all cases. For example, despite the fact that generating CRISPR tagged cells
is becoming more straightforward, it is time consuming, and making cells with multiple
tags could be limited by the availability of selectable markers. Additionally, examining
the distribution of several different proteins following deletion, or deletion/replacement
approaches would be more complicated. For example, many essential mitotic proteins
were discovered using screens for defective phenotypes when they were absent or
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inhibited (Goshima et al., 2007; Neumann et al., 2010; Zhu et al., 2005). For these and
other essential proteins, CRISPR cannot be used for permanent knock-outs otherwise the
cells would have irregularities that would ultimately affect their survival. Inducible
knock-outs could be used as an alternative strategy to permanent deletion in a cell line
(McKinley and Cheeseman, 2017); however, these too have their limitations. Therefore,
testing the effects of specific perturbations regarding essential proteins would require a
variety of different CRISPR lines with appropriate modifications.
In our experiments we used CRISPR modified cell lines that were heterozygotes
(Fig. 5.3B). One drawback of this approach is the possibility that the tagged and
untagged versions of the protein are not equivalent and thus not present in equal amounts
in cellular structures. In addition, differential allele expression has been seen in human
cells (Knight, 2004) and appears to be the case in our CRISPR modified TPX2 clones
(Fig. 5.3C) where the amount of tagged and untagged protein are not equivalent. We
assumed that even though there appears to be differential allele expression that both the
tagged and untagged versions were present in cellular structures without any bias.
However, this assumption needs to be validated by additional experimentation.
Alternatively, having all copies of the protein tagged could also be deleterious due
to potential interference by the tag, and this could impact cellular processes. Prior work
in genetically tractable systems has shown that proteins with GFP tags can complement
deletion of the endogenous protein suggesting that the tag has little or no effect on cells.
However, there are cases where the tag can affect a cellular process. Perhaps the best
example is tubulin, in which cells that express high levels of GFP-tubulin are not viable
or have shortened spindles. In yeast, GFP-TUB1 tagged cells display normal dynamics
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and growth but only if there is a mixture of tagged and untagged TUB1 (Maddox et al.,
1999; Straight et al., 1997). The same is seen in mammalian cells where tubulin
translation is regulated by the cytoplasmic level of tubulin (Yen et al., 1988); thus when
tubulin is expressed from a plasmid, the total level of tubulin is regulated by the cell
(Goodson et al., 2010; Rusan et al., 2001). These examples provide strong evidence that a
tag can affect cellular processes and therefore limiting the amount may be necessary in
some cases, supporting the use of heterozygotes. In order to test this hypothesis,
homozygous CRISPR modified clones would need to be made, characterized and
compared to heterozygotes.

5.3.2 TPX2 is not present at sites where Eg5 is acting
Using cells with tags at the endogenous locus, our results provide new insight into
the regulation of Eg5 by TPX2. Prior work demonstrated that TPX2 reduces the motility
of Eg5 on microtubules in vitro (Balchand et al., 2015; Ma et al., 2011). This result has
been difficult to reconcile with the requirement for active Eg5 during spindle assembly
and maintenance (Kapoor et al., 2000; Mayer et al., 1999; Sawin and Mitchison, 1995).
Our results show that Eg5 is present on regions of the spindle where overlapping
antiparallel microtubules are located, consistent with the active force generation at this
location (Shimamoto et al., 2015). In contrast, TPX2 was barely detected above
background in this region, even though the protein was 4X more enriched on the spindle
than Eg5. Thus the data suggest at sites where Eg5 is active, TPX2 is not detectable.
Consistent with this idea comes from or prophase data. As mentioned, in most
cells, kinesin-5 activity is required for bipolar spindle formation; therefore, it was not
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surprising to find a high local concentration of Eg5 at spindle poles (Fig. 5.10C; Fig.
5.5D). Though TPX2 has been shown to localize to the centrosomes in prophase (Eibes et
al., 2017; Ma et al., 2011) it is potentially not as concentrated or has a different
distribution allowing Eg5 to accumulate and be active.
In contrast to these regions where we observed a difference in localization of
these proteins, both TPX2 and Eg5 were prominently localized to the half spindle,
between the kinetochores and spindle pole, consistent with numerous reports
(Cheerambathur et al., 2008; Gable et al., 2012; Garrett et al., 2002; Gruss et al., 2002;
Sawin et al., 1992; Sawin and Mitchison, 1995; Wittmann et al., 2000). By measuring
the fluorescence of microtubules the data show that TPX2, but not Eg5 is enriched
relative to microtubules near spindle poles. The relatively uniform distribution of Eg5 is
somewhat unexpected, as other work has reported that it is enriched at spindle poles and
further, Eg5 has been reported to be transported poleward by dynein (Gable et al., 2012;
Uteng et al., 2008). In yeast, kinesin-5 family members move toward the minus ends,
and accumulate in the region between kinetochores and spindle poles (Goldstein et al.,
2017; Roostalu et al., 2011; Tytell and Sorger, 2006). Eg5 is highly dynamic with a short
dwell time on microtubules (Gable et al., 2012). This rapid binding and unbinding
behavior may counteract poleward transport or plus end directed motility, resulting in this
even distribution.

5.3.3 In vivo quantification of Eg5 and TPX2 levels in mitosis
Eg5 and TPX2 are both cell cycle regulated with levels increasing in S and G2,
remaining high in M, and dropping in G1 (Gruss et al., 2002; Uzbekov et al., 1999;
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Venere et al., 2015). Previous work showed that Eg5 and TPX2 are specifically
ubiquitinated and degraded by the anaphase-promoting complex as cells exit mitosis
(Stewart and Fang, 2005; Venere et al., 2015). Our data show that the levels do not
appear to significantly decrease as cells progress through mitosis, but rather remain
constant even through late anaphase (Fig. 5.5 A, B, C). It is possible that the methods
used account for these differences and because we are imaging single cells live we are
better able to detect subtle differences that a bulk assay cannot.
The ability to observe single cells live provided us the ability to correlate
fluorescence to protein amount (Wu and Pollard, 2005). Knowing the concentrations and
stoichiometries of proteins helps provide insight into how biological processes form and
change as well as form the basis for modeling. Given that TPX2 is a multifunctional
microtubule associated protein it is perhaps not surprising that it is present at a ~4x
higher relative level than Eg5 on the spindle and ~1.5x more concentrated as a whole
(Fig. 5.2E, Fig. 5.10D). Additionally, the fraction of each EGFP tagged protein is not
particularly high on the spindle (Fig. 5.5B), which was also not unexpected, given that
these are dynamic proteins in vivo (Gable et al., 2012; Ma et al., 2010).
Mammalian cells are more complex than yeast making them more challenging to
quantify. Additionally, unlike yeast which have a reliable, endogenously tagged EGFP
standard for comparison (Joglekar et al., 2006; Lawrimore et al., 2011), the mammalian
cell standard does not have an endogenous tag (Suzuki et al., 2015). Therefore, it is
subject to potential cellular problems like those mentioned above (section 5.3.1). Despite
these potential problems, determining the protein amount in vivo both locally and
globally is needed in the mammalian field. Our cells are potentially an improvement on
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the mammalian standard due to the endogenous tag. In the future, this technique could be
useful not only for quantifying other mitotic proteins but for analyzing targeting
mechanisms and asking how specific proteins change after perturbations.

5.4 Materials and Methods

5.4.1 Materials
All chemicals, unless otherwise specified, were purchased from Sigma-Aldrich.

5.4.2 CRISPR gene editing
EGFP or FKBP-EGFP tags were added to the C-terminus of human TPX2, Eg5,
and HURP using methods described previously (Sheridan and Bentley, 2016; StewartOrnstein and Lahav, 2016). In brief, repair cassettes containing either EGFP or FKBPEGFP linked to a cleavable peptide (T2A) followed by a selectable marker (Neomycin)
were cloned and used for PCR reactions. Each also encoded for Glycine-Alanine linkers
between proteins. Guide sequences were selected using the CRISPR design tool
(http://crispr.mit.edu/) from the Zhang lab at MIT (Ran et al., 2013). The parameters used
were: “other regions” and the human target genome (hg19). We then had the tool search
for guides close to the C-terminus of the protein of interest (~100nt surrounding and
including the stop codon). Top and bottom oligos were obtained for each guide (Table
5.1) with the bases 5’-CACC -3’added to the top oligo and 5’-AAAC-3’ added to the
complement of the bottom oligo.
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Table 5.1 Guide RNAs (PAM)
Target Protein

Guide RNAs 5’-3’

TPX2

TGCGGATACCGCCCGGCAAT(GGG)

Eg5

AGGTTGATCTGGGCTCGCAG(AGG)

HURP

ACTTTTTCACCTCTACAACC(AGG)

Guides were cloned into a Cas9 containing plasmid (PX459) obtained from
Addgene (Cambridge, MA) (#62988) following methods previously outlined (Moyer and
Holland, 2015). Briefly, top and bottom oligos were annealed and then phosphorylated by
T4 PNK (NEB, Ipswich, MA). Guides were then cloned into PX459 that was cut using
BbsI (NEB, Ipswich, MA) and ligated using T4 ligase (NEB Ipswich, MA). Guide-Cas9
containing plamids were then sequenced using the U6 promotor primer (Ran et al., 2013)
and purified using either endotoxin free mini-preps or midi-preps according to
manufacturer protocol (Promega, Madison, WI).
Repair cassettes were amplified using primers designed to be homologous to the
C-terminal genomic DNA surrounding the STOP codon (Table 5.2). In all cases, the
guide target sequence was mutated to prevent Cas9 from recognizing the repair cassette
and described previously (Moyer and Holland, 2015).
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Table 5.2 Oligonucleotides Used
Protein

Repair Cassette PCR Primers 5’-3’

TPX2 F

GTACCAGGGTCTGGAGATAAAGTCAAGTGACCAGCCTCTGACTGTGCCTGT
ATCTCCCAAATTCTCCACTCGATTCCACTGCGGAGCTGGTGCAGGCG

TPX2 R

CTATCGCCTTCTTGACGAGTTCTTCTAAACTCAGCTGTGAGCTGCGGATA
CCGCCCGGCAATGCGACCTGCTCTTAACCTCAAACCTAGGACCGTCTTG

Eg5 F

CACTGGAGAGGTCTAAAGTGGAAGAAACTACAGAGCACTTGGTTACAAAG
AGCAGATTACCACTCCGTGCGCAGATTAACCTTGGAGCTGGTGCAGGCG

Eg5 R

CTATCGCCTTCTTGACGAGTTCTTCTAATTCACTTGGGGGTTGGCAATTT
TATTTTTAAAGAAAACTTAAAAATAAAACCTGAAACCCCAGAACTTGAGC

HURP F

GACATCAAGAACATGCCAGACACATTTCTTTTGGTGGTAACCTGATTACTT
TTTCTCCTCTTCAGCCTGGTGAATTTGGAGCTGGTGCAGGCG

HURP R

CTATCGCCTTCTTGACGAGTTCTTCTGAATTTAAAAATAAATCCAAACA
TTTTCCTTCATATTATCAATGCTTATATATTCCTTAGACTATTGAAATTT

Protein

Genomic DNA PCR Primers 5’-3’

TPX2 F

GTGACTGGGACCTGTAAAACTC

TPX2 R

CTACCCGTGCCTGAGAAAG

Eg5 F
Eg5 R
GFP R

GAAGGCATTTGGCGCTAC
CTTGAGCCCAGGAGTTTG
CTACAACAGCCACAACGTC

Primer
Eg5 F
Eg5 R
Cassette F
Cassette R

Knock-Sideways, Gibson Assembly Primers 5’-3’
CTTATGGCCATGGAGGCCCGAATTCGGATGGCGTCGCAGCCAAATTC
CGCCTGCACCAGCTCCAAGGTTGATCTGGGCTCG
CGAGCCCAGATCAACCTTGGAGCTGGTGCAGGCG
CATGTCTGGATCCCCGCGGCCGCTCAGAAGAACTCGTCAAGAAGGC

Protein
Eg5

siRNA 5’-3’
CUGAAGACCUGAAGACAAU

Cells were grown in DMEM medium (ThermoFisher Scientific) with 10% Fetal
bovine serum (FBS, Atlanta Biologicals, Flowery Branch, GA) and 0.5X

169

antibiotic/antimycotic solution (final concentrations 50 U/mL penicillin, 0.05 mg/mL
streptomycin, 0.125 ug/mL amphotericin B; Sigma-Aldrich, St. Louis, MO) at 37 C and
5% carbon dioxide (CO2). For long term storage cells were frozen in DMEM medium
with 5% FBS and 0.5X antibiotic/antimycotic solution and held at -80C for 1-2 days
before moving to liquid nitrogen.
Parental HeLa Cells were nucleofected using an Amaxa Nucleofector (Lonza,
Portsmouth, NH) program I-013 and Mirus nucleofection reagent (Mirus Bio LLC,
Madison, WI) according to the manufacturers recommendations. Plasmids and Repair
cassettes were used at ratio of 1:1 at a concentration of 1 μg DNA each. Following
nucleofection, cells were grown in regular growth media in 100mm dishes for 48-72 Hrs
and then 0.2g/L Neomycin/G418 (InvivoGen, San Diego, CA) selection media was
added. Media was then changed daily for 10-14 days and then colonies of green, CRISPR
positive, cells were picked using cloning rings and returned to regular media for further
screening and experiments.

5.4.3 Genotyping
Genomic DNA was isolated from clonal CRISPR tagged cells using the DNeasy
Blood and Tissue Kit (Qiagen, Valencia, CA) according to manufacturers
recommendations. DNA was then amplified by PCR using genomic primers (Table 5.2)
targeting the C-terminus of each protein, the GFP tag, and downstream of the Stop codon
(Fig. 5.3). KOD polymerase (MilliporeSigma, St. Louis, MO) was used to amplify 2 μL
of isolated genomic DNA in a 20 μL reaction for 35 cycles. Extension times were varied
based on primer combinations and products were analyzed using 1% agarose gel
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electrophoresis. PCR Products of clones that produced bands of expected sizes were
purified using a PrepEase DNA clean-up kit (USB Corporation, Cleveland, OH) and
sequenced to verify proper integration of the tag.

5.4.4 Western Blotting and Quantification
Cell extracts of clonal CRISPR tagged cells were prepared by adding 1X SDS
Sample buffer to cells grown to confluency in 35 mm dishes. Samples were boiled for 5
minutes and run on either an 8 or 10% SDS polyacrylamide gels using the formulation of
Laemmli (Laemmli, 1970). Gels were transferred onto Amersham Hybond-P membrane
(GE Healthcare, Waukesha, WI). Blots were probed with Eg5, TPX2 or Hec1 antibodies
(Novus Biologicals, Littleton, CO) used at 1:1000 (Eg5 and TPX2) and 1:200 (Hec1) for
1 h at room temperature in 5% non-fat dry milk dissolved in Tris buffered saline
containing 0.02% Tween-20 (TBS-Tween). Blots were then probed using goat anti-rabbit
HRP conjugated secondary antibody (Eg5 and TPX2) and goat anti-mouse HRP
conjugated secondary antibody (Hec1) (Jackson Immunoresearch Laboratories, Inc.)
(1:5000) for 1 hr at room temperature in 5% non-fat dry milk dissolved in TBS-Tween
and blots were imaged using chemiluminescence.
To quantify the levels of tagged and untagged protein in each sample from clonal
cell populations, densitometry was used (Fiji). The total protein level was determined by
adding the total fluorescence in each lane. The amount of tagged and untagged protein
was calculated as a percentage of this total amount.

5.4.5 Knock-Sideways (Rapamycin-induced Dimerization)
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Proteins were tagged on the C-terminus with an FKBP and an EGFP tag in either
a plasmid (Eg5) or at the endogenous locus (DHC; see CRISPR gene editing methods).
Cloning Eg5, FKBP, and EGFP into a Clonetech Laboratories (Mountain View, CA)
expression vector (pCMV-Myc) was done using Gibson Assembly. Cloning was
designed to mimic the endogenous tag in CRISPR modified cells (CRISPR gene editing
methods) including a 10AA (Gly-Ala) linker between the C-terminus of Eg5 and FKBP.
Eg5 and FKBP-EGFP-T2A-Neomycin cassette were amplified by PCR (Table 5.2). The
Eg5 was made resistant to siRNA as described previously (Bickel et al., 2017).
The siRNA resistant pCMV-Myc-Eg5-FKBP-EGFP construct was nucleofected
into mCherry-Tubulin expressing LLC-Pk1 cells as previously described (Bickel et al.,
2017). With the help of Dr. Amy Burnside, GFP and mCherry positive cells were sorted
by flow cytometry. These cells were then maintained as described previously (Bickel et
al., 2017). Cells were then co-nucleofected with Eg5 siRNA (Table 5.2) obtained from
Dharmacon (GE Healthcare Life Sciences, Pittsburgh, PA) and a membrane targeted
FRB-BFP construct that was provided by Dr. Linda Wordeman and used previously for
knock-sideways experiment (Wordeman et al., 2016). For knock-sideways experiments
with DHC-FKBP-EGFP CRISPR modified HeLa cells, only the FRB-BFP construct was
nucleofected as described above (CRISPR gene editing methods). Following
nucleofection, cells were plated on mattek dishes and imaged ~24 hrs later.

5.4.6 Cell Fixation and Immunofluorescence
HeLa cells were rinsed twice with room temperature PBS lacking calcium and
magnesium and were then fixed for 10 minutes in 3.2% paraformaldehyde, 0.1%
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glutaraldehyde, and 0.5% Triton X 100, made fresh daily in PBS lacking calcium and
magnesium. Fixed cells were rinsed in PBS containing 0.02% TWEEN-20 and 0.02%
sodium azide (PBS-Tw-Az), treated with sodium borohydride (10mg/10mL H2O) for 10
minutes and then rehydrated in PBS-Tw-Az.
The following antibodies were used: tubulin, DM1α mouse anti-tubulin (SigmaAldrich) or YL1/2 rat anti-tubulin (Accurate Chemical and Scientific Corporation,
Westbury, NY), Eg5 rabbit polyclonal (Novus Biologicals, Littleton, CO), TPX2 rabbit
polyclonal (Novus Biologicals, Littleton, CO) and appropriate secondary antibodies as
previously described (Avunie-Masala et al., 2011). Primary antibodies were mixed with
2% BSA in PBS-Tw-Az to block non-specific binding and used at the following final
dilutions: Eg5 and TPX2 1:1,000, DM1α and YL1/2 1:100; cells were incubated in
primary antibodies for 1 hour at 37°C. Stained cells were mounted on glass slides using
DAPI Fluomount G (Southern Biotech, Birmingham, AL) to stain DNA.

5.4.7 Microscopy
1-2 days prior to imaging, cells were plated on Mattek glass bottom dishes
(Mattek Corporation, Ashland, MA). Before imaging, cells were transferred to imaging
(non CO2) media lacking phenol red (Collins et al., 2014) and maintained on the
microscope in an Okolab UNO (Burlingame, CA) environmental chamber set to 37C.
For z-stacks, cells were imaged on a Nikon Ti-E microscope with a CSU-X1
Yokogawa spinning-disk confocal scan head (PerkinElmer, Wellesley, MA), an Andor
iXon+ electron-multiplying charge-coupled device camera (Andor), and a 100×/1.4 NA
objective lens. Z-step size was set at 0.33 μm to optimize signal collected but not

173

oversample. Z-steps were taken relative to the bottom of the cell for a total Z-stack of 25
μm (77 steps) for live cells and 20 μm (62 steps) for fixed cells. In order to ensure cells
did not photobleach prior to imaging, mitotics were identified using Phase Contrast and
the focus was dropped below the cell before imaging began.
Laser powers and exposures were chosen to ensure that the sum of the fluorescent
signal would not be saturated. For cells expressing EGFP tags, images were acquired
using a 488nm laser at 20% power and 750 msec exposure. For cells also expressing
mCherry tags (Tubulin) images were taken using a 561 laser at 32% power with 500ms
exposure. For cells with far-red tags (SiR Tubulin, DRAQ5), images were acquired using
a 640 laser at 20% power and 750 msec exposure. When 2 colors were imaged, each
color was acquired before moving up in z. In the case of DRAQ5 (DNA marker), a single
image was acquired following the 488 z-stack of the corresponding cell.
Timelapse images were acquired using a CSU-10 Yokogawa spinning-disk
confocal scan head on a Nikon TE300 as previously described (Tulu et al., 2003). Images
were acquired every minute with an exposure of 1000 msec and 4x4 binning.
To quantify mitotic phenotypes of fixed cells, a Nikon Eclipse Ti with an X-Cite
series 120Q excitation light source, and a 100 X, 1.3 N.A., objective lens, was used.
Mitotic phenotypes were classified by spindle morphology based on microtubule staining
as bipole, multipole, monopole, or disorganized. Disorganized spindles included spindles
with extra foci, fragmented poles, short spindles, no pole, and bent spindles.
For knock-sideways experiments, a Nikon A1R point scanning confocal
microscopy with 60X/1.4 NA objective was used. Cells expressing the membrane bound
FRB-BFP “trap” were found using epifluorescence and a Violet excitation block BFP
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filter. Eg5-FKBP-GFP, mCherry Tubulin expressing LLC-Pk1 cells were then imaged for
GFP and mCherry to determine spindle phenotypes following Rapamycin treatment. For
time-lapse imaging of DHC-FKBP-GFP CRISPR modified HeLa cells, only the GFP
signal was acquired and cell positions were marked using XY positioning in NIS
elements.

5.4.8 Image Analysis
Analysis was performed in Fiji (Image J) (Schindelin et al., 2012). Sum intensity
projections of z-stacks were created for single or double colors. For whole cell
Fluorescence Intensity, images were background subtracted using a region of the same
size from a z-stack of parental HeLa cells imaged using identical conditions. For
background-corrected fluorescence intensity on the spindle, a region within a region
background subtraction was used. This was done by manually drawing a region around
the spindle and then a concentric larger region around the spindle, encompassing the
spindle and surrounding cytoplasm. Then using the formulas: Background signal =
(Integrated Fluorescence Intensity big area – Integrated Fluorescence Intensity small
area)⁄(Area big

– Area small). Total Intensity = Integrated Fluorescence Intensity small area –

(Background signal × Area small) (Ye et al., 2015), fluorescence intensity was calculated.
Cells were grouped according to cell stage (identified using DRAQ5 to label DNA). In
order to account for untagged protein in the cell, following background subtraction,
fluorescence values were adjusted based on the amount of tagged and untagged protein
determined to be in the clonal population (Fig. 5.3).
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For local accumulation, the fluorescence of the whole cell was measured by
drawing a freehand shape around the cell and then background subtracted using the
region within a region method described above. The total fluorescence was then divided
by the area, which resulted in the total fluorescence per unit area (μm2). A smaller region
was drawn around the centrosome within the cell and the same region was used for
background subtraction. This total fluorescence was also divided by the area, which
resulted in the total fluorescence per unit area (μm2). Finally, the ratio of the fluorescence
per area of the centrosome to the fluorescence per area of the whole cell was calculated.
For absolute levels, Hec1-EGFP expressing HeLa cells were imaged under the
same conditions as the CRISPR modified Eg5 and TPX2 cells and served as a standard.
Using a subset of the acquired z-slices that included all the fluorescence present in the
kinetochores, circles were drawn around single kinetochores in a sum projection image,
background subtracted and adjusted for untagged protein to determine the total
fluorescence intensity. There are 244 molecules of Hec1 at the kinetochore (Suzuki et al.,
2015). Therefore, the number of molecules of either Eg5 or TPX2 could be calculated
using a ratio comparing their fluorescence to Hec1. To further determine the
concentrations of each, number of molecules was converted to Molarity using an
approximate volume of a HeLa cell (3000 μm3) (Puck et al., 1956; Zhao et al., 2008)
and/or the volume of a cylinder that contained all of the centrosome fluorescence.
For relative levels, boxes of 5 x 5 pixels were drawn on the GFP Sum intensity
projections; measured areas include the spindle pole, the spindle midzone, and a
background area outside the spindle but in the cytoplasm. Boxes were drawn in the
corresponding places on the Tubulin (mCherry or SiR) sum projection using the ROI
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manager. Integrated Fluorescence Intensity was measured and background subtracted.
Ratios were then made between regions (pole:midzone) in each color and then a ratio of
the ratio was taken to compare the GFP-tagged proteins to Tubulin.
These images were also used for line scans. Using the line tool, a line was drawn
from pole-to-pole with a width of 50 pixels and 100 pixels for background subtraction.
All of the spindle lengths were then normalized to the smallest spindle length and the
fluorescence intensities were normalized to 1 to account for the difference in intensity
between fluorescent channels.
Line scans were also used to determine the dynamics of TPX2 and Eg5. Lines
were drawn both perpendicular to and through the pole-to-pole axis of the spindle
(through the spindle midzone) and at each time interval. The fluorescence intensities
were normalized to 1 to account for differences in expression and corresponding
fluorescence between Eg5 and TPX2-EGFP.

5.4.9 Live Cell Labeling and Inhibitors
SiR tubulin (Cytoskeleton, Denver, CO), used at a concentration of 50 nM in
combination with 10 μM Verapamil, was added between 30-90 min prior to imaging.
MG132 was used at a concentration of 10 μM for 90 minutes. In experiments with both
MG132 and SiR Tubulin, they were added to cells at the same time and both were
washed out after 90 min by transferring cells to non-CO2 media for imaging. DRAQ5
(Thermo Fisher Scientific) was used at 1 μM and was added to cells just before imaging
(~1-5 min). For knock-sideways, 200nM Rapamycin was added to imaging media.
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Figure 5.1 Rapamycin re-localizes Eg5 producing monopolar spindles and relocalizes Dynein to membranes in minutes. (A) Diagram of Knock-sideways method in
LLC-Pk1 cells expressing siRNA-resistant Eg5-FKBP-GFP. (B) Images of Eg5-FKBPGFP (green), Microtubules (red), Membrane targeted FRB-BFP (Trap; Blue) in cells with
and without 200nM Rapamycin after 30 minutes. (C) Diagram of Knock-sideways in
HeLa DHC-FKBP-GFP CRISPR modified cells. (D) Time-lapse images of DHC-FKBPGFP before and after addition of 200nM Rapamycin. Time in min:sec:msec. Marker bar
= 10 μm.
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Figure 5.2 Eg5 and TPX2 are concentrated at spindle poles in metaphase, but only
TPX2 is concentrated relative to microtubules. (A) Diagram of CRISPR strategy. (B)
Sum intensity projections of endogenous GFP-tagged proteins: Eg5 (top), TPX2 (middle)
and HURP (bottom) in live cells arrested at metaphase using MG132. Cells were either
expressing mCherry-Tubulin or labeled with 50nM SiR Tubulin ~30 min prior to imaging
to stain microtubules. (C) Line scans of spindles; GFP-tagged protein (green) and tubulin
(red) (see methods). (D) Ratio of spindle poles:midzone for each GFP-tagged protein
(green) and tubulin (red); the ratio of poles:midzone of each protein:tubulin (yellow). (E)
Relative, background subtracted (methods) Total Fluorescence Intensity for Eg5 (blue)
and TPX2 (red) on a spindle in a cell arrested at metaphase using MG132. Amounts were
adjusted to account for untagged protein. Error bars = St Dev. Marker bar = 10 μm.
****p≤0.0001. n= 8 each.
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Figure 5.3 Generation and characterization of CRISPR cell lines. (A) Schematic
diagram of DNA modified by CRISPR (top) and unmodified (lower) for Eg5 (top) and
TPX2 (lower). (B) Genotyping of Eg5 (left) and TPX2 (right) CRISPR cell clones
showing fragment size from genomic DNA and sequence analysis; yellow stars show
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bands of correct size and the clones that were sequenced. (C) Quantification of EGFPtagged and untagged proteins for Eg5 (top) and TPX2 (bottom) clones by Western Blot;
quantification of blots shown below. Additional TPX2 blot showing tagged and
untagged protein levels remain constant as passage number increases (bottom right) (D)
Quantification of band intensity for Eg5 (blue) and TPX2 (red) from titration western
blots. Linear trend lines, equations, and R2 shown. (E) Eg5 (blue) and TPX2 (red)
CRISPR modified cells display normal mitotic phenotypes compared to parental HeLa
cells (gray).
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Figure 5.4 Only TPX2 is enriched relative to microtubules along K-fibers (A) Eg5EGFP and TPX2-EGFP are enriched to the same extent at poles relative to the midzone
in cells with and without Tubulin labeling. (B) Ratio of spindle poles:K-fiber for each
GFP-tagged protein (green) and tubulin (red); the ratio of poles:K-fiber of each
protein:tubulin (yellow). (C) Fixation for immunofluorescence results in spindle
shrinking. Bar graph of length from pole-pole for live CRISPR cells compared to
Immuofluorescence (left). Example images of Z distance from live CRISPR cells and
Immunofluorescence (right). Error bars = St Dev. ****p≤0.0001.
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Figure 5.5 Relative amounts of Eg5 and TPX2 throughout mitosis. (A) Comparison
of Eg5 (blue) and TPX2 (red) total Fluorescence levels on the spindle through mitosis.
(B) Total Fluorescence Levels of TPX2 (top) and Eg5 (bottom) of the whole cell (dark
colors) relative to the spindle (light colors) through mitosis; stages were identified using
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DRAQ5. (C) As length increases the total fluorescence of TPX2 (red, top) and Eg5 (blue,
bottom) on the spindle remain constant. Diagrams in A, B and C show region of the cell
(whole cell or spindle) that was used for measuring fluorescence; all images were
background subtracted. (D) Relative local concentration of Centrosomes vs. Whole cell.
Box plot of the ratio of the Integrated Fluorescence Intensity per unit area.
Whiskers define the range, boxes encompass the 25th to 75th quartiles, and lines depict
the medians. Diagram representing Eg5 fluorescence distribution in a Prophase cell
(right). Note that on average Eg5 is ~7.6X concentrated on centrosomes relative to the
whole cell. Marker bars = 10 μm. Error Bars = St Dev.

Figure 5.6 Immunofluorescence and CRISPR quantification differ. (A) Sum Intensity
Projections of Parental cells arrested at metaphase using MG132, fixed and stained for αTubulin (green) and either Eg5 (top) or TPX2 (bottom) (red). (B) Line scans of immunostained spindles; Eg5 (top) a TPX2 (bottom) (green) and tubulin (red). (C) Ratio of
spindle poles:midzone for Eg5 and TPX2 (green) and tubulin (red); the ratio of
poles:midzone of Eg5/TPX2:Tubulin (yellow). (D) Comparison of the ratio of
poles:midzone of Eg5:Tubulin for CRISPR and Immunofluorescently labeled cells. Error
bars = St Dev. Marker bar = 10 μm. *p≤0.05 (p=0.025). n=8 Eg5, n=6 TPX2.
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Figure 5.7 Distinct distribution of Eg5 and TPX2 throughout mitosis. (A) Time-lapse
images of Eg5 and TPX2 from metaphase (0:00) through anaphase. (B) Schematic
diagram and representative line scans perpendicular to pole-to-pole axis of Eg5 (blue)
and TPX2 (red). Vertical lines indicate when protein begins to repopulate the midzone.
(C) Box plot of spindle poles:midzone ratios for Eg5 (blue) and TPX2 (red) through
different stages of mitosis. Whiskers define the range, boxes encompass the 25th to 75th
quartiles, and lines depict the medians. (D) Line scans through the pole-to-pole spindle
axis at indicated timepoints for Eg5 (blue) and TPX2 (red); schematic diagram of
spindles. Note that Eg5 accumulates on interzonal microtubules before TPX2. Time in
min:sec. Marker bar = 10 μm.
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Figure 5.8 Eg5, but not TPX2, localizes to the spindle midzone in metaphase and
anaphase. (A) Schematic diagram of image acquisition and images of slices (0.33 μm)
through metaphase (left) and anaphase (right) spindles oriented at 90° relative to the
coverslip surface. (B) Sum projections of 1.32 μm total through the midzone (top) and
kinetochore fibers (bottom) of metaphase spindles in CRISPR modified cells. Top rows
Eg5, lower rows TPX2. SiR Tubulin was used as a microtubule marker. Right images
show zoomed in area in the middle of the spindle. Schematic diagrams (left) show where
sum projections were made. (C) Anaphase cells, imaged as in A. Top rows Eg5, lower
rows TPX2. Marker bars = 10 μm and 2 μm (zoom).
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Figure 5.9 Eg5 is enriched in the spindle midzone relative to TPX2 at metaphase
and anaphase. (A) Series of Z-slices through the middle of MG132 arrested metaphase
spindles in GFP-tagged CRISPR cells oriented 90° from the surface of the coverslip; Eg5
(top) and TPX2 (bottom). Tubulin was stained using SiR Tubulin (methods). (B) Series
of Z-slices through the middle of Anaphase cells imaged as in A. YZ images (right) show
microtubules and length of spndle. Z-slices = 0.33μm. Marker bar = 10 μm.
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Figure 5.10 In vivo concentration of Eg5 and TPX2. (A) Sum projection image of
Hec1-EGFP expressing cell using a subset of planes from a z-stack (left); cartoon shows
location of Hec1 spots in a spindle. Western Blot showing expression level of GFP
tagged vs. untagged Hec1 in cells (right). (B) Box plot of total fluorescence of Eg5 at the
prophase centrosome (purple) compared to Hec1-EGFP (pink); left. Box plot of the
number of GFP molecules of Eg5 at the prophase centrosome (purple) compared to 1
GFP molecule (pink), calculated based on 244 Hec1 molecules in a kinetochore (Suzuki
et al., 2015); right. (C) Box plot of the Eg5 concentration (μM) at the prophase
centrosome (purple) vs. the whole cell (blue). (D) Box plot of the whole cell
concentrations (μM) of Eg5 (blue) and TPX2 (red). Whiskers define the
range, boxes encompass the 25th to 75th quartiles, and lines depict the medians. Marker
bar in A = 10 μm. ****p≤0.0001.
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Figure 5.11 Relative amounts of Eg5 and TPX2 on the mitotic spindle. (A) Average,
background subtracted (methods) Total Fluorescence Intensity per μm3 for Eg5 (blue)
and TPX2 (red) on a spindle close to the pole. (B) Max projection examples of Eg5 and
TPX2 EGFP cells at different stages of mitosis (left); Quantification of the relative,
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background subtracted Total Fluorescence intensity per μm3 for Eg5 (blue) and TPX2
(red) on a spindle close to the pole at different mitotic stages (right). (C) Cartoon
demonstrating the change in relative fluorescence on the spindle as mitosis progresses.
The scale is shown bottom right. Amounts were adjusted to account for untagged protein.
Marker bar in B = 10 μm. ****p≤0.0001.
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